Query         tr|A0A075B6V7|A0A075B6V7_HUMAN
Match_columns 20
No_of_seqs    1 out of 3
Neff          1
Searched_HMMs 92111
Date          Thu Dec 14 08:45:54 2023
Command       /home/ec2-user/data/hhsuite/bin/hhsearch -i tmp/0514.a3m -cpu 2 -d /home/ec2-user/data/pdb70/pdb70 

 No Hit                             Prob E-value P-value  Score    SS Cols Query HMM  Template HMM
  1 5YAX_A scFv1 antibody, Large e  93.2    0.17 1.8E-06   22.1   1.7   14    6-19    233-246 (246)
  2 5YAX_B scFv1 antibody, Large e  93.2    0.17 1.8E-06   22.1   1.7   14    6-19    233-246 (246)
  3 6TYL_J Resistance to inhibitor  93.2   0.082 8.8E-07   21.0   0.6   14    7-20    108-121 (131)
  4 3LRG_A anti-huntingtin VL doma  92.2    0.15 1.6E-06   19.9   0.7   13    7-19    101-113 (121)
  5 4HGM_A shark V-NAR, serum albu  91.9     0.3 3.3E-06   18.1   1.4   13    7-19     91-103 (112)
  6 2I26_N New Antigen Receptor An  91.6    0.24 2.6E-06   22.7   1.2   12    8-19    101-112 (121)
  7 4H1L_G HLA class II histocompa  91.6    0.27 2.9E-06   17.9   1.1   14    7-20    100-113 (113)
  8 2I24_N New Antigen Receptor PB  90.6     0.3 3.3E-06   19.2   0.9   14    7-20    100-113 (121)
  9 2I25_N New Antigen Receptor PB  90.6     0.3 3.3E-06   19.2   0.9   14    7-20    100-113 (121)
 10 6APO_A Anti-Marburgvirus Nucle  90.0    0.36 3.9E-06   18.4   0.9   12    8-19    106-117 (126)
 11 6KNM_A Apelin receptor, Single  90.0    0.72 7.8E-06   16.9   1.6   11    9-19    118-128 (129)
 12 2D7T_L anti polyhydroxybutyrat  89.9    0.35 3.8E-06   18.9   0.8   13    6-18     94-106 (116)
 13 3TF7_C H2-Ld SBM2, QL9, 42F3 M  89.2    0.44 4.8E-06   21.1   0.9   14    7-20    235-248 (256)
 14 3TF7_K H2-Ld SBM2, QL9, 42F3 M  89.2    0.44 4.8E-06   21.1   0.9   14    7-20    235-248 (256)
 15 7L56_H Spike glycoprotein, Fab  89.1    0.39 4.2E-06   17.9   0.6   14    6-19    115-128 (129)
 16 6CUE_N PGT122 Heavy chain, PGT  87.9     0.8 8.6E-06   16.4   1.1   12    8-19     96-107 (107)
 17 6MPG_n A12V163-b.01 Light Chai  87.9     0.8 8.6E-06   16.4   1.1   12    8-19     96-107 (107)
 18 6WDT_H viral protein 1, viral   87.6    0.97 1.1E-05   16.4   1.3   13    8-20    114-126 (126)
 19 5U64_B VHH-28; neutralizing an  87.5    0.67 7.3E-06   18.2   0.8   13    7-19    115-127 (137)
 20 6NN3_H Capsid protein 2, antib  87.5    0.67 7.2E-06   16.6   0.8   12    7-18    110-121 (121)
 21 6NB6_I Spike glycoprotein, S23  87.1     1.1 1.2E-05   16.1   1.3   12    8-19    115-126 (127)
 22 7EAK_F heavy chain of 5G3 fab;  87.1     1.2 1.4E-05   15.3   1.4   11    8-18    101-111 (112)
 23 4M62_H GEP2 FV light chain, GE  86.6     1.2 1.3E-05   16.3   1.3   13    7-19    114-126 (127)
 24 4W6X_B FedF lectin domain (res  85.9       2 2.2E-05   16.9   1.8   13    7-19    112-124 (131)
 25 4AJ0_A GERMINAL LINE LAMBDA 3   85.6     1.8   2E-05   16.4   1.6   12    8-19     96-107 (107)
 26 3JBD_7 Capsid protein VP1, Cap  85.3       1 1.1E-05   17.2   0.9   14    7-20    107-120 (126)
 27 3OMZ_A human Vdelta1 gamma del  85.2     1.2 1.3E-05   19.6   1.1   14    6-19    236-249 (259)
 28 3OMZ_C human Vdelta1 gamma del  85.2     1.2 1.3E-05   19.6   1.1   14    6-19    236-249 (259)
 29 7D3K_H O/TIBET/99 VP1, O/TIBET  84.9     1.6 1.7E-05   15.7   1.2   14    7-20    111-124 (124)
 30 7LZP_B Single domain antibody,  84.9     1.9   2E-05   16.3   1.5   13    7-19    122-134 (135)
 31 6NIJ_H PGT145 Fab heavy chain,  84.6     1.1 1.2E-05   17.8   0.8   13    6-18    126-138 (140)
 32 6U59_J SOSIP.664 gp120, SOSIP.  84.5     1.6 1.7E-05   15.5   1.1   12    7-18    100-111 (112)
 33 7SOE_B kappa, spike, antibody,  84.3     1.2 1.3E-05   16.1   0.8   12    8-19    113-124 (125)
 34 7EOW_B von Willebrand factor,   84.3     1.7 1.8E-05   17.4   1.3   13    7-19    116-128 (137)
 35 7CWS_N Heavy Chain of FC05 Fab  84.3     1.2 1.3E-05   15.8   0.8   11    8-18    110-120 (120)
 36 7E5R_P Complex, Antibody, VIRU  84.3     1.2 1.3E-05   15.8   0.8   12    7-18    109-120 (120)
 37 6K3M_A Protein A, 3LRH intrabo  84.2     1.2 1.3E-05   18.1   0.8   13    7-19    121-133 (135)
 38 6K64_A Protein A, 3LRH intrabo  84.2     1.2 1.3E-05   18.1   0.8   15    6-20    120-134 (135)
 39 7SPP_C RBD, VIRAL PROTEIN, VNA  84.1     1.6 1.7E-05   16.6   1.1   13    7-19     98-110 (117)
 40 7N5H_E SARS-CoV-2, Viral Spike  84.0     1.7 1.8E-05   15.9   1.1   12    8-19    116-127 (128)
 41 6MTJ_E Envelope glycoprotein g  83.9     1.5 1.6E-05   17.2   1.1   13    7-19     99-111 (114)
 42 6MU8_E Envelope glycoprotein g  83.9     1.5 1.6E-05   17.2   1.1   13    7-19     99-111 (114)
 43 6MUF_E Envelope glycoprotein g  83.9     1.5 1.6E-05   17.2   1.1   13    7-19     99-111 (114)
 44 7CN2_H The light chain variabl  83.9     1.2 1.3E-05   15.8   0.6   13    7-19    107-119 (120)
 45 7CN2_M The light chain variabl  83.9     1.2 1.3E-05   15.8   0.6   12    7-18    107-118 (120)
 46 2PXY_A T cell receptor alpha c  83.8     1.9 2.1E-05   15.7   1.2   14    7-20    101-114 (114)
 47 6CNW_A SD84h; single domain an  83.7     1.9 2.1E-05   16.2   1.3   12    8-19    104-115 (116)
 48 4HGK_D Serum albumin, V-NAR; I  83.6     1.5 1.7E-05   17.1   1.0   13    7-19    108-120 (128)
 49 7LX5_A Spike glycoprotein, WNb  83.6     1.8 1.9E-05   15.6   1.1   12    8-19    111-122 (123)
 50 7NQA_C Nup98, Nanobody, comple  83.6     1.5 1.6E-05   15.7   0.9   13    7-19    111-123 (124)
 51 7NQA_D Nup98, Nanobody, comple  83.6     1.5 1.6E-05   15.7   0.9   13    7-19    111-123 (124)
 52 4KV5_E Transforming growth fac  83.6     1.8   2E-05   19.1   1.3   14    6-19    232-245 (252)
 53 4B50_A 2H10 LLAMA VHH; IMMUNE   83.4     1.6 1.8E-05   15.5   1.0   12    8-19    110-121 (122)
 54 1FO0_A MURIN ALLOREACTIVE SCFV  83.4     2.2 2.3E-05   15.7   1.3   14    7-20    103-116 (116)
 55 5IVN_A BC2-nanobody, Cadherin-  83.3     1.6 1.7E-05   16.5   0.9   12    8-19    110-121 (131)
 56 7B17_B Spike glycoprotein, Neu  83.1     1.7 1.8E-05   20.3   1.2   14    7-20    252-265 (283)
 57 4UDF_7T HUMAN PARECHOVIRUS 1 C  83.0     1.8 1.9E-05   15.4   1.0   12    7-18    110-121 (122)
 58 3IY0_H Fab 14, xray structure   83.0     1.5 1.6E-05   15.5   0.8   13    7-19    107-119 (120)
 59 1KB5_B KB5-C20 T-CELL ANTIGEN   83.0     1.9 2.1E-05   15.9   1.1   14    6-19    104-117 (117)
 60 1KJ2_B Allogeneic H-2Kb MHC Cl  83.0     1.9 2.1E-05   15.9   1.1   14    6-19    104-117 (117)
 61 6VPX_L Envelope glycoprotein g  82.8     1.9 2.1E-05   15.3   1.1   12    8-19     97-108 (108)
 62 5J57_B Ricin (E.C.3.2.2.22), V  82.6     1.3 1.4E-05   16.4   0.6   15    5-19    110-124 (127)
 63 1MOE_A anti-CEA mAb T84.66; an  82.6     1.5 1.6E-05   19.0   0.9   13    7-19    227-239 (240)
 64 4K3G_A L5(L89S); immunoglobuli  82.5     1.2 1.3E-05   16.9   0.5   13    7-19     97-109 (118)
 65 4K3H_H L5(L89S); immunoglobuli  82.5     1.2 1.3E-05   16.9   0.5   13    7-19     97-109 (118)
 66 1MFA_H FV FRAGMENT (MURINE SE1  82.5     1.5 1.6E-05   15.4   0.7   13    7-19    105-117 (120)
 67 2A9N_H anti-glycoprotein VI im  82.4     1.7 1.9E-05   15.8   0.9   13    6-18    113-125 (126)
 68 6U59_K SOSIP.664 gp120, SOSIP.  82.3       2 2.2E-05   15.1   1.0   12    8-19    107-118 (119)
 69 1FO0_B MURIN ALLOREACTIVE SCFV  82.3     1.4 1.5E-05   16.1   0.6   12    7-18    101-112 (112)
 70 5UJZ_G Hemagglutinin HA1, Hema  82.2     1.1 1.2E-05   20.2   0.4   15    6-20    238-252 (266)
 71 5KEM_G BDBV91 variable Fab dom  82.2    0.72 7.8E-06   16.6  -0.2   12    6-17    110-121 (121)
 72 7K22_H4 8A7H5 Fab light chain,  81.9     2.3 2.5E-05   14.8   1.1   11    8-18    106-116 (117)
 73 7K23_H2 8A7H5 Fab light chain,  81.9     2.3 2.5E-05   14.8   1.1   11    8-18    106-116 (117)
 74 6J9O_H Heavy chain of AF4H1K1   81.7     2.8   3E-05   15.3   1.4   14    7-20    117-130 (130)
 75 5VM4_L Single domain camelid n  81.6     2.8 3.1E-05   17.2   1.5   12    7-18    118-129 (137)
 76 5VM6_A single domain camelid n  81.6     2.8 3.1E-05   17.2   1.5   13    7-19    118-130 (137)
 77 7ME7_A SARS-CoV-2 Receptor bin  81.6     1.7 1.9E-05   15.4   0.7   13    7-19    106-118 (119)
 78 6VN0_K Envelope glycoprotein g  81.3     2.3 2.5E-05   15.5   1.1   11    8-18     96-106 (107)
 79 7A6O_B Thrombosis Von Willebra  81.2       3 3.3E-05   15.4   1.4   13    7-19    115-127 (128)
 80 4LAS_H Single chain antibody f  81.2     1.9 2.1E-05   20.0   1.0   12    7-18    228-239 (249)
 81 7N65_K HIV-1 Envelope, superin  81.0     3.8 4.1E-05   15.1   1.6   12    8-19    116-127 (128)
 82 7AZB_B Discoidin domain-contai  80.9       3 3.3E-05   16.4   1.4   13    7-19    131-143 (153)
 83 5YY5_D MERS-CoV RBD, Heavy cha  80.7     1.6 1.8E-05   14.9   0.5   11    7-17     95-105 (105)
 84 6J14_B GY-14 heavy chain V fra  80.6     2.5 2.7E-05   15.2   1.0   12    7-18    100-111 (112)
 85 6MPG_M A12V163-b.01 Light Chai  80.6     2.3 2.5E-05   15.9   1.0   10    9-18    121-130 (132)
 86 6RBB_H VHH domain; VHH, antibo  80.6       2 2.1E-05   15.4   0.8   13    7-19    110-122 (123)
 87 7SHU_E IgE, omalizumab, xolair  80.6       2 2.2E-05   15.2   0.8   11    9-19    111-121 (123)
 88 7NQK_B proton-coupled peptide   80.5     2.2 2.4E-05   15.8   0.9   14    6-19    116-129 (131)
 89 3J8V_I L1, H16.14J light chain  80.4     2.4 2.6E-05   14.9   0.9   11    8-18    108-118 (119)
 90 6MN7_I Envelope Glycoprotein g  80.3     3.1 3.4E-05   18.0   1.4   13    6-18    223-235 (236)
 91 1I3V_B Antibody VHH lama domai  80.3     2.7   3E-05   15.4   1.1   13    7-19    116-128 (129)
 92 7JV2_L S2H13 Fab heavy chain,   80.3     4.1 4.5E-05   14.9   1.6   13    7-19     98-110 (110)
 93 6VN0_H Envelope glycoprotein g  80.3     1.9 2.1E-05   15.8   0.7   14    6-19    112-125 (126)
 94 6VN0_I Envelope glycoprotein g  80.3     1.9 2.1E-05   15.8   0.7   14    6-19    112-125 (126)
 95 2YC1_D SINGLE CHAIN ANTIBODY F  80.2     2.8   3E-05   14.4   1.1   12    8-19    105-116 (117)
 96 3E3Q_C TCR, MHC, high affinity  80.0     3.9 4.2E-05   14.3   1.8   13    7-19     97-109 (109)
 97 7LPN_D CD4, HIV-1, SOSIP, Vacc  79.8     2.4 2.7E-05   16.0   0.9   13    7-19    108-120 (130)
 98 6NB3_H Spike glycoprotein, LCA  79.7     2.3 2.5E-05   15.3   0.8   13    7-19    114-126 (127)
 99 6U53_A Anti-Zaire ebolavirus N  79.5     2.8 3.1E-05   15.4   1.1   12    8-19    102-113 (123)
100 7LXW_H S2X333 Fab Light Chain   79.3     2.1 2.3E-05   15.2   0.6   11    8-18    111-121 (121)
101 7LXY_G Spike glycoprotein, S2M  79.3     2.1 2.3E-05   15.2   0.6   12    7-18    110-121 (121)
102 7EO0_H FOOT AND MOUTH DISEASE   79.3     2.8 3.1E-05   15.5   1.0   13    8-20    117-129 (129)
103 5VLV_A Single Domain Camelid N  79.1     2.2 2.4E-05   16.9   0.7   12    8-19    114-125 (132)
104 5YOY_P Tumor necrosis factor,   79.1     2.6 2.8E-05   15.3   0.9   13    7-19    116-128 (129)
105 5YOY_Q Tumor necrosis factor,   79.1     2.6 2.8E-05   15.3   0.9   13    7-19    116-128 (129)
106 5O02_C Viral protein 1, Nanobo  79.1     4.2 4.5E-05   14.5   1.4   13    7-19    111-123 (124)
107 5JA9_A Toxin HigB-2, Nanobody   78.4     2.5 2.8E-05   16.1   0.8   12    7-18    104-115 (123)
108 5N88_A VH59 antibody, PC4 and   78.2     2.7 2.9E-05   15.2   0.8   11    8-18    115-125 (126)
109 4FFY_L DENV1-E111 single chain  77.9     4.3 4.7E-05   15.3   1.4   13    7-19     99-111 (126)
110 4UU9_H MEDI7814, COMPLEMENT C5  77.8     3.2 3.5E-05   14.6   0.9   12    7-18    111-122 (123)
111 5VM0_B Camelid Nanobody VHH T9  77.7       5 5.4E-05   14.5   1.5   12    8-19    114-125 (128)
112 6DZM_J Envelope glycoprotein,   77.7     3.3 3.5E-05   14.5   0.9   12    7-18    108-119 (120)
113 6VLR_F Envelope glycoprotein g  77.7     2.6 2.8E-05   15.1   0.7   12    8-19    111-122 (123)
114 2X89_C ANTIBODY, BETA-2-MICROG  77.6     3.5 3.8E-05   15.2   1.0   13    7-19    115-127 (128)
115 7OMN_C VH domain, EphA1, IMMUN  77.5     3.2 3.5E-05   14.9   0.9   11    9-19    114-124 (125)
116 7E53_B Aequorea victoria, Came  77.4       4 4.4E-05   14.9   1.2   12    8-19    116-127 (128)
117 4JVP_A Anti-HCV E2 alpaca nano  77.2     3.7   4E-05   16.2   1.1   13    7-19    116-128 (143)
118 3JBF_7 Capsid protein VP1, Cap  77.2     3.2 3.5E-05   16.4   0.9   11    8-18    109-119 (127)
119 7SOB_H kappa, spike, antibody,  77.1     4.9 5.3E-05   14.7   1.4   13    7-19    113-125 (128)
120 7SOB_N kappa, spike, antibody,  77.1     4.9 5.3E-05   14.7   1.4   12    8-19    114-125 (128)
121 6LI3_N G-protein coupled recep  77.1     2.3 2.5E-05   16.2   0.5   11    8-18    139-149 (149)
122 7EVW_N GPCR, Class F, Frizzled  77.1     2.3 2.5E-05   16.2   0.5   11    8-18    139-149 (149)
123 6VPX_H Envelope glycoprotein g  77.0     2.3 2.5E-05   15.7   0.5   12    7-18    118-129 (129)
124 7JOO_K anti-kappa VHH, STIM003  77.0     3.1 3.3E-05   15.6   0.8   12    8-19    109-120 (121)
125 5KEL_M Ebola surface glycoprot  77.0     3.4 3.7E-05   14.6   0.9   10    9-18    111-120 (121)
126 5KEN_J Ebola surface glycoprot  77.0     3.4 3.7E-05   14.6   0.9   11    8-18    110-120 (121)
127 5W3L_G viral protein 1, viral   76.8     3.8 4.1E-05   14.5   1.0   12    7-18     95-106 (107)
128 1FGV_H FV FRAGMENT OF A HUMANI  76.7     3.7   4E-05   14.6   1.0   11    9-19    113-123 (124)
129 2OI9_B Major Histocompatibilit  76.7     5.6 6.1E-05   14.3   1.5   13    7-19     98-110 (113)
130 7L6V_C neurotoxin, enzyme inhi  76.6     4.4 4.8E-05   14.7   1.2   13    7-19    114-126 (127)
131 4UNU_B IG LAMBDA CHAIN V-II RE  76.5     5.1 5.6E-05   13.8   1.4   12    8-19    100-111 (111)
132 5ACM_A MCG; IMMUNE SYSTEM, MCG  76.5     5.1 5.6E-05   13.8   1.4   12    8-19    100-111 (111)
133 3E3Q_F TCR, MHC, high affinity  76.4     3.8 4.2E-05   15.8   1.1   14    7-20     98-111 (111)
134 6J14_A GY-14 heavy chain V fra  76.3     3.7 4.1E-05   14.4   0.9   13    7-19    107-119 (120)
135 3NN8_A scFv; beta barrel, anti  76.3     3.1 3.4E-05   14.7   0.7   12    8-19    110-121 (122)
136 3NN8_C scFv; beta barrel, anti  76.3     3.1 3.4E-05   14.7   0.7   13    7-19    109-121 (122)
137 7K7H_H Typhoid Toxin, A2B5, An  76.2       5 5.4E-05   14.0   1.3   12    8-19    106-117 (118)
138 7CWS_D Heavy Chain of FC05 Fab  76.1     3.9 4.3E-05   15.1   1.0   13    7-19     93-105 (107)
139 7MEP_H Immune complex, monoclo  75.9     4.1 4.4E-05   14.9   1.0   12    8-19    117-128 (129)
140 7KN5_C Spike protein S1, VHH E  75.8     4.4 4.7E-05   14.9   1.1   13    7-19    116-128 (129)
141 4C57_C CYCLIN-G-ASSOCIATED KIN  75.8     6.2 6.7E-05   15.3   1.6   13    7-19    109-121 (141)
142 4C57_D CYCLIN-G-ASSOCIATED KIN  75.8     6.2 6.7E-05   15.3   1.6   13    7-19    109-121 (141)
143 1XIW_D T-cell surface glycopro  75.7     4.5 4.9E-05   14.3   1.1   12    8-19    110-121 (122)
144 1KXV_C ALPHA-AMYLASE, PANCREAT  75.6     4.2 4.6E-05   14.4   1.0   13    7-19    108-120 (121)
145 1KXV_D ALPHA-AMYLASE, PANCREAT  75.6     4.2 4.6E-05   14.4   1.0   12    7-18    108-119 (121)
146 4U3X_C Human VH domain antibod  75.3     3.9 4.3E-05   14.4   0.9   13    7-19    108-120 (121)
147 6SXI_B Fab heavy chain, Fab li  75.0     3.2 3.5E-05   16.0   0.7   11    7-17     98-108 (108)
148 2APT_B T-cell receptor beta ch  74.9     4.5 4.9E-05   15.2   1.1   12    8-19    101-112 (112)
149 7N8H_C coronavirus, antibody,   74.7     3.7   4E-05   14.5   0.7   12    7-18    109-120 (121)
150 6K65_H Protein A, 3LRH intrabo  74.5     5.4 5.8E-05   13.8   1.1   13    7-19    100-112 (113)
151 4RZC_D Fv M6P-1 light chain ;   74.5     4.1 4.4E-05   14.6   0.9   12    8-19     99-110 (112)
152 7BUF_H SIgN-3C IgG heavy chain  74.4     5.5   6E-05   15.1   1.2   12    8-19    120-131 (132)
153 2E27_L anti-ciguatoxin antibod  74.2     5.6 6.1E-05   14.5   1.2   13    7-19     97-109 (119)
154 3IY2_B antibody fragment; cryo  74.2       4 4.3E-05   14.0   0.8   11    8-18    100-110 (111)
155 6NIU_F Zika Virus Envelope pro  74.2     4.8 5.2E-05   14.2   1.0   13    7-19    107-119 (120)
156 7V3I_G VIRUS, complexed, antib  74.1     4.4 4.8E-05   14.8   0.9   10    9-18    117-126 (127)
157 7NKT_BBB Surface glycoprotein,  74.1     4.7 5.1E-05   16.2   1.1   13    7-19    112-124 (144)
158 5KEL_D Ebola surface glycoprot  74.0     4.3 4.6E-05   15.2   0.9   11    8-18     96-106 (107)
159 2X1Q_B GELSOLIN NANOBODY; CONT  74.0     5.5   6E-05   14.4   1.2   12    8-19    115-126 (127)
160 6IBB_B Succinate receptor 1, N  73.9     5.3 5.8E-05   15.7   1.2   13    7-19    123-135 (142)
161 6RNK_B Succinate receptor 1, N  73.9     5.3 5.8E-05   15.7   1.2   13    7-19    123-135 (142)
162 4OB5_H 4E10 antibody germline   73.7     6.1 6.6E-05   14.3   1.3   13    7-19    114-126 (127)
163 7BYR_H Spike glycoprotein, Ab2  73.6     4.3 4.6E-05   14.5   0.8   10    9-18    115-124 (126)
164 5T93_A ALT-05 immunoglobulin l  73.4     5.3 5.8E-05   13.7   1.0   12    8-19     99-110 (110)
165 7N9C_E CovS NB21 nanobody, VIR  73.1     5.1 5.6E-05   16.4   1.1   12    7-18    129-140 (155)
166 7SHZ_E IgE, omalizumab, xolair  72.9     4.6   5E-05   14.4   0.8   12    8-19    110-121 (123)
167 6MPH_H DF1W-a.01 heavy chain,   72.8     3.7   4E-05   14.3   0.5   13    7-19    105-117 (118)
168 6FYS_F Single domain antibody   72.6     5.8 6.3E-05   14.6   1.1   11    9-19    118-128 (129)
169 6FYW_C Hemagglutinin, Hemagglu  72.6     5.8 6.3E-05   14.6   1.1   11    9-19    118-128 (129)
170 6J5D_H Envelope, antibody heav  72.6     4.5 4.9E-05   14.1   0.8   13    7-19    107-119 (120)
171 6VPX_P Envelope glycoprotein g  72.5     5.6 6.1E-05   15.0   1.1   13    7-19    121-133 (134)
172 6JB9_A Nanobody D3-L11; nanobo  72.4     5.9 6.4E-05   14.6   1.1   13    7-19    115-127 (128)
173 6FPV_A Nanobody; nanobody, JBP  72.4     4.4 4.8E-05   16.8   0.8   12    7-18    131-142 (154)
174 7D5Q_C Drug transporter, putat  72.3     6.5 7.1E-05   14.6   1.2   15    5-19    116-130 (131)
175 1I3U_A Antibody VHH lama domai  72.1     4.6   5E-05   14.7   0.7   12    7-18    116-127 (127)
176 5DHV_H Anti-Rev Antibody Fab s  71.8     6.7 7.3E-05   13.5   1.1   13    7-19    104-116 (117)
177 5DHY_H Anti-Rev Antibody Fab s  71.8     6.7 7.3E-05   13.5   1.1   13    7-19    104-116 (117)
178 5C1M_B Mu-type opioid receptor  71.7       8 8.7E-05   13.8   1.4   14    6-19    108-121 (125)
179 7VYT_H Antibody, Immune Checkp  71.4       4 4.4E-05   14.4   0.5   12    8-19    110-121 (122)
180 7LUC_I Fusion glycoprotein F0,  71.4       6 6.6E-05   15.0   1.0   11    8-18    101-111 (112)
181 7D3M_H O/TIBET/99 VP1, O/TIBET  71.3     5.2 5.7E-05   18.5   1.0   12    8-19    155-166 (167)
182 7D3R_H A/WH/CHA/09 VP1, A/WH/C  71.3     5.2 5.7E-05   18.5   1.0   11    9-19    156-166 (167)
183 5DFW_H CD81 antigen, SINGLE CH  71.2     6.1 6.6E-05   17.6   1.2   13    6-18    230-242 (243)
184 4CDG_D BLOOM SYNDROME PROTEIN   71.2     4.9 5.4E-05   15.7   0.8   12    7-18    128-139 (147)
185 6J9O_L Heavy chain of AF4H1K1   71.1     6.2 6.7E-05   14.5   1.0   12    8-19     96-107 (108)
186 1OL0_B IMMUNOGLOBULIN G; IMMUN  70.9     5.5   6E-05   13.9   0.8   13    7-19    108-120 (121)
187 7RA8_G SARS-CoV-2, Spike glyco  70.9     6.9 7.5E-05   13.5   1.1   12    8-19    102-113 (113)
188 6VUG_D Reverse transcriptase/r  70.9     5.1 5.5E-05   14.3   0.7   11    9-19    113-123 (124)
189 6RQM_B Cytotoxic T-lymphocyte   70.8     9.7 0.00011   15.3   1.6   13    7-19    115-127 (144)
190 7M1H_E VHH, protease domain, T  70.7     6.9 7.5E-05   14.0   1.1   13    7-19    113-125 (126)
191 3MOQ_D New antigen receptor va  70.6     6.5   7E-05   15.7   1.1   13    8-20    113-125 (126)
192 1A2Y_B COMPLEX (IMMUNOGLOBULIN  70.6     5.5   6E-05   13.6   0.8   11    9-19    105-115 (116)
193 6PCU_H Outer capsid protein VP  70.5     8.8 9.6E-05   16.5   1.5   17    4-20    236-252 (252)
194 6Q6Z_B Protein EDS1L, EDS1-spe  70.3     7.7 8.4E-05   15.2   1.3   14    6-19    109-122 (142)
195 6GJQ_F Cystic fibrosis transme  70.2     5.9 6.4E-05   16.3   0.9   12    8-19    109-120 (147)
196 6VO1_I Envelope glycoprotein g  70.2     6.7 7.3E-05   13.5   1.0   12    8-19    106-117 (118)
197 6IEC_C NSmGnGc, R17 H chain, R  70.1     4.4 4.7E-05   13.8   0.5    9    8-16    107-115 (115)
198 6ZKE_c NADH dehydrogenase [ubi  70.0     3.6 3.9E-05   23.8   0.4   16    2-17    153-168 (170)
199 6ZKQ_c NADH dehydrogenase [ubi  70.0     3.6 3.9E-05   23.8   0.4   16    2-17    153-168 (170)
200 1JV5_B Anti-blood group A Fv,   69.9     5.9 6.4E-05   13.7   0.8   11    8-18    106-116 (117)
201 6T2J_A Single domain antibody;  69.9     8.7 9.5E-05   13.5   1.4   12    8-19    108-119 (120)
202 4H1L_H HLA class II histocompa  69.8       4 4.3E-05   14.1   0.4   11    8-18    101-111 (111)
203 2XTJ_D PROPROTEIN CONVERTASE S  69.8     4.8 5.2E-05   15.3   0.6   13    7-19    118-130 (131)
204 5LWY_H Adiponectin receptor pr  69.8       7 7.6E-05   13.6   1.0   12    8-19    106-117 (119)
205 6Y0E_A Nanobody 22 LBM; Nanobo  69.8     5.5 5.9E-05   15.9   0.8   11    8-18    114-124 (132)
206 6Y0E_B Nanobody 22 LBM; Nanobo  69.8     5.5 5.9E-05   15.9   0.8   11    8-18    114-124 (132)
207 6CRK_H Guanine nucleotide-bind  69.8     6.1 6.6E-05   17.8   1.0   14    7-20    236-249 (259)
208 2P1Y_A bispecific alpha/beta T  69.6     5.9 6.4E-05   17.1   0.9   16    5-20    223-238 (238)
209 7B27_CCC Surface glycoprotein,  69.6     6.6 7.1E-05   15.5   1.0   13    7-19    109-121 (141)
210 6LHF_G MHC class I, Beta-2-mic  69.6     3.4 3.7E-05   14.4   0.1   11    8-18    102-112 (112)
211 7N9E_D CovS NB34 nanobody, VIR  69.4     8.9 9.7E-05   16.0   1.4   13    7-19    129-141 (155)
212 1N4X_I immunoglobulin kappa ch  69.4     6.8 7.4E-05   14.1   1.0   12    8-19    108-119 (120)
213 1NMB_H N9 NEURAMINIDASE, FAB N  69.3     9.1 9.9E-05   13.5   1.4   13    7-19    109-121 (122)
214 4YJZ_L influenza viral hemaggl  69.3     6.9 7.5E-05   17.9   1.1   13    7-19    242-254 (269)
215 4YQX_L JES6-1 VH domain, JES6-  69.3     7.6 8.3E-05   14.3   1.1   13    7-19    103-115 (118)
216 3B9V_C heavy chain variable do  69.2     6.6 7.1E-05   13.8   0.9   13    7-19    107-119 (120)
217 5Y80_B Cyclin-G-associated kin  69.1      10 0.00011   15.2   1.5   13    7-19    116-128 (148)
218 2OTU_A Fv light chain variable  69.0     4.6   5E-05   14.0   0.4   11    8-18    105-115 (115)
219 2OTW_C Fv light chain avriable  69.0     4.6   5E-05   14.0   0.4   11    8-18    105-115 (115)
220 1A14_L NEURAMINIDASE, SINGLE C  68.8       4 4.4E-05   15.0   0.3    9    8-16     96-104 (104)
221 7SOE_G kappa, spike, antibody,  68.8     4.9 5.3E-05   14.5   0.5   10    9-18     96-105 (105)
222 7JO8_B 47G4-CD828Z; Chimeric A  68.7     6.2 6.7E-05   14.7   0.8   13    7-19     96-108 (110)
223 6OL7_J glVRC01 Heavy Chain, gl  68.6     8.8 9.6E-05   14.6   1.2   11    8-18    102-112 (125)
224 6JRI_B Nanobody; Nanobody, the  68.6     6.4   7E-05   14.5   0.8   13    7-19    117-129 (130)
225 6JRI_F Nanobody; Nanobody, the  68.6     6.4   7E-05   14.5   0.8   13    7-19    117-129 (130)
226 6UZ1_I MHC class I antigen, A-  68.5     8.8 9.6E-05   13.6   1.2   13    8-20     97-109 (110)
227 6ZE1_B Cystic fibrosis transme  68.4     6.5   7E-05   16.1   0.9   13    7-19    108-120 (147)
228 1JTT_A Vh Single-Domain Antibo  68.3     8.4 9.2E-05   14.7   1.2   13    7-19    120-132 (133)
229 6K4Z_B scFv of C6; antigen bin  68.0       6 6.5E-05   17.2   0.8   11    9-19    236-246 (247)
230 1NMC_B NEURAMINIDASE, SINGLE C  68.0     9.3  0.0001   13.5   1.2   13    7-19    109-121 (122)
231 6IVZ_H Envelope protein, Heavy  67.9     3.8 4.1E-05   14.6   0.1    9    9-17    113-121 (121)
232 7JVB_D Spike glycoprotein, Nan  67.9       9 9.8E-05   13.2   1.1   11    8-18    105-115 (117)
233 1SVZ_A single-chain Fv fragmen  67.6     6.4 6.9E-05   17.1   0.8   11    9-19    236-246 (247)
234 7LUC_N Fusion glycoprotein F0,  67.5     7.7 8.3E-05   14.4   0.9   12    8-19    117-128 (129)
235 7LY2_G Spike glycoprotein, S2M  67.4     7.8 8.5E-05   13.3   0.9   10    9-18    107-116 (117)
236 1BWW_A REIV, STABILIZED IMMUNO  67.3     6.7 7.2E-05   14.6   0.8   11    8-18     98-108 (109)
237 5GS1_N light chain, heavy chai  67.1      10 0.00011   13.1   1.2   13    7-19    106-118 (124)
238 6TEJ_C Drug ABC transporter AT  67.0     7.7 8.4E-05   13.7   0.9   11    9-19    113-123 (124)
239 6U50_C Anti-Sudan ebolavirus N  66.8      11 0.00012   13.6   1.4   13    7-19    107-119 (120)
240 6U51_A Anti-Sudan ebolavirus N  66.8      11 0.00012   13.6   1.4   13    7-19    107-119 (120)
241 6IW2_E Envelope protein E, Hea  66.7     3.8 4.1E-05   14.5   0.0   10    8-17    111-120 (120)
242 6I2G_A ALFA nanobody, N7P-SER-  66.6     8.1 8.8E-05   13.6   0.9   12    8-19    112-123 (124)
243 2H3N_B VpreB protein/Ig lambda  66.6     9.2  0.0001   13.6   1.0   11    8-18      3-13  (117)
244 4YGA_B ?; Serine/Threonine Pro  66.5     8.2 8.9E-05   15.0   1.0   12    8-19    112-123 (141)
245 4YGA_H ?; Serine/Threonine Pro  66.5     8.2 8.9E-05   15.0   1.0   12    8-19    112-123 (141)
246 6OSV_L Variable domain of Ligh  66.5     8.3   9E-05   13.3   0.9   11    8-18    100-110 (111)
247 5CBA_C 3b4 heavy chain, 3b4 li  66.4     9.8 0.00011   14.9   1.2   13    7-19    114-126 (142)
248 5CBE_A E10 heavy chain, E10 li  66.4     9.8 0.00011   14.9   1.2   13    7-19    114-126 (142)
249 2Z35_A T-cell receptor alpha-c  66.2      11 0.00012   13.6   1.3   14    7-20     99-112 (112)
250 3ZHK_B MG2X1 SCAFFOLD ANTIBODY  66.2     9.1 9.9E-05   14.4   1.0   12    7-18    106-117 (127)
251 5I0Z_A catalytic DNA antibody;  66.1     8.3 9.1E-05   14.8   0.9   13    8-20    130-142 (143)
252 7Q9G_E SARS-CoV2, Spike, glyco  65.9      10 0.00011   13.4   1.1   12    8-19    107-118 (119)
253 6XRT_H Envelope glycoprotein g  65.7      10 0.00011   14.0   1.1   10    9-18    122-131 (133)
254 5C9K_G Amyloid lambda 6 light   65.7     9.6  0.0001   13.4   1.0   13    7-19     99-111 (111)
255 6DBD_B VHH R326; nanobody VHH   65.4     8.1 8.8E-05   14.5   0.8   11    8-18    104-114 (129)
256 1OAQ_H HEAVY CHAIN, LIGHT CHAI  65.4      12 0.00013   13.2   1.2   12    8-19    108-119 (121)
257 1QFW_M GONADOTROPIN ALPHA SUBU  65.3      10 0.00011   13.9   1.1   12    8-19     96-107 (108)
258 6ITP_B anti-cortisol camelid a  65.1     6.9 7.5E-05   14.3   0.6   12    8-19    115-126 (127)
259 6ITQ_A anti-cortisol camelid a  65.1     6.9 7.5E-05   14.3   0.6   12    8-19    115-126 (127)
260 7LXZ_I Spike glycoprotein, S2M  65.1     5.9 6.4E-05   13.5   0.4    9    8-16     98-106 (107)
261 6CVK_A PROTEIN; HEPATITIS B, S  65.0     9.3  0.0001   16.9   1.1   11    9-19    238-248 (261)
262 5U8R_H Insulin-like growth fac  65.0     9.4  0.0001   13.5   0.9   12    8-19    108-119 (126)
263 6VO0_H 43A2 light chain, 43A2   64.9     6.5   7E-05   14.1   0.5    9    8-16    112-120 (120)
264 6VO0_I 43A2 light chain, 43A2   64.9     6.5   7E-05   14.1   0.5    9    8-16    112-120 (120)
265 5IP4_B Neuronal migration prot  64.9      12 0.00012   14.0   1.2   12    8-19     99-110 (121)
266 4RZC_A Fv M6P-1 light chain ;   64.9     8.9 9.6E-05   14.7   0.9   12    8-19    107-118 (119)
267 4RZC_H Fv M6P-1 light chain ;   64.9     8.9 9.6E-05   14.7   0.9   11    8-18    107-117 (119)
268 7LUC_H Fusion glycoprotein F0,  64.9       8 8.7E-05   13.6   0.7   12    8-19    109-120 (121)
269 6OC8_A VHH8c; VHH heavy chain   64.8      11 0.00012   13.5   1.1   13    7-19    112-124 (125)
270 6OC8_B VHH8c; VHH heavy chain   64.8      11 0.00012   13.5   1.1   13    7-19    112-124 (125)
271 6Z2M_D Spike glycoprotein, Ant  64.8      12 0.00013   13.5   1.2   13    7-19    114-126 (127)
272 6SGE_B Rho-related GTP-binding  64.7      12 0.00013   13.8   1.2   13    7-19    112-124 (134)
273 2UZI_L ANTI-RAS FV HEAVY CHAIN  64.6     6.1 6.6E-05   14.1   0.4   10    7-16     94-103 (104)
274 3GKZ_A anti-methamphetamine si  64.1     8.6 9.3E-05   17.1   0.9   13    7-19    236-248 (257)
275 1KXQ_E alpha-amylase, pancreat  64.0     9.5  0.0001   14.2   0.9   12    8-19    108-119 (120)
276 1PEW_A Jto2, a LAMBDA-6 TYPE I  64.0      10 0.00011   13.8   1.0   12    8-19     97-108 (109)
277 3IY1_A Fab B; cryoEM, neutrali  63.6      13 0.00014   13.4   1.2   12    8-19     94-105 (107)
278 5TBD_A Fv fragment (mAb4D1) he  63.4      11 0.00012   13.3   1.0   12    8-19    102-113 (114)
279 1U3H_E T-cell receptor alpha-c  63.4      14 0.00015   13.4   1.3   11   10-20    100-110 (110)
280 6NM6_V Envelope glycoprotein g  63.3     8.7 9.5E-05   16.5   0.8   11    9-19     93-103 (122)
281 6LGW_C scFv 523-11 VH, scFv 52  63.1      10 0.00011   13.1   0.9   12    8-19    107-118 (119)
282 7LXW_L S2X333 Fab Light Chain   62.8     5.2 5.6E-05   14.1   0.1   10    8-17     91-100 (100)
283 7LXY_I Spike glycoprotein, S2M  62.8     5.2 5.6E-05   14.1   0.1    9    8-16     91-99  (100)
284 7N0R_C SARS-CoV-2, nanobody, n  62.8       9 9.8E-05   14.4   0.8   13    7-19    110-122 (134)
285 5IR3_A Ig lambda chain V-VI re  62.8      12 0.00013   13.4   1.0   12    8-19    100-111 (112)
286 1SQ2_N Lysozyme C (E.C.3.2.1.1  62.8      11 0.00012   14.6   1.0   13    6-18    100-112 (113)
287 1T6V_O Lysozyme C (E.C.3.2.1.1  62.8      11 0.00012   14.6   1.0   13    6-18    100-112 (113)
288 2A0L_E Voltage-gated potassium  62.8     6.7 7.3E-05   13.5   0.4    9    8-16     96-104 (105)
289 2UUD_H NQ10-1.12 ANTI-PHOX ANT  62.7      10 0.00011   13.1   0.8   11    9-19    110-120 (121)
290 1KB9_J UBIQUINOL-CYTOCHROME C   62.6      11 0.00012   13.4   0.9   11    9-19    111-121 (127)
291 3CX5_J Cytochrome b-c1 complex  62.6      11 0.00012   13.4   0.9   11    9-19    111-121 (127)
292 7A3Q_I VIRAL PROTEIN, FLAVIVIR  62.3      11 0.00012   14.7   1.0   11    9-19    119-129 (144)
293 7CTH_H Dengue virus, antibody,  62.3      11 0.00012   14.7   1.0   11    9-19    119-129 (144)
294 7SHY_C IgE, omalizumab, xolair  62.3      11 0.00012   13.2   0.9   12    8-19    110-121 (122)
295 6UZ1_J MHC class I antigen, A-  62.1      12 0.00013   13.0   1.0   12    8-19    103-114 (115)
296 7T3D_N anchor, antibodies, inf  62.0      10 0.00011   13.6   0.8   11    8-18     96-106 (107)
297 1FVC_D FV FRAGMENT OF HUMANIZE  61.9      11 0.00012   13.1   0.8   13    7-19    107-119 (120)
298 4OGA_C Insulin A Chain, Insuli  61.7      11 0.00012   13.0   0.9   13    7-19    105-117 (118)
299 1OHQ_A IMMUNOGLOBULIN; ANTIBOD  61.4      14 0.00015   12.8   1.1   12    8-19    108-119 (120)
300 7L6V_D neurotoxin, enzyme inhi  61.4      12 0.00013   13.7   1.0   12    8-19    110-121 (122)
301 3WUZ_A Paired immunoglobulin-l  61.3      15 0.00016   13.1   1.3   11    8-18    109-119 (120)
302 3DUR_D antibody Fv fragment SA  61.3      13 0.00014   12.9   1.0   13    7-19    108-120 (121)
303 5L6Q_B H5AL antibody; Antibody  61.0      14 0.00015   13.1   1.1   13    7-19     95-107 (115)
304 5HM1_C lama antibodyVHH 2E7, g  61.0      14 0.00015   13.6   1.1   10    9-18    109-118 (119)
305 1KJ2_A Allogeneic H-2Kb MHC Cl  60.9      15 0.00017   13.1   1.4   13    8-20     99-111 (111)
306 6CUE_q PGT122 Heavy chain, PGT  60.7      12 0.00013   15.3   1.0   11    8-18    118-128 (129)
307 6N1V_Q 17D4 Heavy chain, 17D4   60.7      12 0.00013   15.3   1.0   11    8-18    118-128 (129)
308 1BFV_H FV4155, ESTRIOL 3-(B-D-  60.6      11 0.00012   12.9   0.8   12    8-19    107-118 (119)
309 1CFV_H MONOCLONAL ANTIBODY FV4  60.6      11 0.00012   12.9   0.8   12    8-19    107-118 (119)
310 5A2J_H SCFV-SM3, THE NAKED PEP  60.6      13 0.00014   16.1   1.1   14    6-19    230-243 (244)
311 7SPO_C IMMUNE SYSTEM, VIRAL PR  60.3      11 0.00012   16.9   0.9   12    8-19    105-116 (141)
312 7MEP_M Immune complex, monoclo  60.2      13 0.00014   12.9   0.9   12    8-19    109-120 (121)
313 5EB9_A CD8 alpha chain; CD8, C  60.1     6.8 7.4E-05   13.8   0.2   10    8-17    108-117 (118)
314 6U14_B VHH R303 C33A/C102A mut  60.0     8.3   9E-05   15.1   0.4   13    7-19    110-122 (142)
315 5LBS_I Polyprotein, BROADLY NE  60.0      15 0.00016   13.6   1.1   12    8-19    110-121 (141)
316 7MDW_A SARS-CoV-2 Receptor bin  59.8      13 0.00014   12.8   0.9   11    8-18    105-115 (117)
317 6Z1O_F lambda 3 immunoglobulin  59.5     7.6 8.2E-05   12.9   0.3   11    8-18     79-89  (89)
318 1BVK_A HULYS11, LYSOZYME; HUMA  59.2      15 0.00017   13.2   1.1   12    8-19     96-107 (108)
319 4YQX_N JES6-1 VH domain, JES6-  59.1      12 0.00013   13.2   0.8   13    7-19    110-122 (123)
320 4WEM_B Donor strand complement  59.1     8.5 9.2E-05   14.6   0.4   14    7-20    108-121 (127)
321 6TYS_F Fusion glycoprotein F0,  59.1      14 0.00016   12.7   1.0   12    8-19    106-117 (120)
322 6NNJ_U Envelope glycoprotein g  58.9      12 0.00013   14.5   0.8   13    7-19    118-130 (137)
323 7DV4_H anti-tumor, VH domain,   58.8      13 0.00014   12.9   0.8   13    7-19    107-119 (120)
324 5L21_B Botulinum neurotoxin ty  58.8      14 0.00015   12.9   0.9   10   10-19    108-117 (119)
325 6GJS_B Cystic fibrosis transme  58.7      18 0.00019   15.0   1.3   12    8-19    111-122 (149)
326 6GKD_B Cystic fibrosis transme  58.7      18 0.00019   15.0   1.3   12    8-19    111-122 (149)
327 1NMC_C NEURAMINIDASE, SINGLE C  58.7      15 0.00016   13.8   1.1   13    7-19     95-107 (109)
328 7MJH_D Spike glycoprotein, VH   58.6      12 0.00014   15.1   0.9   12    8-19    112-123 (145)
329 3IY1_B Fab B; cryoEM, neutrali  58.6      14 0.00015   13.0   0.9   10    9-18     99-108 (109)
330 43CA_C 43C9 ANTIBODY (FV FRAGM  58.4      16 0.00017   13.0   1.0   11    8-18    102-112 (113)
331 6IEC_D NSmGnGc, R17 H chain, R  57.9      14 0.00015   12.8   0.9   12    8-19     98-109 (111)
332 2ATP_B T-cell surface glycopro  57.9      16 0.00017   14.6   1.1   13    7-19    103-115 (115)
333 2ATP_D T-cell surface glycopro  57.9      16 0.00017   14.6   1.1   11    8-18    104-114 (115)
334 5JDS_B Nanobody, Programmed ce  57.6      12 0.00013   15.0   0.7   13    7-19    117-129 (146)
335 6BA5_F Variable domain of Ligh  57.6      16 0.00017   12.6   1.0   13    7-19    104-116 (117)
336 6BAN_F Variable domain of Ligh  57.6      16 0.00017   12.6   1.0   13    7-19    104-116 (117)
337 6X05_K Nucleoporin NUP133, VHH  57.6     8.8 9.6E-05   14.3   0.3   11    8-18    110-120 (122)
338 1I8K_B antibody-peptide comple  57.5      16 0.00018   12.9   1.0   12    8-19    108-119 (124)
339 1VES_A New Antigen Receptor va  57.4      12 0.00013   14.1   0.7   10    9-18    103-112 (113)
340 4NKD_E Engineered scFv heavy c  57.3      12 0.00013   14.0   0.7   12    8-19    110-121 (133)
341 5FCS_L Diabody; antibody, diab  57.1      17 0.00019   16.4   1.2   11    9-19    232-242 (256)
342 6Z1I_B lambda 3 light chain fr  56.5      14 0.00015   11.3   1.1   10    8-17     71-80  (81)
343 4FFY_H DENV1-E111 single chain  56.4      12 0.00014   13.8   0.6   13    7-19    105-117 (130)
344 7JOZ_N Dopamine receptor, D1,   56.2      14 0.00015   15.7   0.8   13    6-18    136-148 (160)
345 1XFP_A heavy chain antibody, L  56.1      14 0.00016   14.6   0.8   13    7-19    120-132 (142)
346 7D3L_H O/TIBET/99 VP1, O/TIBET  55.7      17 0.00018   15.4   1.0   10    9-18    145-154 (156)
347 3CX5_K Cytochrome b-c1 complex  55.7      17 0.00018   13.4   0.9   11    8-18     96-106 (107)
348 3J7E_C H16.V5 Fab light chain,  55.6      20 0.00022   12.9   1.4   13    7-19    101-113 (115)
349 6KZ0_K Genome polyprotein (E.C  55.3      17 0.00019   13.9   1.0   13    7-19    114-126 (142)
350 6NM6_U Envelope glycoprotein g  55.3      17 0.00018   15.0   1.0   13    7-19    116-128 (145)
351 6MTJ_D Envelope glycoprotein g  55.2      16 0.00017   14.1   0.9   13    7-19    118-130 (134)
352 6MU7_D Envelope glycoprotein g  55.2      16 0.00017   14.1   0.9   13    7-19    118-130 (134)
353 6MU8_D Envelope glycoprotein g  55.2      16 0.00017   14.1   0.9   13    7-19    118-130 (134)
354 7VNB_A SARS-CoV-2, nanobody, V  55.2      15 0.00016   12.7   0.7   13    7-19    105-117 (118)
355 2Q20_B Vk1 O18/O8 germline lig  55.0      17 0.00018   13.0   0.9   11    8-18     98-108 (109)
356 2APX_A T cell receptor beta ch  54.6      18  0.0002   12.3   0.9   12    8-19    101-112 (112)
357 7D6Y_B VH domain, Cap-Dependen  54.5      19 0.00021   15.8   1.2   12    8-19    123-134 (161)
358 6XXO_A NB_8; Nanobody, prostat  54.3      22 0.00023   13.9   1.2   12    8-19    112-123 (143)
359 6EJG_C CD81 antigen, SINGLE CH  54.0      21 0.00022   15.4   1.2   13    8-20    239-251 (251)
360 5F1O_B ADP-ribosyl cyclase/cyc  53.9      26 0.00028   14.9   1.5   12    8-19    116-127 (163)
361 5JYM_B Cadherin-3/Antibody scF  53.7      22 0.00024   15.7   1.3   13    6-18    236-248 (257)
362 6ZWK_D NANOBODY, PHOSPHOPEPTID  53.2      22 0.00024   14.2   1.2   12    8-19    114-125 (150)
363 6ZWK_E NANOBODY, PHOSPHOPEPTID  53.2      22 0.00024   14.2   1.2   12    8-19    114-125 (150)
364 5FCS_H Diabody; antibody, diab  53.0      21 0.00023   15.9   1.1   11    9-19    225-235 (247)
365 3WBD_B single chain Fv fragmen  52.7      18  0.0002   16.1   1.0   12    7-18    233-244 (246)
366 7TE8_B Nanobody, Cannabidiol,   52.7      20 0.00021   12.9   0.9   11    9-19    109-119 (120)
367 3J8Z_G L1, H16.1A light chain,  52.6      17 0.00018   12.5   0.7   11    8-18    103-113 (114)
368 3ESV_G single-chain FV, monocl  52.6      30 0.00033   14.8   1.6   13    7-19    239-251 (252)
369 6LFW_A PCB4scFv(hN56D); Co-PCB  52.4      18  0.0002   15.8   0.9   11    9-19    238-248 (253)
370 6LFX_A PCB4scFv(hN56D); Co-PCB  52.4      18  0.0002   15.8   0.9   11    9-19    238-248 (253)
371 1QNZ_H 0.5B ANTIBODY (HEAVY CH  52.3      21 0.00023   12.8   1.0   12    8-19    107-118 (119)
372 6XYF_A Nanobody 22; Nanobody,   52.2      22 0.00024   14.1   1.1   12    7-18    113-124 (132)
373 6FRJ_H scFv-SM3, APD-SeThr-RP;  52.0      24 0.00026   15.2   1.2   13    7-19    231-243 (244)
374 6OSH_L Variable domain of Ligh  52.0      21 0.00023   12.9   0.9   11    8-18    102-112 (113)
375 4Y8D_C kinase domain of GAK, n  51.8      27 0.00029   13.7   1.3   14    6-19    107-120 (140)
376 4Y8D_D kinase domain of GAK, n  51.8      27 0.00029   13.7   1.3   14    6-19    107-120 (140)
377 7DX4_L SARS-CoV-2, Spike, neut  51.6      22 0.00024   12.9   1.0   12    8-19     99-110 (112)
378 6ZXN_D Spike glycoprotein, Nan  51.4      28  0.0003   13.2   1.5   13    7-19    107-119 (134)
379 7JHG_N AMPK, ATP, fully inacti  51.4      21 0.00022   14.1   0.9   12    7-18    146-157 (159)
380 7MDU_H monoclonal antibody, im  51.3      22 0.00023   12.1   0.9   11    8-18    104-114 (116)
381 6DBF_B InlB, VHH R303; nanobod  51.2      19  0.0002   14.1   0.8   13    7-19    110-122 (142)
382 5F1K_D ADP-ribosyl cyclase/cyc  51.2      26 0.00028   14.6   1.2   13    7-19    111-123 (159)
383 3T0V_A M8VL; immunoglobulin fo  51.1      20 0.00022   13.3   0.8   12    8-19     99-110 (123)
384 3T0W_B immunoglobulin variable  51.1      20 0.00022   13.3   0.8   12    8-19     99-110 (123)
385 5GS2_H Maltose-binding peripla  51.0      18 0.00019   16.7   0.8   11    8-18    228-238 (239)
386 1C08_B ANTI-HEN EGG WHITE LYSO  51.0      21 0.00023   12.9   0.9   11    9-19    102-112 (114)
387 3QYC_A VH domain of IgG molecu  51.0      32 0.00034   13.7   1.6   14    6-19    113-126 (146)
388 4LCI_L anti canine CD28 antibo  50.9      20 0.00022   13.3   0.8   13    7-19    101-113 (117)
389 5E9D_D HLA class I histocompat  50.4      29 0.00031   13.1   1.3   13    7-19     98-110 (129)
390 5XTB_L NADH dehydrogenase [ubi  50.3      13 0.00014   19.7   0.3   16    2-17    101-116 (118)
391 5XTD_L NADH dehydrogenase [ubi  50.3      13 0.00014   19.7   0.3   16    2-17    101-116 (118)
392 4NBZ_B TcdA, A26.8 VHH; Antibo  50.2      30 0.00033   14.2   1.4   13    7-19    111-123 (152)
393 7V2E_L Respiratory, Complex, E  49.6      15 0.00016   19.7   0.5   16    2-17    108-123 (125)
394 7V2H_L Respiratory, Complex, E  49.6      15 0.00016   19.7   0.5   16    2-17    108-123 (125)
395 3DUU_B antibody Fv fragment SA  49.6      25 0.00027   12.3   1.0   12    8-19    109-120 (121)
396 2MFS_A Ep-AMP1; cystine-knot,   49.2      15 0.00016   17.9   0.4    8    6-13      8-15  (35)
397 4B41_A ANTIBODY G7; IMMUNE SYS  49.0      27  0.0003   12.4   1.4   12    8-19    106-117 (118)
398 5TBD_B Fv fragment (mAb4D1) he  49.0      23 0.00025   13.5   0.9   11    8-18    101-111 (112)
399 5TBD_G Fv fragment (mAb4D1) he  49.0      23 0.00025   13.5   0.9   11    8-18    101-111 (112)
400 4QY8_A Fv fragment(mAb6D8) hea  49.0      26 0.00028   12.1   1.2   11    9-19    103-113 (114)
401 4QYO_A Fv fragment(mAb6D8) hea  49.0      26 0.00028   12.1   1.2   11    9-19    103-113 (114)
402 1MQK_L antibody 7E2 FV fragmen  49.0      30 0.00033   12.8   1.8   12    8-19     97-108 (120)
403 3K3Q_A llama Aa1 VHH domain, B  48.9      34 0.00037   15.1   1.5   13    7-19    127-139 (151)
404 6TCS_A Omalizumab scFv; Fab, A  48.8      22 0.00024   16.2   0.9   14    7-20    241-254 (277)
405 6NNJ_V Envelope glycoprotein g  48.5      31 0.00033   12.8   1.2   10    9-18     93-102 (117)
406 5GS0_F Toll-like receptor 3, l  48.5      25 0.00027   12.3   0.9   11    9-19    111-121 (127)
407 5WB1_A Envelope protein US28,n  48.4      28 0.00031   17.5   1.3   13    7-19    441-453 (458)
408 7LY2_K Spike glycoprotein, S2M  48.1      12 0.00013   12.7   0.0    9    8-16     96-104 (104)
409 6OSH_H Variable domain of Ligh  47.6      27 0.00029   11.9   0.9   12    7-18    102-113 (114)
410 4NBX_B TcdA, A20.1 VHH; Antibo  47.4      24 0.00026   14.4   0.9   12    8-19    118-129 (154)
411 6H3U_H scFv 4B6 VH, scFv 4B6;   47.3      26 0.00028   13.3   0.9   12    8-19    110-121 (142)
412 6H3U_I scFv 4B6 VH, scFv 4B6;   47.3      26 0.00028   13.3   0.9   12    8-19    110-121 (142)
413 5H8D_A VHH nanobody; VHH nanob  47.2      27 0.00029   12.3   0.9   10   10-19    102-111 (114)
414 5M7Q_A Nanobody NbD2; Nanobody  47.1      31 0.00034   13.2   1.1   14    6-19    104-117 (137)
415 5F3J_C Duffy receptor, Antibod  46.8      27 0.00029   16.7   1.1   12    8-19    277-288 (305)
416 6J11_H Spike glycoprotein, VH   46.8      24 0.00026   12.9   0.7   12    8-19    120-131 (132)
417 6UFT_B Botulinum neurotoxin ty  46.7      28 0.00031   14.3   1.0   12    8-19    135-146 (155)
418 1YJD_C Fab fragment of 5.11A1   46.5      32 0.00035   14.3   1.2   10   10-19    111-120 (140)
419 3U6R_A Antibody 1:7 (Heavy cha  46.5      31 0.00033   13.6   1.1   13    7-19    116-128 (149)
420 6KYZ_B Genome polyprotein (E.C  46.1      31 0.00033   13.2   1.0   12    8-19    118-129 (145)
421 5LHN_B Urokinase-type plasmino  45.9      31 0.00033   14.3   1.1   14    6-19    119-132 (152)
422 5LHQ_B Urokinase-type plasmino  45.9      31 0.00033   14.3   1.1   14    6-19    119-132 (152)
423 5E03_A CTLA-4 nanobody; IG FOL  45.8      31 0.00033   12.8   1.0   11    9-19    104-114 (129)
424 7P78_B SARS-CoV-2 spike protei  45.8      25 0.00027   13.3   0.7   10    9-18    104-113 (114)
425 6Z3X_A DesAb-anti-HSA-P1; prot  45.5      28  0.0003   14.0   0.9   11    9-19    118-128 (137)
426 6Z3X_B DesAb-anti-HSA-P1; prot  45.5      28  0.0003   14.0   0.9   11    9-19    118-128 (137)
427 7CEA_A HUTS-4 VH(S112C)-SARAH,  45.4      24 0.00026   14.5   0.7   12    8-19    111-122 (174)
428 7K93_E Non-structural protein   45.0      48 0.00052   14.1   1.7   12    7-18    239-250 (251)
429 7K93_I Non-structural protein   45.0      48 0.00052   14.1   1.7   12    7-18    239-250 (251)
430 6OL6_H ib2 Heavy Chain, ib2 Li  44.7      22 0.00024   13.3   0.5   13    7-19    116-128 (139)
431 6VEP_I Insulin A chain, Insuli  44.0      40 0.00043   12.9   1.3   13    7-19    105-117 (138)
432 6VEP_O Insulin A chain, Insuli  44.0      40 0.00043   12.9   1.3   13    7-19    105-117 (138)
433 5OVW_K Vitamin B12-binding pro  43.8      34 0.00037   14.2   1.1   11    8-18    137-147 (159)
434 6C5W_C calcium uniporter, nano  43.3      35 0.00038   12.0   1.0   11    8-18    105-115 (117)
435 4LCI_H anti canine CD28 antibo  43.3      35 0.00038   12.8   1.0   10    9-18    103-112 (120)
436 7E6U_B G-protein-coupled recep  42.8      33 0.00036   13.3   0.9   13    7-19    111-123 (143)
437 7CWS_G Heavy Chain of FC05 Fab  42.8      35 0.00038   11.8   1.2   10    9-18    108-117 (122)
438 3ESU_F single-chain FV, monocl  42.8      29 0.00032   14.9   0.8   13    7-19    237-249 (250)
439 7LK4_G swap dimer, antibody fr  42.3      36 0.00039   11.8   1.2   11    8-18     98-108 (109)
440 7JTR_B Maltose/maltodextrin-bi  42.2      35 0.00038   15.2   1.0   13    7-19    231-243 (251)
441 7JTR_F Maltose/maltodextrin-bi  42.2      35 0.00038   15.2   1.0   13    7-19    231-243 (251)
442 6E0P_N Histone H3-like centrom  42.1      32 0.00035   15.6   0.9   12    8-19    252-263 (265)
443 2VYR_H MDM4 PROTEIN, HUMAN SIN  42.1      34 0.00036   13.8   0.9   12    8-19    112-123 (153)
444 2VYR_L MDM4 PROTEIN, HUMAN SIN  42.1      34 0.00036   13.8   0.9   12    8-19    112-123 (153)
445 6A3W_G utomilumab VH, utomilum  42.1      34 0.00037   11.7   0.8   12    8-19    104-115 (116)
446 6H3T_H scFv 1C11 VH, scFv 1C11  42.0      37 0.00041   12.8   1.0   12    8-19    108-119 (140)
447 7A48_A coiled-coil, nanobody,   41.9      39 0.00042   12.1   1.1   12    8-19    106-117 (133)
448 1UAC_H ANTIGEN-ANTIBODY COMPLE  41.8      36 0.00039   12.2   0.9   11    9-19    102-112 (114)
449 6AD0_H VL of Fab 2G8, VH; CVA1  41.7      21 0.00023   12.4   0.2    6    9-14    110-115 (115)
450 6A78_I Roundabout homolog 1, L  41.7      41 0.00045   12.3   1.3   13    7-19    109-121 (138)
451 1EEQ_B Human Kappa-4 Immunoglo  41.4      36 0.00039   12.2   0.9   11    8-18    102-112 (114)
452 6NNF_U Envelope glycoprotein g  40.9      37  0.0004   14.5   1.0   11    8-18    116-126 (142)
453 6J7W_B UniAb, Tumor necrosis f  40.7      37  0.0004   11.6   1.9   10    9-18    108-117 (118)
454 6NM6_D Envelope glycoprotein g  40.7      38 0.00041   14.2   1.0   12    7-18    118-129 (153)
455 6NNJ_D Envelope glycoprotein g  40.7      38 0.00041   14.2   1.0   12    7-18    118-129 (153)
456 7O85_B Anthrax, PA, neutralizi  40.4      26 0.00028   12.0   0.4    8    8-15     96-103 (104)
457 5FOJ_A VIRUS, NANOBODY, COMPLE  39.9      41 0.00044   13.5   1.0    9    9-17    120-128 (137)
458 2GWR_A DNA-binding response re  39.5      24 0.00026   15.6   0.3   14    4-17    219-232 (238)
459 2HP4_B CD8, Co-receptor, Solub  39.3      40 0.00043   11.6   0.8   11    8-18    102-112 (114)
460 3QZW_G HLA class I histocompat  39.1      40 0.00043   11.6   0.8   11    8-18    102-112 (114)
461 3KG5_A B-cell antigen receptor  39.0      52 0.00057   12.8   1.2   11    8-18    107-117 (134)
462 6KR0_A Diabody, IMMUNE SYSTEM;  38.9      64 0.00069   15.4   1.6   14    6-19    248-261 (290)
463 6KR0_C Diabody, IMMUNE SYSTEM;  38.9      64 0.00069   15.4   1.6   14    6-19    248-261 (290)
464 4XVJ_H HCV E2 antigen, antibod  38.8      49 0.00054   12.4   1.3   12    8-19    116-127 (141)
465 7RG7_A IMMUNE SYSTEM; HET: MTX  38.8      49 0.00054   15.9   1.3   13    7-19    293-305 (306)
466 4QO1_A Nb139  Nanobody against  38.7      44 0.00048   13.7   1.0   13    7-19    111-123 (154)
467 5WTS_A Green fluorescent prote  38.7      35 0.00038   18.9   0.9   11    9-19    342-352 (358)
468 5DXW_A PD-L1 nanobody; IG FOLD  38.6      48 0.00052   12.2   1.1   11    9-19    105-115 (130)
469 3UPC_H heavy chain variable do  38.6      45 0.00049   12.0   0.9   10    9-18    103-112 (113)
470 6S3Y_J PlyP35; HYDROLASE; HET:  38.4      45 0.00049   17.8   1.2   18    3-20     95-112 (140)
471 6S4S_J PlyP35; ----, HYDROLASE  38.4      45 0.00049   17.8   1.2   18    3-20     95-112 (140)
472 6J5D_L Envelope, antibody heav  38.2      43 0.00046   11.5   1.4   12    8-19     97-108 (109)
473 4F9L_C Butyrophilin subfamily   38.1      39 0.00042   14.6   0.8   12    8-19    241-252 (259)
474 4NFD_A Paired immunoglobulin-l  38.0      39 0.00043   12.0   0.7   10    9-18    110-119 (120)
475 4I13_B Dihydrofolate reductase  38.0      39 0.00042   13.0   0.7   11    8-18    106-116 (133)
476 3UZQ_A anti-dengue Mab 4E11, e  37.5      56 0.00061   14.3   1.3   12    8-19    232-243 (253)
477 6HUD_B Monoclonal immunoglobul  37.4      43 0.00046   12.9   0.8   11    8-18    100-110 (136)
478 5GRV_L homo-specific diabody h  36.9      46  0.0005   11.5   1.2   12    8-19    107-118 (124)
479 4LLQ_B Putative uncharacterize  36.9      33 0.00036   14.5   0.5   12    6-18     10-21  (151)
480 2COQ_A new antigen receptor va  36.8      47 0.00051   11.6   1.2   11    8-18     97-107 (108)
481 6LCS_A AGE, antibody fragment,  36.6      45 0.00049   13.6   0.9   12    8-19    108-119 (171)
482 4L1H_A Ig kappa chain V-I regi  36.5      46  0.0005   11.5   0.8   11    8-18     96-106 (107)
483 3E5P_C alr, alanine racemase,   36.5      49 0.00053   18.4   1.2   17    4-20    267-283 (371)
484 3E6E_A alr, scp, Isomerase, Py  36.5      49 0.00053   18.4   1.2   17    4-20    267-283 (371)
485 4UT7_H BROADLY NEUTRALIZING HU  36.5      54 0.00058   13.0   1.1   12    8-19    121-132 (150)
486 6OQ6_D Toxin B, 5D; Toxin VHH,  36.5      49 0.00053   12.8   0.9   12    8-19    118-129 (153)
487 6IW0_H Envelope protein E, Hea  36.5      54 0.00058   12.3   1.0   12    8-19    112-123 (145)
488 7JLK_L iv1 Heavy Chain, glVRC0  36.4      54 0.00059   12.3   1.0   13    7-19     95-107 (122)
489 3JBE_7 Capsid protein VP1, Cap  36.4      60 0.00065   12.7   1.2   12    7-18    113-124 (132)
490 1DLF_H ANTI-DANSYL IMMUNOGLOBU  36.3      37  0.0004   11.9   0.5   11    9-19    110-120 (124)
491 5GS0_X Toll-like receptor 3, l  36.2      47 0.00051   11.4   0.9   10    9-18    105-114 (121)
492 6OSV_H Variable domain of Ligh  36.1      48 0.00052   11.5   1.0   11    9-19    105-115 (126)
493 5WB2_A Envelope protein US28,n  36.0      47 0.00051   16.9   1.0   12    8-19    441-452 (460)
494 6R7T_A anti MAGEB1 nanobody, M  35.9      46 0.00049   11.5   0.7   11    9-19    109-119 (123)
495 5YY5_C MERS-CoV RBD, Heavy cha  35.9      30 0.00032   11.6   0.2    8    9-16    101-108 (109)
496 6PIL_A scFv-M204 antibody; ant  35.8      49 0.00054   14.8   1.0   12    8-19    233-244 (257)
497 6S4S_K PlyP35; ----, HYDROLASE  35.8      52 0.00057   17.5   1.2   18    3-20     94-111 (139)
498 5VXK_B single-domain antibody   35.7      55  0.0006   12.8   1.0   12    8-19    119-130 (155)
499 6UC6_D Botulinum neurotoxin ty  35.6      54 0.00058   13.4   1.0   11    9-19    135-145 (154)
500 4QY8_B Fv fragment(mAb6D8) hea  35.5      49 0.00053   11.4   0.9   11    8-18    100-110 (111)

No 1
>5YAX_A scFv1 antibody, Large envelope protein; HBV, NTCP, preS1, antibody, Fc; 2.5A {Homo sapiens}
Probab=93.25  E-value=0.17  Score=22.06  Aligned_cols=14  Identities=50%  Similarity=0.963  Sum_probs=11.6  Template_Neff=13.500

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ..++||.||+|.|+
T Consensus       233 ~~~~~~~gt~l~v~  246 (246)
T 5YAX_A          233 SGVIFGGGTKLTVL  246 (246)
T ss_dssp             TEEEECCCEEEEEC
T ss_pred             CceeecCceEEEEC
Confidence            34789999999986


No 2
>5YAX_B scFv1 antibody, Large envelope protein; HBV, NTCP, preS1, antibody, Fc; 2.5A {Homo sapiens}
Probab=93.25  E-value=0.17  Score=22.06  Aligned_cols=14  Identities=50%  Similarity=0.963  Sum_probs=11.6  Template_Neff=13.500

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ..++||.||+|.|+
T Consensus       233 ~~~~~~~gt~l~v~  246 (246)
T 5YAX_B          233 SGVIFGGGTKLTVL  246 (246)
T ss_dssp             TEEEEBCCEEEEEC
T ss_pred             CceeecCceEEEEC
Confidence            34789999999986


No 3
>6TYL_J Resistance to inhibitors of cholinesterase; Ric-8A, G protein, GEF, SIGNALING; HET: TPO, SEP; 3.3A {Rattus norvegicus}
Probab=93.21  E-value=0.082  Score=21.02  Aligned_cols=14  Identities=36%  Similarity=0.636  Sum_probs=11.3  Template_Neff=13.300

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      ..+||.||+|.|-+
T Consensus       108 ~~~~g~G~~~~~~~  121 (131)
T 6TYL_J          108 NNYYGQGTQVTVSS  121 (131)
T ss_pred             eEEEecCceeEeee
Confidence            46899999998853


No 4
>3LRG_A anti-huntingtin VL domain; Huntington's disease, Huntingtin, Variable light; 2.05A {Homo sapiens}
Probab=92.22  E-value=0.15  Score=19.88  Aligned_cols=13  Identities=54%  Similarity=1.073  Sum_probs=10.4  Template_Neff=13.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||+||++.|-
T Consensus       101 ~~~~g~gt~~~~~  113 (121)
T 3LRG_A          101 GWVFGGGTKVTVL  113 (121)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             eEEEcCceEEEEc
Confidence            3589999999873


No 5
>4HGM_A shark V-NAR, serum albumin; Ig-fold, human albumin, V-nar, IMMUNE; 2.34A {Squalus acanthias}
Probab=91.92  E-value=0.3  Score=18.09  Aligned_cols=13  Identities=23%  Similarity=0.210  Sum_probs=10.8  Template_Neff=14.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      -+.||.||++.|.
T Consensus        91 ~~~~g~gt~~~~~  103 (112)
T 4HGM_A           91 WTGDGAGTKVEIK  103 (112)
T ss_dssp             CEEECCCEEEEEC
T ss_pred             ceeecCCcEEEEe
Confidence            3489999999885


No 6
>2I26_N New Antigen Receptor Ancestral, Lysozyme; immunoglobulin fold, protein-protein complex, immune; HET: SO4; 2.5A {Gallus gallus} SCOP: b.1.1.1
Probab=91.63  E-value=0.24  Score=22.66  Aligned_cols=12  Identities=33%  Similarity=0.415  Sum_probs=10.9  Template_Neff=10.200

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      +.||.||+|.|+
T Consensus       101 ~~~~~g~~~~~~  112 (121)
T 2I26_N          101 DQYGGGTVVTVN  112 (121)
T ss_dssp             TCCCCCEEEEEE
T ss_pred             cccCCceEEEec
Confidence            889999999985


No 7
>4H1L_G HLA class II histocompatibility antigen; PROTEIN-PROTEIN COMPLEX, immunoglobin fold, TCR; 3.3A {Homo sapiens}
Probab=91.61  E-value=0.27  Score=17.95  Aligned_cols=14  Identities=50%  Similarity=0.982  Sum_probs=11.1  Template_Neff=14.300

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      ..+||.||+|.|-|
T Consensus       100 ~~~~~~~t~l~v~~  113 (113)
T 4H1L_G          100 KLIFGQGTTLQVKP  113 (113)
T ss_dssp             CEEECCCEEEEEEC
T ss_pred             cEEecCCeeeEEcC
Confidence            35789999998865


No 8
>2I24_N New Antigen Receptor PBLA8; immunoglobulin fold, immune system; 1.35A {Ginglymostoma cirratum}
Probab=90.60  E-value=0.3  Score=19.21  Aligned_cols=14  Identities=36%  Similarity=0.453  Sum_probs=11.6  Template_Neff=13.200

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      .++||.||++.|.+
T Consensus       100 ~~~~g~gt~~~~~~  113 (121)
T 2I24_N          100 NDQYGGGTVVTVNA  113 (121)
T ss_dssp             TTCCCCCEEEEEEC
T ss_pred             hcccCCeeEEEEee
Confidence            47899999998854


No 9
>2I25_N New Antigen Receptor PBLA8, Lysozyme; immunoglobulin fold, protein-protein complex, immune; 1.8A {Gallus gallus}
Probab=90.60  E-value=0.3  Score=19.21  Aligned_cols=14  Identities=36%  Similarity=0.453  Sum_probs=11.6  Template_Neff=13.200

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      .++||.||++.|.+
T Consensus       100 ~~~~g~gt~~~~~~  113 (121)
T 2I25_N          100 NDQYGGGTVVTVNA  113 (121)
T ss_dssp             TTCCCCCEEEEEEC
T ss_pred             hcccCCeeEEEEee
Confidence            47899999998854


No 10
>6APO_A Anti-Marburgvirus Nucleoprotein Single Domain Antibody; single domain antibody, IMMUNE SYSTEM; 1.168A {Lama glama}
Probab=90.03  E-value=0.36  Score=18.38  Aligned_cols=12  Identities=33%  Similarity=0.581  Sum_probs=10.1  Template_Neff=13.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+||.||++.|.
T Consensus       106 ~~~g~gt~~~~~  117 (126)
T 6APO_A          106 RYWGQGTQVTVS  117 (126)
T ss_dssp             EEECCCEEEEEE
T ss_pred             EEeccceeeEec
Confidence            689999999874


No 11
>6KNM_A Apelin receptor, Single domain antibody; GPCR, Single-domain antibody, Antagonist, Agonist; 3.2A {Homo sapiens}
Probab=90.03  E-value=0.72  Score=16.90  Aligned_cols=11  Identities=36%  Similarity=0.733  Sum_probs=9.1  Template_Neff=14.600

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .||.||+++|.
T Consensus       118 ~~~~gt~l~v~  128 (129)
T 6KNM_A          118 SWGQGTQVTVS  128 (129)
T ss_pred             cccCCceEEec
Confidence            58999998874


No 12
>2D7T_L anti polyhydroxybutyrate antibody Fv, heavy; antibody, plastic, polyhydroxybutyrate, IMMUNE SYSTEM; 1.7A {Homo sapiens}
Probab=89.92  E-value=0.35  Score=18.90  Aligned_cols=13  Identities=31%  Similarity=0.733  Sum_probs=10.6  Template_Neff=13.200

Q ss_pred             CCcccCCCCeeee
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSV   18 (20)
Q Consensus         6 qnfvfgpgtrlsv   18 (20)
                      ..+.||.||++.|
T Consensus        94 ~~~~~g~gt~~~~  106 (116)
T 2D7T_L           94 YPLTFGGGTKVDI  106 (116)
T ss_dssp             SSCEECCCEEEEE
T ss_pred             ceEEEcCCeEEEE
Confidence            3468999999987


No 13
>3TF7_C H2-Ld SBM2, QL9, 42F3 Mut7; Ig and MHC, Antigen Recognition; HET: GOL; 2.75A {Mus musculus}
Probab=89.19  E-value=0.44  Score=21.09  Aligned_cols=14  Identities=43%  Similarity=0.902  Sum_probs=11.1  Template_Neff=13.300

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      ...||+||++.+.+
T Consensus       235 ~~~~g~~t~~~~~~  248 (256)
T 3TF7_C          235 QLYFGEGSKLTVLE  248 (256)
T ss_dssp             EEEECCCEEEEEEC
T ss_pred             eEEeccCceeEEEe
Confidence            35799999998754


No 14
>3TF7_K H2-Ld SBM2, QL9, 42F3 Mut7; Ig and MHC, Antigen Recognition; HET: GOL; 2.75A {Mus musculus}
Probab=89.19  E-value=0.44  Score=21.09  Aligned_cols=14  Identities=43%  Similarity=0.902  Sum_probs=11.1  Template_Neff=13.300

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      ...||+||++.+.+
T Consensus       235 ~~~~g~~t~~~~~~  248 (256)
T 3TF7_K          235 QLYFGEGSKLTVLE  248 (256)
T ss_dssp             EEEECCCEEEEEEC
T ss_pred             eEEeccCceeEEEe
Confidence            35799999998754


No 15
>7L56_H Spike glycoprotein, Fab 2-43 variable; SARS-CoV-2, spike, glycoprotein, antibody, VIRAL; HET: BMA, NAG, MAN, GAL; 3.6A {Severe acute respiratory syndrome coronavirus 2}
Probab=89.10  E-value=0.39  Score=17.94  Aligned_cols=14  Identities=36%  Similarity=0.432  Sum_probs=10.8  Template_Neff=14.300

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ....|+.||+|+|.
T Consensus       115 ~~~~~~~~~~l~v~  128 (129)
T 7L56_H          115 YMDVWGKGTTVTVS  128 (129)
T ss_pred             eeeeeecCceeeec
Confidence            35689999998873


No 16
>6CUE_N PGT122 Heavy chain, PGT122 Light; HIV-1 Env, BG505 SOSIP, fusion; HET: BMA, NAG, MAN; 4.0A {Human immunodeficiency virus 1}
Probab=87.85  E-value=0.8  Score=16.39  Aligned_cols=12  Identities=67%  Similarity=1.071  Sum_probs=9.2  Template_Neff=14.400

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||+|.|+
T Consensus        96 ~~~~~gt~l~v~  107 (107)
T 6CUE_N           96 WVFGEGTTLIVL  107 (107)
T ss_pred             EEECCCeEEEEC
Confidence            568889988764


No 17
>6MPG_n A12V163-b.01 Light Chain, Envelope glycoprotein; Complex, Fusion peptide, Neutralizing antibody; HET: BMA, NAG, MAN; 3.2A {Macaca mulatta}
Probab=87.85  E-value=0.8  Score=16.39  Aligned_cols=12  Identities=67%  Similarity=1.071  Sum_probs=9.2  Template_Neff=14.400

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||+|.|+
T Consensus        96 ~~~~~gt~l~v~  107 (107)
T 6MPG_n           96 WVFGEGTTLIVL  107 (107)
T ss_pred             EEECCCeEEEEC
Confidence            568889988764


No 18
>6WDT_H viral protein 1, viral protein; virus, enterovirus, antibody, Structural Genomics;{Enterovirus D68}
Probab=87.60  E-value=0.97  Score=16.37  Aligned_cols=13  Identities=31%  Similarity=0.391  Sum_probs=10.2  Template_Neff=14.700

Q ss_pred             cccCCCCeeeeCC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVLP   20 (20)
Q Consensus         8 fvfgpgtrlsvlp   20 (20)
                      ..||.||+|.|.+
T Consensus       114 ~~~~~~~~l~v~~  126 (126)
T 6WDT_H          114 DNWGQGTLVTVSS  126 (126)
T ss_dssp             EECCCCCCBCCCC
T ss_pred             eecccccEEEEcC
Confidence            4689999998753


No 19
>5U64_B VHH-28; neutralizing antibody, camel vhh nanobody; 1.153A {Camelus dromedarius}
Probab=87.50  E-value=0.67  Score=18.21  Aligned_cols=13  Identities=31%  Similarity=0.468  Sum_probs=10.6  Template_Neff=13.600

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||.||++.|.
T Consensus       115 ~~~~~~gt~l~v~  127 (137)
T 5U64_B          115 FSYWGQGTQVTVS  127 (137)
T ss_dssp             CCEECCCEEEEEE
T ss_pred             ceeceeceeEEEE
Confidence            4689999999874


No 20
>6NN3_H Capsid protein 2, antibody 860-55D; B19, VP2, antibody, epitope, VIRUS; 3.22A {Homo sapiens}
Probab=87.50  E-value=0.67  Score=16.58  Aligned_cols=12  Identities=33%  Similarity=0.371  Sum_probs=8.8  Template_Neff=14.800

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ..+||+||.|.|
T Consensus       110 ~~~~~~gt~l~v  121 (121)
T 6NN3_H          110 FDPWGHGTLVTV  121 (121)
T ss_dssp             CCSBBCCBCCBC
T ss_pred             ceecCCCceeeC
Confidence            356899998764


No 21
>6NB6_I Spike glycoprotein, S230 heavy chain; coronavirus spike glycoprotein, MERS-CoV, SARS-CoV; HET: BMA, NAG, MAN; 4.2A {SARS coronavirus}
Probab=87.15  E-value=1.1  Score=16.12  Aligned_cols=12  Identities=42%  Similarity=0.612  Sum_probs=9.2  Template_Neff=14.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+||.||+++|.
T Consensus       115 ~~~~~~~~l~v~  126 (127)
T 6NB6_I          115 DVWGQGTTVAVS  126 (127)
T ss_pred             eeeCCcceEEec
Confidence            467999988774


No 22
>7EAK_F heavy chain of 5G3 fab; Echovirus3, full particle, 5G3 fab; HET: MYR, SPH; 3.9A {Echovirus E3}
Probab=87.07  E-value=1.2  Score=15.31  Aligned_cols=11  Identities=36%  Similarity=0.546  Sum_probs=8.6  Template_Neff=15.100

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.|+.||+++|
T Consensus       101 ~~~~~~~~l~v  111 (112)
T 7EAK_F          101 DYWGQGTLVTV  111 (112)
T ss_pred             eeecCCeEEEe
Confidence            67888888875


No 23
>4M62_H GEP2 FV light chain, GEP2; GEP, 4E10 germline, Immunoglobulin, Antiboody; HET: SO4; 1.8A {Homo sapiens}
Probab=86.56  E-value=1.2  Score=16.34  Aligned_cols=13  Identities=31%  Similarity=0.386  Sum_probs=10.3  Template_Neff=14.500

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||.|+|-
T Consensus       114 ~~~~~~~~~l~v~  126 (127)
T 4M62_H          114 FAYWGQGTLVTVS  126 (127)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             ceeeeccceeEec
Confidence            3478999999874


No 24
>4W6X_B FedF lectin domain (residues 15-165); Lectin, Fimbriae, cell adhesion, Inhibitor; 1.88A {Escherichia coli}
Probab=85.88  E-value=2  Score=16.89  Aligned_cols=13  Identities=31%  Similarity=0.458  Sum_probs=10.4  Template_Neff=13.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||+|+++.|.
T Consensus       112 ~~~~g~g~~~~~~  124 (131)
T 4W6X_B          112 YNDWGQGTQVTVS  124 (131)
T ss_dssp             CSEECCCEEEEEE
T ss_pred             ccCCCCceeEEEe
Confidence            4578999999873


No 25
>4AJ0_A GERMINAL LINE LAMBDA 3 3RCW; IMMUNE SYSTEM, AMYLOIDOSIS; HET: PG0; 1.7A {HOMO SAPIENS}
Probab=85.57  E-value=1.8  Score=16.38  Aligned_cols=12  Identities=67%  Similarity=1.115  Sum_probs=10.0  Template_Neff=13.400

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      +.||.||+|.|+
T Consensus        96 ~~~~~~t~l~v~  107 (107)
T 4AJ0_A           96 VVFGGGTKLTVL  107 (107)
T ss_dssp             CEEBCCEEEEEC
T ss_pred             EEecCceEEEEC
Confidence            578999999875


No 26
>3JBD_7 Capsid protein VP1, Capsid protein; VHH, nanobody, poliovirus, VIRUS-IMMUNE SYSTEM; HET: MYR, PLM; 4.7A {Human poliovirus 1 Mahoney}
Probab=85.28  E-value=1  Score=17.18  Aligned_cols=14  Identities=29%  Similarity=0.617  Sum_probs=10.8  Template_Neff=13.800

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      ...||.||++.|-|
T Consensus       107 ~~~~g~g~~~~~~~  120 (126)
T 3JBD_7          107 YMFWGQGTQVTVSS  120 (126)
T ss_dssp             CSCCCCCEEECCBC
T ss_pred             EEEEccceEEEecc
Confidence            45789999998743


No 27
>3OMZ_A human Vdelta1 gamma delta T; Immunoglobulin fold, Immune surveillance of; 3.04A {Homo sapiens}
Probab=85.22  E-value=1.2  Score=19.58  Aligned_cols=14  Identities=43%  Similarity=0.892  Sum_probs=11.4  Template_Neff=13.500

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ...+||.||+|.|+
T Consensus       236 ~~~~~~~gt~l~v~  249 (259)
T 3OMZ_A          236 DKLIFGKGTRVTVE  249 (259)
T ss_dssp             CCCEECCCEEEEEE
T ss_pred             ceeeccCCeEEEEe
Confidence            34689999999885


No 28
>3OMZ_C human Vdelta1 gamma delta T; Immunoglobulin fold, Immune surveillance of; 3.04A {Homo sapiens}
Probab=85.22  E-value=1.2  Score=19.58  Aligned_cols=14  Identities=43%  Similarity=0.892  Sum_probs=5.1  Template_Neff=13.500

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ...+||.||+|.|+
T Consensus       236 ~~~~~~~gt~l~v~  249 (259)
T 3OMZ_C          236 DKLIFGKGTRVTVE  249 (259)
T ss_dssp             CCEEECC-------
T ss_pred             ceeeccCCeEEEEe
Confidence            34689999999876


No 29
>7D3K_H O/TIBET/99 VP1, O/TIBET/99 VP2, O/TIBET/99; FOOT AND MOUTH DISEASE VIRUS; 3.9A {Foot-and-mouth disease virus}
Probab=84.91  E-value=1.6  Score=15.73  Aligned_cols=14  Identities=21%  Similarity=0.299  Sum_probs=6.8  Template_Neff=14.700

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      ...|+.||.|.|.+
T Consensus       111 ~~~~~~~~~l~v~~  124 (124)
T 7D3K_H          111 VDAWGQGLLITVSS  124 (124)
T ss_dssp             CTTTC----CCCCC
T ss_pred             eecccCceEEEecC
Confidence            45789999988753


No 30
>7LZP_B Single domain antibody, VHH, protease; 2.86A {Clostridium botulinum}
Probab=84.89  E-value=1.9  Score=16.28  Aligned_cols=13  Identities=31%  Similarity=0.468  Sum_probs=10.5  Template_Neff=14.200

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      .+.|+.||+|+|.
T Consensus       122 ~~~~~~~t~l~v~  134 (135)
T 7LZP_B          122 YDYWGQGTQVTVS  134 (135)
T ss_dssp             CEEECCCEEEEEC
T ss_pred             eeeeeCCeEEEec
Confidence            3589999999875


No 31
>6NIJ_H PGT145 Fab heavy chain, PGT145; HIV-1, antibody, glycoprotein, IMMUNE SYSTEM; HET: BMA, NAG; 5.7A {Homo sapiens}
Probab=84.64  E-value=1.1  Score=17.81  Aligned_cols=13  Identities=38%  Similarity=0.519  Sum_probs=10.5  Template_Neff=13.400

Q ss_pred             CCcccCCCCeeee
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSV   18 (20)
Q Consensus         6 qnfvfgpgtrlsv   18 (20)
                      ..++||.||.|.|
T Consensus       126 ~~~~~~~gt~l~v  138 (140)
T 6NIJ_H          126 TLDVWGHGTAVTV  138 (140)
T ss_pred             eeeeeccCeeeEe
Confidence            3568999999876


No 32
>6U59_J SOSIP.664 gp120, SOSIP.664 gp41, rabbit; HIV-1, rabbit antibody, SOSIP, VIRAL; HET: BMA, NAG, MAN; 3.86A {Human immunodeficiency virus 1}
Probab=84.54  E-value=1.6  Score=15.53  Aligned_cols=12  Identities=50%  Similarity=0.971  Sum_probs=9.2  Template_Neff=14.600

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...||.+|.|.|
T Consensus       100 ~~~~~~~~~l~v  111 (112)
T 6U59_J          100 DFAFGGGTEVVV  111 (112)
T ss_pred             ceeecCCeeEEe
Confidence            467888888876


No 33
>7SOE_B kappa, spike, antibody, Structural Genomics; HET: NAG; 2.8A {Severe acute respiratory syndrome coronavirus 2}
Probab=84.34  E-value=1.2  Score=16.13  Aligned_cols=12  Identities=42%  Similarity=0.581  Sum_probs=9.4  Template_Neff=14.700

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+||.||+|.|.
T Consensus       113 ~~~~~~~~l~v~  124 (125)
T 7SOE_B          113 DVWGQGTMVTVS  124 (125)
T ss_pred             HhcccceeeEEc
Confidence            468999998774


No 34
>7EOW_B von Willebrand factor, caplacizumab; vWF, vFW A1, caplacizumab, nanobody; 1.6A {Homo sapiens}
Probab=84.29  E-value=1.7  Score=17.45  Aligned_cols=13  Identities=31%  Similarity=0.557  Sum_probs=10.4  Template_Neff=13.200

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||++.|-
T Consensus       116 ~~~~g~gt~~~~~  128 (137)
T 7EOW_B          116 YTFWGQGTQVTVS  128 (137)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             ceeeccCceEEEe
Confidence            3579999999875


No 35
>7CWS_N Heavy Chain of FC05 Fab; VIRAL PROTEIN; HET: NAG; 3.4A {Homo sapiens}
Probab=84.26  E-value=1.2  Score=15.78  Aligned_cols=11  Identities=36%  Similarity=0.525  Sum_probs=7.7  Template_Neff=14.900

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..||.||+|.|
T Consensus       110 ~~~~~~~~l~v  120 (120)
T 7CWS_N          110 DPWGQGTLVTV  120 (120)
T ss_pred             cccccceEeeC
Confidence            35688888764


No 36
>7E5R_P Complex, Antibody, VIRUS, VIRAL PROTEIN-IMMUNE; HET: NAG; 3.6A {Homo sapiens}
Probab=84.26  E-value=1.2  Score=15.78  Aligned_cols=12  Identities=33%  Similarity=0.396  Sum_probs=8.6  Template_Neff=14.900

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...||.||+|.|
T Consensus       109 ~~~~~~~~~l~v  120 (120)
T 7E5R_P          109 FDPWGQGTLVTV  120 (120)
T ss_dssp             CCSBCCCCBCCC
T ss_pred             ccccccceEeeC
Confidence            346788988865


No 37
>6K3M_A Protein A, 3LRH intrabody; antibody, protein design, STRUCTURAL PROTEIN; 1.8A {Staphylococcus aureus}
Probab=84.20  E-value=1.2  Score=18.12  Aligned_cols=13  Identities=54%  Similarity=1.073  Sum_probs=10.4  Template_Neff=12.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||+|.|.
T Consensus       121 ~~~~g~gt~l~v~  133 (135)
T 6K3M_A          121 GWVFGGGTKVTVL  133 (135)
T ss_pred             eEEEeccEEEEEe
Confidence            4678999999875


No 38
>6K64_A Protein A, 3LRH intrabody; antibody, protein design, STRUCTURAL PROTEIN; 1.933A {Homo sapiens}
Probab=84.20  E-value=1.2  Score=18.12  Aligned_cols=15  Identities=47%  Similarity=0.955  Sum_probs=11.1  Template_Neff=12.900

Q ss_pred             CCcccCCCCeeeeCC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVLP   20 (20)
Q Consensus         6 qnfvfgpgtrlsvlp   20 (20)
                      +...||.||+|.|.+
T Consensus       120 ~~~~~g~gt~l~v~~  134 (135)
T 6K64_A          120 NGWVFGGGTKVTVLS  134 (135)
T ss_dssp             TEEEEBCCEEEEEC-
T ss_pred             CeEEEeccEEEEEeC
Confidence            346789999998863


No 39
>7SPP_C RBD, VIRAL PROTEIN, VNAR, VIRAL; HET: NAG, EDO; 1.96A {Severe acute respiratory syndrome coronavirus 2}
Probab=84.11  E-value=1.6  Score=16.56  Aligned_cols=13  Identities=38%  Similarity=0.286  Sum_probs=10.4  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||.|+++.|.
T Consensus        98 ~~~~~~g~~~~~~  110 (117)
T 7SPP_C           98 FHYDGAGTVLTVN  110 (117)
T ss_dssp             EEEECCCEEEEEE
T ss_pred             EEEeCCCcEEEEe
Confidence            4589999999874


No 40
>7N5H_E SARS-CoV-2, Viral Spike, Trimer, Glycoprotein; HET: NAG; 3.24A {Severe acute respiratory syndrome coronavirus 2}
Probab=84.00  E-value=1.7  Score=15.88  Aligned_cols=12  Identities=33%  Similarity=0.573  Sum_probs=9.4  Template_Neff=14.600

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+||.||.+.|.
T Consensus       116 ~~~~~~~~l~v~  127 (128)
T 7N5H_E          116 DIWGQGTMVTVS  127 (128)
T ss_pred             eeecCceeEEec
Confidence            478999988774


No 41
>6MTJ_E Envelope glycoprotein gp160, 35O22 scFv; HIV-1 Envelope Prefusion Trimer, Entry; HET: BMA, NAG, MAN, 83G; 2.336A {Human immunodeficiency virus 1}
Probab=83.90  E-value=1.5  Score=17.20  Aligned_cols=13  Identities=62%  Similarity=1.022  Sum_probs=10.2  Template_Neff=13.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      .++||.||+|.|.
T Consensus        99 ~~~~~~~~~l~v~  111 (114)
T 6MTJ_E           99 GCVFGTGTKVSVL  111 (114)
T ss_pred             cEEECCCeEEEEe
Confidence            4688999998874


No 42
>6MU8_E Envelope glycoprotein gp160, 35O22 scFv; HIV-1 Envelope Prefusion Trimer, Entry; HET: JYS, BMA, NAG, MAN; 2.993A {Human immunodeficiency virus 1}
Probab=83.90  E-value=1.5  Score=17.20  Aligned_cols=13  Identities=62%  Similarity=1.022  Sum_probs=10.2  Template_Neff=13.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      .++||.||+|.|.
T Consensus        99 ~~~~~~~~~l~v~  111 (114)
T 6MU8_E           99 GCVFGTGTKVSVL  111 (114)
T ss_pred             cEEECCCeEEEEe
Confidence            4688999998874


No 43
>6MUF_E Envelope glycoprotein gp160, 35O22 scFv; HIV-1 Envelope Prefusion Trimer, Entry; HET: BMA, NAG, MAN; 2.91A {Human immunodeficiency virus 1}
Probab=83.90  E-value=1.5  Score=17.20  Aligned_cols=13  Identities=62%  Similarity=1.022  Sum_probs=10.2  Template_Neff=13.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      .++||.||+|.|.
T Consensus        99 ~~~~~~~~~l~v~  111 (114)
T 6MUF_E           99 GCVFGTGTKVSVL  111 (114)
T ss_pred             cEEECCCeEEEEe
Confidence            4688999998874


No 44
>7CN2_H The light chain variable region; Virus, immune complex, IMMUNE SYSTEM-VIRAL; 3.43A {Oryctolagus cuniculus}
Probab=83.86  E-value=1.2  Score=15.81  Aligned_cols=13  Identities=31%  Similarity=0.406  Sum_probs=10.1  Template_Neff=14.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ++.|+.||.|.|-
T Consensus       107 ~~~~~~~~~l~v~  119 (120)
T 7CN2_H          107 LDLWGQGTLVTVS  119 (120)
T ss_dssp             CCBCBCCEEEEEC
T ss_pred             eeEEeccceeEec
Confidence            4579999998873


No 45
>7CN2_M The light chain variable region; Virus, immune complex, IMMUNE SYSTEM-VIRAL; 3.43A {Oryctolagus cuniculus}
Probab=83.86  E-value=1.2  Score=15.81  Aligned_cols=12  Identities=33%  Similarity=0.498  Sum_probs=9.0  Template_Neff=14.900

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ++.|+.||.|.|
T Consensus       107 ~~~~~~~~~l~v  118 (120)
T 7CN2_M          107 LDLWGQGTLVTV  118 (120)
T ss_pred             eeEEeccceeEe
Confidence            346888998876


No 46
>2PXY_A T cell receptor alpha chain; complex, IMMUNE SYSTEM; 2.23A {Mus musculus}
Probab=83.76  E-value=1.9  Score=15.66  Aligned_cols=14  Identities=50%  Similarity=1.058  Sum_probs=10.8  Template_Neff=14.300

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      ...|+.+|.|.|.|
T Consensus       101 ~~~~~~~~~l~v~~  114 (114)
T 2PXY_A          101 KITFGAGTKLQVVP  114 (114)
T ss_dssp             CCEECCCEEEEEEC
T ss_pred             EEEeCCCceEEECC
Confidence            46788999988764


No 47
>6CNW_A SD84h; single domain antibody, humanization, influenza; HET: PEG, ACT; 0.92A {hybrid }
Probab=83.69  E-value=1.9  Score=16.20  Aligned_cols=12  Identities=33%  Similarity=0.304  Sum_probs=9.9  Template_Neff=13.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+||.||.++|.
T Consensus       104 ~~~~~gt~l~v~  115 (116)
T 6CNW_A          104 PTRGQGTLVTVS  115 (116)
T ss_dssp             CEECCCEEEEEC
T ss_pred             CcccCCeEEEEc
Confidence            578999999874


No 48
>4HGK_D Serum albumin, V-NAR; Ig-fold, human albumin, IMMUNE SYSTEM; 3.04A {Homo sapiens}
Probab=83.63  E-value=1.5  Score=17.14  Aligned_cols=13  Identities=23%  Similarity=0.266  Sum_probs=9.8  Template_Neff=13.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||++.|.
T Consensus       108 ~~~~g~gt~~~~~  120 (128)
T 4HGK_D          108 NIWTGDGAGTVLT  120 (128)
T ss_dssp             TCCEEECCCEEEE
T ss_pred             CEEEccceEEEEe
Confidence            3578999988763


No 49
>7LX5_A Spike glycoprotein, WNb 2, WNb; SARS-CoV-2, nanobody cocktail, coronavirus spike; 3.44A {Severe acute respiratory syndrome coronavirus 2}
Probab=83.62  E-value=1.8  Score=15.58  Aligned_cols=12  Identities=33%  Similarity=0.529  Sum_probs=9.5  Template_Neff=14.700

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+||.||+|.|.
T Consensus       111 ~~~~~~~~l~v~  122 (123)
T 7LX5_A          111 GSWGQGTQVTVS  122 (123)
T ss_pred             cceecceeeEEe
Confidence            578999988763


No 50
>7NQA_C Nup98, Nanobody, complex, NUCLEAR PROTEIN; 2.2A {Xenopus tropicalis}
Probab=83.61  E-value=1.5  Score=15.74  Aligned_cols=13  Identities=38%  Similarity=0.567  Sum_probs=9.7  Template_Neff=14.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||.||+|.|.
T Consensus       111 ~~~~~~~~~l~v~  123 (124)
T 7NQA_C          111 YPYWGQGTRVTVS  123 (124)
T ss_pred             eeeeccCceeeec
Confidence            4578899988763


No 51
>7NQA_D Nup98, Nanobody, complex, NUCLEAR PROTEIN; 2.2A {Xenopus tropicalis}
Probab=83.61  E-value=1.5  Score=15.74  Aligned_cols=13  Identities=38%  Similarity=0.567  Sum_probs=10.0  Template_Neff=14.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||.||+|.|.
T Consensus       111 ~~~~~~~~~l~v~  123 (124)
T 7NQA_D          111 YPYWGQGTRVTVS  123 (124)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             eeeeccCceeeec
Confidence            3568999999874


No 52
>4KV5_E Transforming growth factor beta-1, GC1009; Cysteine knot, Fab, TGF-beta receptor; 3.0A {Homo sapiens}
Probab=83.56  E-value=1.8  Score=19.10  Aligned_cols=14  Identities=43%  Similarity=0.778  Sum_probs=11.6  Template_Neff=13.300

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ..++||.||+|.++
T Consensus       232 ~~~~~~~g~~~~~~  245 (252)
T 4KV5_E          232 SPITFGQGTRLEIK  245 (252)
T ss_dssp             SSCEECCCEEEEEC
T ss_pred             CCEEEcCCceeEEc
Confidence            35789999999875


No 53
>4B50_A 2H10 LLAMA VHH; IMMUNE SYSTEM, NEUTRALIZING ANTIBODY; 1.3A {LAMA GLAMA}
Probab=83.44  E-value=1.6  Score=15.55  Aligned_cols=12  Identities=42%  Similarity=0.650  Sum_probs=9.7  Template_Neff=14.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      +.||.||++.|-
T Consensus       110 ~~~~~~~~l~v~  121 (122)
T 4B50_A          110 DVWGRGTQVTVS  121 (122)
T ss_dssp             EEECCCEEEEEC
T ss_pred             ceeccCceeEEc
Confidence            478999999874


No 54
>1FO0_A MURIN ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS; T CELL RECEPTOR, CLASS I; 2.5A {Mus musculus} SCOP: b.1.1.1
Probab=83.40  E-value=2.2  Score=15.75  Aligned_cols=14  Identities=57%  Similarity=0.990  Sum_probs=10.4  Template_Neff=14.100

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      ...|+.++.|.|.|
T Consensus       103 ~~~~~~~~~l~v~~  116 (116)
T 1FO0_A          103 KLIFGTGTLLSVKP  116 (116)
T ss_pred             EEEeCCCceEEecC
Confidence            45688888887764


No 55
>5IVN_A BC2-nanobody, Cadherin-associated protein; Nanobody, Tag, Capture, Affinity, Catenin; HET: N7P, 6E4; 1.0A {Vicugna pacos}
Probab=83.26  E-value=1.6  Score=16.51  Aligned_cols=12  Identities=33%  Similarity=0.578  Sum_probs=9.9  Template_Neff=14.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+||.||.+.|.
T Consensus       110 ~~~g~gt~l~v~  121 (131)
T 5IVN_A          110 DFWGQGTQVTVS  121 (131)
T ss_dssp             EECSCCEEEEEC
T ss_pred             eEecCcceeEec
Confidence            578999999875


No 56
>7B17_B Spike glycoprotein, Neutralising nanobody E; spike glycoprotein, SARS-CoV-2, nanobody, VIRAL; HET: NAG; 4.01A {Severe acute respiratory syndrome coronavirus 2}
Probab=83.09  E-value=1.7  Score=20.27  Aligned_cols=14  Identities=29%  Similarity=0.415  Sum_probs=11.5  Template_Neff=12.600

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      .++||.||+|+|.+
T Consensus       252 ~~~~~~gt~l~v~~  265 (283)
T 7B17_B          252 MDYWGKGTQVTVSS  265 (283)
T ss_dssp             CSCCCCCEEEEECC
T ss_pred             ceeccCCeEEEEec
Confidence            46799999999863


No 57
>4UDF_7T HUMAN PARECHOVIRUS 1 CAPSID PROTEINS; HUMAN PARECHOVIRUS 1, VIRUS, HUMAN; 20.0A {Human parechovirus 1 (strain Harris)}
Probab=83.03  E-value=1.8  Score=15.37  Aligned_cols=12  Identities=33%  Similarity=0.418  Sum_probs=9.0  Template_Neff=14.900

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...|+.||++.|
T Consensus       110 ~~~~~~~~~l~v  121 (122)
T 4UDF_7T         110 FDSWGQGTLVTV  121 (122)
T ss_pred             eeeccccceEEe
Confidence            357888888876


No 58
>3IY0_H Fab 14, xray structure of; cryoEM, neutralizing antibody, parvovirus, canine; 12.5A {Mus musculus}
Probab=83.01  E-value=1.5  Score=15.54  Aligned_cols=13  Identities=23%  Similarity=0.243  Sum_probs=10.3  Template_Neff=14.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||+|.|.
T Consensus       107 ~~~~~~~~~l~v~  119 (120)
T 3IY0_H          107 FAYWGQGTLVTAG  119 (120)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             eeeEccceeEEeC
Confidence            3578999999874


No 59
>1KB5_B KB5-C20 T-CELL ANTIGEN RECEPTOR, ANTIBODY; T-CELL RECEPTOR, STRAND SWITCH, FAB; 2.5A {Mus musculus} SCOP: b.1.1.1
Probab=82.95  E-value=1.9  Score=15.93  Aligned_cols=14  Identities=57%  Similarity=1.042  Sum_probs=10.4  Template_Neff=14.100

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ....||.||++.|.
T Consensus       104 ~~~~~~~~t~l~v~  117 (117)
T 1KB5_B          104 ETLYFGSGTRLTVL  117 (117)
T ss_dssp             CCCEECCCEEEBCC
T ss_pred             cEEEecCCceEEeC
Confidence            34578999998764


No 60
>1KJ2_B Allogeneic H-2Kb MHC Class I; T CELL RECEPTOR, CLASS I; HET: NAG, SIA, MAN, GAL; 2.71A {Mus musculus} SCOP: b.1.1.1
Probab=82.95  E-value=1.9  Score=15.93  Aligned_cols=14  Identities=57%  Similarity=1.042  Sum_probs=10.7  Template_Neff=14.100

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ....||.||++.|.
T Consensus       104 ~~~~~~~~t~l~v~  117 (117)
T 1KJ2_B          104 ETLYFGSGTRLTVL  117 (117)
T ss_dssp             SSCCCCSCEEEEEC
T ss_pred             cEEEecCCceEEeC
Confidence            34678999999874


No 61
>6VPX_L Envelope glycoprotein gp120, Envelope glycoprotein; HIV, Envelope glycoprotein, Env, neutralizing; HET: FUC, NAG, BMA, 44E, GAL, MAN; 5.0A {Human immunodeficiency virus 1}
Probab=82.75  E-value=1.9  Score=15.27  Aligned_cols=12  Identities=67%  Similarity=1.035  Sum_probs=8.6  Template_Neff=14.500

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||+|.|+
T Consensus        97 ~~~~~~~~l~v~  108 (108)
T 6VPX_L           97 SVFGGGTKLTVL  108 (108)
T ss_pred             EEecCccEEEeC
Confidence            467888888763


No 62
>5J57_B Ricin (E.C.3.2.2.22), V5E1; Ricin, RTA, single chain antibodies; HET: EDO; 1.7A {Ricinus communis}
Probab=82.61  E-value=1.3  Score=16.45  Aligned_cols=15  Identities=40%  Similarity=0.490  Sum_probs=11.8  Template_Neff=14.300

Q ss_pred             CCCcccCCCCeeeeC
Q tr|A0A075B6V7|    5 GQNFVFGPGTRLSVL   19 (20)
Q Consensus         5 gqnfvfgpgtrlsvl   19 (20)
                      .....||.||+++|.
T Consensus       110 ~~~~~~~~~t~l~v~  124 (127)
T 5J57_B          110 GSYGVRGQGTQVTVS  124 (127)
T ss_dssp             SCCCEEBCCEEEEEC
T ss_pred             eeEEEecccEEEEEe
Confidence            345689999999885


No 63
>1MOE_A anti-CEA mAb T84.66; anti carcinoembryonic antigen, T84.66, diabody; HET: SO4; 2.6A {Mus musculus} SCOP: b.1.1.1
Probab=82.57  E-value=1.5  Score=19.03  Aligned_cols=13  Identities=31%  Similarity=0.460  Sum_probs=11.2  Template_Neff=13.500

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      +.+||.||+|.|-
T Consensus       227 ~~~~~~~t~l~v~  239 (240)
T 1MOE_A          227 MAYWGQGTSVTVS  239 (240)
T ss_dssp             CCCCCCCEEEEEC
T ss_pred             eeeecCCeeEEEc
Confidence            5799999999884


No 64
>4K3G_A L5(L89S); immunoglobulin fold, fluorescence, malachite green; HET: MAN; 1.93A {Homo sapiens}
Probab=82.50  E-value=1.2  Score=16.88  Aligned_cols=13  Identities=54%  Similarity=1.096  Sum_probs=10.4  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||.||+|.|-
T Consensus        97 ~~~~g~gt~~~~~  109 (118)
T 4K3G_A           97 GYLFGGGTQLTVL  109 (118)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             cEEECCeEEeEec
Confidence            3678999999874


No 65
>4K3H_H L5(L89S); immunoglobulin fold, fluorescensce, malachite green; HET: GOL, 1OM, MAN; 2.45A {Homo sapiens}
Probab=82.50  E-value=1.2  Score=16.88  Aligned_cols=13  Identities=54%  Similarity=1.096  Sum_probs=10.3  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||.||+|.|-
T Consensus        97 ~~~~g~gt~~~~~  109 (118)
T 4K3H_H           97 GYLFGGGTQLTVL  109 (118)
T ss_dssp             EEEEBCCEEEEEC
T ss_pred             cEEECCeEEeEec
Confidence            3678999999874


No 66
>1MFA_H FV FRAGMENT (MURINE SE155-4) COMPLEX; IMMUNOGLOBULIN; HET: MMA, GLA; 1.7A {Mus musculus} SCOP: b.1.1.1
Probab=82.48  E-value=1.5  Score=15.40  Aligned_cols=13  Identities=31%  Similarity=0.478  Sum_probs=9.7  Template_Neff=15.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+++++|+|.
T Consensus       105 ~~~~~~~~~l~v~  117 (120)
T 1MFA_H          105 GDYWGQGASLTVS  117 (120)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             eeeecCceEEEEe
Confidence            3467889988875


No 67
>2A9N_H anti-glycoprotein VI immunoglobulin lambda light; immunoglobulin, fluorescein, scFv, Immune System; HET: ORE; 3.0A {Homo sapiens}
Probab=82.37  E-value=1.7  Score=15.78  Aligned_cols=13  Identities=38%  Similarity=0.478  Sum_probs=10.4  Template_Neff=14.600

Q ss_pred             CCcccCCCCeeee
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSV   18 (20)
Q Consensus         6 qnfvfgpgtrlsv   18 (20)
                      ....||.||++.|
T Consensus       113 ~~~~~~~gt~l~v  125 (126)
T 2A9N_H          113 YMDVWGQGTLVTV  125 (126)
T ss_dssp             CCCEECCCEEEEE
T ss_pred             eeeeecCCeEEEe
Confidence            4567899999987


No 68
>6U59_K SOSIP.664 gp120, SOSIP.664 gp41, rabbit; HIV-1, rabbit antibody, SOSIP, VIRAL; HET: BMA, NAG, MAN; 3.86A {Human immunodeficiency virus 1}
Probab=82.27  E-value=2  Score=15.13  Aligned_cols=12  Identities=42%  Similarity=0.778  Sum_probs=8.9  Template_Neff=14.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+||.||++.|.
T Consensus       107 ~~~~~~~~l~v~  118 (119)
T 6U59_K          107 NLWGPGTLVTVS  118 (119)
T ss_pred             EEecCCeeEEEe
Confidence            467888888764


No 69
>1FO0_B MURIN ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS; T CELL RECEPTOR, CLASS I; 2.5A {Mus musculus} SCOP: b.1.1.1
Probab=82.26  E-value=1.4  Score=16.08  Aligned_cols=12  Identities=50%  Similarity=0.913  Sum_probs=8.5  Template_Neff=14.200

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...||.||+|.|
T Consensus       101 ~~~~~~gt~l~v  112 (112)
T 1FO0_B          101 TLYFGEGSRLIV  112 (112)
T ss_pred             EEEEcCCceEeC
Confidence            357888888764


No 70
>5UJZ_G Hemagglutinin HA1, Hemagglutinin HA2, scFv; Viral glycoprotein, Hemagglutinin, Antibody fragment; HET: BMA, NAG; 4.8A {Influenza A virus (A/Solomon Islands/3/2006(H1N1))}
Probab=82.20  E-value=1.1  Score=20.20  Aligned_cols=15  Identities=33%  Similarity=0.503  Sum_probs=12.0  Template_Neff=13.100

Q ss_pred             CCcccCCCCeeeeCC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVLP   20 (20)
Q Consensus         6 qnfvfgpgtrlsvlp   20 (20)
                      .+.+||.||+|+|.+
T Consensus       238 ~~~~~~~g~~~~v~~  252 (266)
T 5UJZ_G          238 AMAVWGQGTTVTVSS  252 (266)
T ss_dssp             SCSBCCCCEEEEECC
T ss_pred             EEEEECCCeEEEEEe
Confidence            356799999999853


No 71
>5KEM_G BDBV91 variable Fab domain light; Ebola virus secreted glycoprotein, sGP; 5.5A {Homo sapiens}
Probab=82.15  E-value=0.72  Score=16.59  Aligned_cols=12  Identities=33%  Similarity=0.465  Sum_probs=8.9  Template_Neff=14.700

Q ss_pred             CCcccCCCCeee
Q tr|A0A075B6V7|    6 QNFVFGPGTRLS   17 (20)
Q Consensus         6 qnfvfgpgtrls   17 (20)
                      ...+||.||+|+
T Consensus       110 ~~~~~g~gt~l~  121 (121)
T 5KEM_G          110 AVDVWGQGTLVT  121 (121)
T ss_dssp             CBCCCCCCEEEC
T ss_pred             eeeeeccCeecC
Confidence            455899998874


No 72
>7K22_H4 8A7H5 Fab light chain, 8A7H5; polyomavirus, capsomer, VIRAL PROTEIN;{Rattus norvegicus}
Probab=81.90  E-value=2.3  Score=14.82  Aligned_cols=11  Identities=36%  Similarity=0.567  Sum_probs=7.8  Template_Neff=15.000

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      .+|+.||+|.|
T Consensus       106 ~~~~~~~~l~v  116 (117)
T 7K22_H4         106 PYWGQGTLVTV  116 (117)
T ss_pred             ccccCCeEEEe
Confidence            35688888765


No 73
>7K23_H2 8A7H5 Fab light chain, 8A7H5; polyomavirus, capsomer, VP1, Fab, VIRAL; 3.3A {Rattus norvegicus}
Probab=81.90  E-value=2.3  Score=14.82  Aligned_cols=11  Identities=36%  Similarity=0.567  Sum_probs=7.8  Template_Neff=15.000

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      .+|+.||+|.|
T Consensus       106 ~~~~~~~~l~v  116 (117)
T 7K23_H2         106 PYWGQGTLVTV  116 (117)
T ss_pred             ccccCCeEEEe
Confidence            35688888765


No 74
>6J9O_H Heavy chain of AF4H1K1 scFv; a free scFv molecule, AF4H1K1; 1.397A {Homo sapiens}
Probab=81.74  E-value=2.8  Score=15.30  Aligned_cols=14  Identities=29%  Similarity=0.316  Sum_probs=10.7  Template_Neff=14.600

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      ...|+.||++.|.+
T Consensus       117 ~~~~~~~t~l~v~~  130 (130)
T 6J9O_H          117 FDYWGQGTLVTVSS  130 (130)
T ss_dssp             CCEECCCEEEEECC
T ss_pred             ceeecCCeEEEEeC
Confidence            35789999998853


No 75
>5VM4_L Single domain camelid nanobody VHH; nanobody, triclocarban, UNKNOWN FUNCTION; HET: FMT, ACT; 1.9A {Lama glama}
Probab=81.61  E-value=2.8  Score=17.25  Aligned_cols=12  Identities=33%  Similarity=0.584  Sum_probs=10.0  Template_Neff=12.700

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...||+|+++.|
T Consensus       118 ~~~~~~g~~~~~  129 (137)
T 5VM4_L          118 YPYWGQGTQVTV  129 (137)
T ss_dssp             CCEECCCEEEEE
T ss_pred             CCcccCCeeeEE
Confidence            457999999987


No 76
>5VM6_A single domain camelid nanobody VHH; nanobody, triclocarban, UNKNOWN FUNCTION; HET: SO4, 9EG; 1.5A {Lama glama}
Probab=81.61  E-value=2.8  Score=17.25  Aligned_cols=13  Identities=31%  Similarity=0.486  Sum_probs=10.4  Template_Neff=12.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||+|+++.|.
T Consensus       118 ~~~~~~g~~~~~~  130 (137)
T 5VM6_A          118 YPYWGQGTQVTVS  130 (137)
T ss_dssp             CCEECCCEEEEEE
T ss_pred             CCcccCCeeeEEe
Confidence            4579999999873


No 77
>7ME7_A SARS-CoV-2 Receptor binding domain nanobody;{Severe acute respiratory syndrome coronavirus 2}
Probab=81.55  E-value=1.7  Score=15.42  Aligned_cols=13  Identities=31%  Similarity=0.567  Sum_probs=9.7  Template_Neff=14.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||+|.|-
T Consensus       106 ~~~~~~~t~l~v~  118 (119)
T 7ME7_A          106 RAYWGQGTQVTVS  118 (119)
T ss_pred             eeEEecCeeeEec
Confidence            4578889988763


No 78
>6VN0_K Envelope glycoprotein gp160, BG505 SOSIPv5.2; HIV, antibody, VIRAL PROTEIN, VIRAL; HET: BMA, NAG, MAN; 4.25A {Human immunodeficiency virus 1}
Probab=81.26  E-value=2.3  Score=15.53  Aligned_cols=11  Identities=45%  Similarity=1.129  Sum_probs=8.2  Template_Neff=14.000

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.|+.+|+|.|
T Consensus        96 ~~~~~~~~l~v  106 (107)
T 6VN0_K           96 CTFGPGTKVEI  106 (107)
T ss_pred             cEeCCCeEEEE
Confidence            56788888765


No 79
>7A6O_B Thrombosis Von Willebrand Factor A1; 2.117A {Homo sapiens}
Probab=81.23  E-value=3  Score=15.35  Aligned_cols=13  Identities=31%  Similarity=0.557  Sum_probs=10.4  Template_Neff=14.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||+|+|.
T Consensus       115 ~~~~~~~t~l~v~  127 (128)
T 7A6O_B          115 YTFWGQGTQVTVS  127 (128)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             eeEecCCceeEec
Confidence            4578999999885


No 80
>4LAS_H Single chain antibody fragment scFv6H4; methamphetamine, anti-methamphetamine antibody, therapeutic antibody; HET: 1WF; 2.33A {Mus musculus}
Probab=81.22  E-value=1.9  Score=20.01  Aligned_cols=12  Identities=50%  Similarity=1.088  Sum_probs=10.2  Template_Neff=12.300

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      .+.||.||+|.|
T Consensus       228 ~~~f~~g~~~~~  239 (249)
T 4LAS_H          228 PFTFGSGTKLEI  239 (249)
T ss_dssp             SCEECCCEEEEE
T ss_pred             CEEeCCCcEEEE
Confidence            368999999987


No 81
>7N65_K HIV-1 Envelope, superinfection antibody QA013.2; HET: BMA, NAG, MAN;{Human immunodeficiency virus 1}
Probab=81.04  E-value=3.8  Score=15.08  Aligned_cols=12  Identities=42%  Similarity=0.639  Sum_probs=9.7  Template_Neff=14.400

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||+|.|.
T Consensus       116 ~~~~~~t~l~v~  127 (128)
T 7N65_K          116 DPWGPGTLVTVS  127 (128)
T ss_dssp             CCCCCCEEEEEC
T ss_pred             CCcCCCceeEec
Confidence            458999999875


No 82
>7AZB_B Discoidin domain-containing receptor 2 (E.C.2.7.10.1); Kinase, Extracellular domain, Receptor Tyrosine; 2.62A {Homo sapiens}
Probab=80.89  E-value=3  Score=16.35  Aligned_cols=13  Identities=31%  Similarity=0.621  Sum_probs=10.5  Template_Neff=13.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||.||.+.|-
T Consensus       131 ~~~~g~gt~l~v~  143 (153)
T 7AZB_B          131 PIYWGQGTQVTVS  143 (153)
T ss_dssp             CCCCCCCEEEECC
T ss_pred             CEEecCCceEEEe
Confidence            4689999998774


No 83
>5YY5_D MERS-CoV RBD, Heavy chain, Light; MERS-CoV, spike glycorptotein, neutralizing antibody; HET: NAG; 2.8A {Middle East respiratory syndrome coronavirus}
Probab=80.71  E-value=1.6  Score=14.89  Aligned_cols=11  Identities=55%  Similarity=0.896  Sum_probs=7.7  Template_Neff=15.000

Q ss_pred             CcccCCCCeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLS   17 (20)
Q Consensus         7 nfvfgpgtrls   17 (20)
                      ...||.||+|+
T Consensus        95 ~~~~~~~~~l~  105 (105)
T 5YY5_D           95 GAVFGGGTQLT  105 (105)
T ss_dssp             EEEECCCEECE
T ss_pred             ceEEcCceecC
Confidence            35678888764


No 84
>6J14_B GY-14 heavy chain V fragment; tumor immunotherapy, complex structure, FG; 1.4A {Mus musculus}
Probab=80.63  E-value=2.5  Score=15.20  Aligned_cols=12  Identities=42%  Similarity=0.938  Sum_probs=9.6  Template_Neff=14.400

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      .+.|+.|++|.|
T Consensus       100 ~~~~~~~~~l~v  111 (112)
T 6J14_B          100 PYTFGGGTKLEM  111 (112)
T ss_dssp             SCEECCCEEEEE
T ss_pred             CeEEcceeeeEE
Confidence            467899998876


No 85
>6MPG_M A12V163-b.01 Light Chain, Envelope glycoprotein; Complex, Fusion peptide, Neutralizing antibody; HET: BMA, NAG, MAN; 3.2A {Macaca mulatta}
Probab=80.60  E-value=2.3  Score=15.86  Aligned_cols=10  Identities=50%  Similarity=0.953  Sum_probs=8.3  Template_Neff=14.300

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      +||.||+|.|
T Consensus       121 ~~~~~t~l~v  130 (132)
T 6MPG_M          121 VWGKGTSVTV  130 (132)
T ss_pred             ccccceEEEe
Confidence            6889998876


No 86
>6RBB_H VHH domain; VHH, antibody netakimab, complementarity determining; 2.45A {Lama glama}
Probab=80.58  E-value=2  Score=15.36  Aligned_cols=13  Identities=31%  Similarity=0.376  Sum_probs=10.0  Template_Neff=14.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||++.|.
T Consensus       110 ~~~~~~~~~l~v~  122 (123)
T 6RBB_H          110 YDSWGQGTLVTVS  122 (123)
T ss_dssp             EEECSCCEEEEEE
T ss_pred             eEeecCceEEEee
Confidence            4568999998874


No 87
>7SHU_E IgE, omalizumab, xolair, inhibitor, immune; HET: BMA, NAG, MAN, EDO; 2.75A {Homo sapiens}
Probab=80.58  E-value=2  Score=15.23  Aligned_cols=11  Identities=45%  Similarity=0.755  Sum_probs=8.3  Template_Neff=14.900

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      +|+.||+|.|.
T Consensus       111 ~~~~~~~l~v~  121 (123)
T 7SHU_E          111 VWGQGTLVTVS  121 (123)
T ss_pred             EEecceEEEEe
Confidence            48888888764


No 88
>7NQK_B proton-coupled peptide transporter, MEMBRANE PROTEIN;{Lama glama}
Probab=80.51  E-value=2.2  Score=15.82  Aligned_cols=14  Identities=29%  Similarity=0.413  Sum_probs=10.3  Template_Neff=14.400

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ....||.||+|+|.
T Consensus       116 ~~~~~~~~t~l~v~  129 (131)
T 7NQK_B          116 FYETWGQGTQVTVS  129 (131)
T ss_dssp             TCCCCCCBCCCCC-
T ss_pred             eeEeeccceEEEEe
Confidence            35678999998874


No 89
>3J8V_I L1, H16.14J light chain, H16.14J; L1 pentamer, quasi-HPV16, L1 capsomer; 13.9A {Human papillomavirus type 16}
Probab=80.36  E-value=2.4  Score=14.85  Aligned_cols=11  Identities=36%  Similarity=0.606  Sum_probs=8.5  Template_Neff=15.000

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..||.||+|.|
T Consensus       108 ~~~~~~t~l~v  118 (119)
T 3J8V_I          108 DYWGQGTSVTV  118 (119)
T ss_dssp             EEECCCEEEEE
T ss_pred             eeccCCeEEEe
Confidence            46788888876


No 90
>6MN7_I Envelope Glycoprotein gp120, Envelope Glycoprotein; VIRAL PROTEIN, Complex, Broadly neutralizing; HET: BMA, NAG, MAN; 4.8A {Human immunodeficiency virus 1}
Probab=80.35  E-value=3.1  Score=17.99  Aligned_cols=13  Identities=46%  Similarity=1.127  Sum_probs=10.9  Template_Neff=13.500

Q ss_pred             CCcccCCCCeeee
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSV   18 (20)
Q Consensus         6 qnfvfgpgtrlsv   18 (20)
                      ..+.||++|+|.|
T Consensus       223 ~~~~~~~~~~l~V  235 (236)
T 6MN7_I          223 SPFTFGPGTKVHI  235 (236)
T ss_dssp             TTCEECCCEEEEE
T ss_pred             CCeeeCCCceEEe
Confidence            4678999999987


No 91
>1I3V_B Antibody VHH lama domain; antibody, domain VHH, Lama, IMMUNE; 2.03A {Lama glama} SCOP: b.1.1.1
Probab=80.29  E-value=2.7  Score=15.41  Aligned_cols=13  Identities=31%  Similarity=0.447  Sum_probs=10.2  Template_Neff=14.500

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+|+.||+|.|.
T Consensus       116 ~~~~~~~t~l~v~  128 (129)
T 1I3V_B          116 WNYWGQGTQVTVS  128 (129)
T ss_dssp             CSEECCCEEEEEE
T ss_pred             ceecccCceeEec
Confidence            4578999999873


No 92
>7JV2_L S2H13 Fab heavy chain, S2H13; SARS-CoV-2, COVID-19, spike glycoprotein, fusion; 3.5A {Homo sapiens}
Probab=80.28  E-value=4.1  Score=14.91  Aligned_cols=13  Identities=62%  Similarity=0.902  Sum_probs=9.8  Template_Neff=14.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.+++|.|+
T Consensus        98 ~~~~~~~~~l~v~  110 (110)
T 7JV2_L           98 RGVFGGGTKLTVL  110 (110)
T ss_dssp             CCEECCCEEEEEC
T ss_pred             cceecCceEEEEC
Confidence            3567888888875


No 93
>6VN0_H Envelope glycoprotein gp160, BG505 SOSIPv5.2; HIV, antibody, VIRAL PROTEIN, VIRAL; HET: BMA, NAG, MAN; 4.25A {Human immunodeficiency virus 1}
Probab=80.25  E-value=1.9  Score=15.77  Aligned_cols=14  Identities=29%  Similarity=0.567  Sum_probs=10.5  Template_Neff=14.500

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ....||.||.|.|.
T Consensus       112 ~~~~~~~~~~l~v~  125 (126)
T 6VN0_H          112 YFDLWGPGTPITIS  125 (126)
T ss_pred             hhHhccCCcceEEe
Confidence            45678999988764


No 94
>6VN0_I Envelope glycoprotein gp160, BG505 SOSIPv5.2; HIV, antibody, VIRAL PROTEIN, VIRAL; HET: BMA, NAG, MAN; 4.25A {Human immunodeficiency virus 1}
Probab=80.25  E-value=1.9  Score=15.77  Aligned_cols=14  Identities=29%  Similarity=0.567  Sum_probs=10.5  Template_Neff=14.500

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ....||.||.|.|.
T Consensus       112 ~~~~~~~~~~l~v~  125 (126)
T 6VN0_I          112 YFDLWGPGTPITIS  125 (126)
T ss_pred             hhHhccCCcceEEe
Confidence            45678999988764


No 95
>2YC1_D SINGLE CHAIN ANTIBODY FRAGMENT 9004G; IMMUNE SYSTEM-TOXIN COMPLEX, SCORPION TOXIN; HET: GOL; 1.9A {CENTRUROIDES NOXIUS HOFFMANN}
Probab=80.18  E-value=2.8  Score=14.42  Aligned_cols=12  Identities=33%  Similarity=0.487  Sum_probs=9.2  Template_Neff=15.200

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|++|++|+|.
T Consensus       105 ~~~~~~~~l~v~  116 (117)
T 2YC1_D          105 DTWGQGTMVTVS  116 (117)
T ss_dssp             EEECCCEEEEEC
T ss_pred             eEecCCeeEEEc
Confidence            467888888874


No 96
>3E3Q_C TCR, MHC, high affinity, cross; 2.95A {Mus musculus}
Probab=80.02  E-value=3.9  Score=14.30  Aligned_cols=13  Identities=46%  Similarity=0.825  Sum_probs=9.8  Template_Neff=14.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.+++|.|+
T Consensus        97 ~~~~~~~~~l~v~  109 (109)
T 3E3Q_C           97 LLTFGSGTKVIVL  109 (109)
T ss_dssp             CEEECCCEEEEEC
T ss_pred             ceeecCCcEEEEC
Confidence            3567888888875


No 97
>7LPN_D CD4, HIV-1, SOSIP, Vaccine, IMMUNE; HET: BMA, NAG, MAN;{Human immunodeficiency virus 1}
Probab=79.79  E-value=2.4  Score=16.04  Aligned_cols=13  Identities=31%  Similarity=0.450  Sum_probs=9.7  Template_Neff=14.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||.||++.|.
T Consensus       108 ~~~~~~gt~l~v~  120 (130)
T 7LPN_D          108 YDYWGRGTQVTVS  120 (130)
T ss_pred             eeEEecCceeEec
Confidence            3478999988763


No 98
>6NB3_H Spike glycoprotein, LCA60 light chain; coronavirus spike glycoprotein, MERS-CoV, SARS-CoV; HET: BMA, NAG, MAN; 3.5A {Middle East respiratory syndrome-related coronavirus}
Probab=79.74  E-value=2.3  Score=15.35  Aligned_cols=13  Identities=23%  Similarity=0.281  Sum_probs=9.7  Template_Neff=14.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||+|.|-
T Consensus       114 ~~~~~~~~~l~v~  126 (127)
T 6NB3_H          114 FDYWGQGALVTVS  126 (127)
T ss_pred             eeeeccceeEEEc
Confidence            4578889988763


No 99
>6U53_A Anti-Zaire ebolavirus Nucleoprotein Single Domain; Antibody, nanobody, Ebola, filovirus, IMMUNE; 1.49A {Lama glama}
Probab=79.50  E-value=2.8  Score=15.40  Aligned_cols=12  Identities=33%  Similarity=0.697  Sum_probs=9.4  Template_Neff=14.300

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||++.|.
T Consensus       102 ~~~~~gt~l~v~  113 (123)
T 6U53_A          102 IYWGQGTQVTVS  113 (123)
T ss_dssp             EEECCCEEEEES
T ss_pred             eEEcCCEEEEec
Confidence            468899988874


No 100
>7LXW_H S2X333 Fab Light Chain variable; Antibody, VIRAL PROTEIN, Structural Genomics; HET: FUC, NAG; 2.8A {Homo sapiens}
Probab=79.33  E-value=2.1  Score=15.15  Aligned_cols=11  Identities=36%  Similarity=0.546  Sum_probs=8.0  Template_Neff=14.900

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      .+||+||.|.|
T Consensus       111 ~~~~~~~~l~v  121 (121)
T 7LXW_H          111 DYWGQGTLVTV  121 (121)
T ss_dssp             EEECCCEEEEC
T ss_pred             EeecCCeeEEC
Confidence            46788888764


No 101
>7LXY_G Spike glycoprotein, S2M11 Fab Light; Antibody, VIRAL PROTEIN, Structural Genomics; HET: BMA, FUC, NAG;{Severe acute respiratory syndrome coronavirus 2}
Probab=79.33  E-value=2.1  Score=15.15  Aligned_cols=12  Identities=33%  Similarity=0.423  Sum_probs=8.2  Template_Neff=14.900

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ..+||+||.|.|
T Consensus       110 ~~~~~~~~~l~v  121 (121)
T 7LXY_G          110 IDYWGQGTLVTV  121 (121)
T ss_pred             EEeecCCeeEEC
Confidence            346788887764


No 102
>7EO0_H FOOT AND MOUTH DISEASE VIRUS; 3.75A {Foot-and-mouth disease virus}
Probab=79.25  E-value=2.8  Score=15.46  Aligned_cols=13  Identities=23%  Similarity=0.353  Sum_probs=10.1  Template_Neff=14.400

Q ss_pred             cccCCCCeeeeCC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVLP   20 (20)
Q Consensus         8 fvfgpgtrlsvlp   20 (20)
                      ..|++||.++|.+
T Consensus       117 ~~~~~gt~~~v~~  129 (129)
T 7EO0_H          117 DAWGQGLLVTVSS  129 (129)
T ss_dssp             EEECCCEEECCCC
T ss_pred             eeecceeEEEEeC
Confidence            5689999988754


No 103
>5VLV_A Single Domain Camelid Nanobody VHH; nanobody, triclocarban, UNKNOWN FUNCTION; 1.35A {Lama glama}
Probab=79.12  E-value=2.2  Score=16.90  Aligned_cols=12  Identities=33%  Similarity=0.661  Sum_probs=9.4  Template_Neff=13.300

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+||.|+++.+.
T Consensus       114 ~~~g~g~~~~~~  125 (132)
T 5VLV_A          114 PIWGRGTQVTVS  125 (132)
T ss_dssp             CEECCCEEEEEE
T ss_pred             ccccccccceee
Confidence            458999998763


No 104
>5YOY_P Tumor necrosis factor, Golimumab light; Cytokine, Antibody, IMMUNE SYSTEM; 2.727A {Homo sapiens}
Probab=79.10  E-value=2.6  Score=15.27  Aligned_cols=13  Identities=38%  Similarity=0.519  Sum_probs=10.5  Template_Neff=14.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||.|+|.
T Consensus       116 ~~~~~~~~~l~v~  128 (129)
T 5YOY_P          116 MDVWGQGTTVTVS  128 (129)
T ss_dssp             CCCBBCCEEEEEC
T ss_pred             ceEEcCCeEEEEc
Confidence            4678999999874


No 105
>5YOY_Q Tumor necrosis factor, Golimumab light; Cytokine, Antibody, IMMUNE SYSTEM; 2.727A {Homo sapiens}
Probab=79.10  E-value=2.6  Score=15.27  Aligned_cols=13  Identities=38%  Similarity=0.519  Sum_probs=10.5  Template_Neff=14.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||.|+|.
T Consensus       116 ~~~~~~~~~l~v~  128 (129)
T 5YOY_Q          116 MDVWGQGTTVTVS  128 (129)
T ss_dssp             CCCBCCCEEEECC
T ss_pred             ceEEcCCeEEEEc
Confidence            4678999999874


No 106
>5O02_C Viral protein 1, Nanobody (VHH); Norovirus, Protruding domain, capsid, VHH; HET: EDO; 1.72A {Norovirus 13-BH-1/2013/GII.17}
Probab=79.10  E-value=4.2  Score=14.50  Aligned_cols=13  Identities=31%  Similarity=0.496  Sum_probs=10.3  Template_Neff=14.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||+++|.
T Consensus       111 ~~~~~~~~~l~v~  123 (124)
T 5O02_C          111 GGYWGQGTQVTVS  123 (124)
T ss_dssp             CBEECCCEEEEEC
T ss_pred             CcccccCceeeec
Confidence            4578999999875


No 107
>5JA9_A Toxin HigB-2, Nanobody 6; toxin-antitoxin system, toxin; HET: SO4, EDO; 1.849A {Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961)}
Probab=78.41  E-value=2.5  Score=16.11  Aligned_cols=12  Identities=33%  Similarity=0.631  Sum_probs=8.8  Template_Neff=13.700

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...||+|+.+.|
T Consensus       104 ~~~~g~g~~~~~  115 (123)
T 5JA9_A          104 SDSWGQGTQVTV  115 (123)
T ss_pred             eEeecCCcEEEc
Confidence            346889988765


No 108
>5N88_A VH59 antibody, PC4 and SFRS1-interacting; MLL: HIV: intracellular antibody: integrase:; 1.7A {Homo sapiens}
Probab=78.16  E-value=2.7  Score=15.25  Aligned_cols=11  Identities=36%  Similarity=0.546  Sum_probs=8.7  Template_Neff=14.600

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..||.||++.|
T Consensus       115 ~~~~~~~~l~v  125 (126)
T 5N88_A          115 DYWGQGTLVTV  125 (126)
T ss_dssp             EEECCCEEEEE
T ss_pred             EEecCceeEEe
Confidence            35899999876


No 109
>4FFY_L DENV1-E111 single chain variable fragment; Viral envelope proteins, structural genomics; 2.5A {Mus musculus}
Probab=77.92  E-value=4.3  Score=15.34  Aligned_cols=13  Identities=38%  Similarity=0.851  Sum_probs=10.0  Template_Neff=13.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      .+.|+.||++.|.
T Consensus        99 ~~~~~~~~~l~v~  111 (126)
T 4FFY_L           99 PYTFGGGTKLEIK  111 (126)
T ss_dssp             SCEECCCEEEEEE
T ss_pred             CcEECCCcEEEEc
Confidence            4678899988774


No 110
>4UU9_H MEDI7814, COMPLEMENT C5; IMMUNE SYSTEM, FV, COMPLEMENT SYSTEM; HET: SO4; 2.12A {HOMO SAPIENS}
Probab=77.84  E-value=3.2  Score=14.61  Aligned_cols=12  Identities=42%  Similarity=0.578  Sum_probs=9.3  Template_Neff=15.000

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...|+.||++.|
T Consensus       111 ~~~~~~~~~l~v  122 (123)
T 4UU9_H          111 MDVWGQGTMVTV  122 (123)
T ss_dssp             CCEECCCEEEEE
T ss_pred             eEEeCCCeeEEe
Confidence            346899999876


No 111
>5VM0_B Camelid Nanobody VHH T9; nanobody, triclocarban, UNKNOWN FUNCTION; HET: 9EG, EDO; 1.79A {Lama glama}
Probab=77.71  E-value=5  Score=14.49  Aligned_cols=12  Identities=33%  Similarity=0.661  Sum_probs=9.6  Template_Neff=14.700

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||+|.|.
T Consensus       114 ~~~~~~t~l~v~  125 (128)
T 5VM0_B          114 PIWGRGTQVTVS  125 (128)
T ss_dssp             CEECCCEEEEEE
T ss_pred             CcccCCceeEee
Confidence            478999998874


No 112
>6DZM_J Envelope glycoprotein, Glycoprotein, Antibody ADI-15878; antibody, pan-ebolavirus, internal fusion loop; HET: BMA, NAG, MAN; 4.29A {Bundibugyo ebolavirus}
Probab=77.69  E-value=3.3  Score=14.51  Aligned_cols=12  Identities=25%  Similarity=0.362  Sum_probs=8.4  Template_Neff=15.000

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...||.||.+.|
T Consensus       108 ~~~~~~~~~l~v  119 (120)
T 6DZM_J          108 FDYWGQGALVTV  119 (120)
T ss_pred             eeEecCCeEEEe
Confidence            346788888765


No 113
>6VLR_F Envelope glycoprotein gp120, BG505 SOSIPv5.2; HIV, antibody, Fab, vaccine, VIRAL; HET: BMA, NAG, MAN; 4.42A {Human immunodeficiency virus 1}
Probab=77.68  E-value=2.6  Score=15.06  Aligned_cols=12  Identities=42%  Similarity=0.714  Sum_probs=9.0  Template_Neff=14.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||.|.|.
T Consensus       111 ~~~~~g~~l~v~  122 (123)
T 6VLR_F          111 DVWGPGVLVTVS  122 (123)
T ss_pred             eeeecceeeEec
Confidence            478888888763


No 114
>2X89_C ANTIBODY, BETA-2-MICROGLOBULIN; IMMUNE SYSTEM; 2.16A {CAMELUS DROMEDARIUS}
Probab=77.61  E-value=3.5  Score=15.19  Aligned_cols=13  Identities=31%  Similarity=0.457  Sum_probs=10.2  Template_Neff=14.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||.|.|.
T Consensus       115 ~~~~~~~~~l~v~  127 (128)
T 2X89_C          115 FRYWGQGTQVTVS  127 (128)
T ss_dssp             CSEECCCEEEEEE
T ss_pred             eEEecCCeEEEEe
Confidence            3578999999874


No 115
>7OMN_C VH domain, EphA1, IMMUNE SYSTEM; HET: IMD; 1.7A {Homo sapiens}
Probab=77.52  E-value=3.2  Score=14.92  Aligned_cols=11  Identities=36%  Similarity=0.619  Sum_probs=9.1  Template_Neff=14.700

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .||.||++.|.
T Consensus       114 ~~~~~~~l~v~  124 (125)
T 7OMN_C          114 YWGQGTLVTVS  124 (125)
T ss_dssp             EECCCEEEEEC
T ss_pred             EEccceEEEec
Confidence            78999998874


No 116
>7E53_B Aequorea victoria, Camelus bactrianus, FLUORESCENT; HET: CRO; 2.21A {Aequorea victoria}
Probab=77.42  E-value=4  Score=14.92  Aligned_cols=12  Identities=33%  Similarity=0.545  Sum_probs=9.4  Template_Neff=14.500

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||+|.|.
T Consensus       116 ~~~~~~t~l~v~  127 (128)
T 7E53_B          116 DYWGQGTQVTVS  127 (128)
T ss_dssp             SEECCCEEEEC-
T ss_pred             eeeecceeeEec
Confidence            678999998874


No 117
>4JVP_A Anti-HCV E2 alpaca nanobody D03; Heavy-chain antibody, nanobody, Immunoglobulin fold; HET: SO4; 1.76A {Vicugna pacos}
Probab=77.20  E-value=3.7  Score=16.20  Aligned_cols=13  Identities=31%  Similarity=0.409  Sum_probs=9.7  Template_Neff=13.600

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||+|.|.
T Consensus       116 ~~~~~~gt~l~v~  128 (143)
T 4JVP_A          116 FGSWGQGTQVTVS  128 (143)
T ss_dssp             SEEEEEEEEEEEC
T ss_pred             ceeecCCceEEEe
Confidence            3567889988874


No 118
>3JBF_7 Capsid protein VP1, Capsid protein; poliovirus, nanobodies, VHH, neutralizing antibodies; HET: MYR, PLM; 4.6A {Human poliovirus 1 Mahoney}
Probab=77.15  E-value=3.2  Score=16.39  Aligned_cols=11  Identities=36%  Similarity=0.715  Sum_probs=9.0  Template_Neff=13.200

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      -+||+|+.+.|
T Consensus       109 ~~~g~g~~~~~  119 (127)
T 3JBF_7          109 QYWGQGTQVTV  119 (127)
T ss_dssp             SEECCCEECEE
T ss_pred             eeecCCeEEEe
Confidence            47899998876


No 119
>7SOB_H kappa, spike, antibody, Structural Genomics; HET: NAG; 2.4A {Severe acute respiratory syndrome coronavirus 2}
Probab=77.09  E-value=4.9  Score=14.68  Aligned_cols=13  Identities=31%  Similarity=0.302  Sum_probs=8.6  Template_Neff=14.500

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||.||.|.|.
T Consensus       113 ~~~~~~~~~l~v~  125 (128)
T 7SOB_H          113 FDNWGQGTLVTVS  125 (128)
T ss_dssp             ---ECCCEEEEEC
T ss_pred             cceecccceEEEe
Confidence            3478999999875


No 120
>7SOB_N kappa, spike, antibody, Structural Genomics; HET: NAG; 2.4A {Severe acute respiratory syndrome coronavirus 2}
Probab=77.09  E-value=4.9  Score=14.68  Aligned_cols=12  Identities=33%  Similarity=0.412  Sum_probs=9.7  Template_Neff=14.500

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+||.||.|.|.
T Consensus       114 ~~~~~~~~l~v~  125 (128)
T 7SOB_N          114 DNWGQGTLVTVS  125 (128)
T ss_dssp             EEECCCEEEEEC
T ss_pred             ceecccceEEEe
Confidence            378999999875


No 121
>6LI3_N G-protein coupled receptor 52, Guanine; G-protein coupled receptor, orphan GPCR; 3.32A {Homo sapiens}
Probab=77.06  E-value=2.3  Score=16.23  Aligned_cols=11  Identities=36%  Similarity=0.519  Sum_probs=8.6  Template_Neff=14.300

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..||.||+|.|
T Consensus       139 ~~~~~gt~l~v  149 (149)
T 6LI3_N          139 AYRGQGTQVTV  149 (149)
T ss_dssp             SSSCCCEEECC
T ss_pred             EEeccCceeeC
Confidence            37899998865


No 122
>7EVW_N GPCR, Class F, Frizzled, Fzd7; 3.22A {Homo sapiens}
Probab=77.06  E-value=2.3  Score=16.23  Aligned_cols=11  Identities=36%  Similarity=0.519  Sum_probs=8.7  Template_Neff=14.300

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..||.||+|.|
T Consensus       139 ~~~~~gt~l~v  149 (149)
T 7EVW_N          139 AYRGQGTQVTV  149 (149)
T ss_dssp             TTBCCCEEEEC
T ss_pred             EEeccCceeeC
Confidence            37899998875


No 123
>6VPX_H Envelope glycoprotein gp120, Envelope glycoprotein; HIV, Envelope glycoprotein, Env, neutralizing; HET: FUC, NAG, BMA, 44E, GAL, MAN; 5.0A {Human immunodeficiency virus 1}
Probab=77.05  E-value=2.3  Score=15.70  Aligned_cols=12  Identities=33%  Similarity=0.399  Sum_probs=8.8  Template_Neff=14.400

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...||.||++.|
T Consensus       118 ~~~~~~~t~l~v  129 (129)
T 6VPX_H          118 FQDWGRGTLVTV  129 (129)
T ss_pred             eeeecCceeeeC
Confidence            456888888765


No 124
>7JOO_K anti-kappa VHH, STIM003 Fab Heavy; Immune checkpoint, immune system, glycoprotein; HET: NAG; 2.4A {Lama glama}
Probab=77.02  E-value=3.1  Score=15.64  Aligned_cols=12  Identities=33%  Similarity=0.595  Sum_probs=9.7  Template_Neff=13.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||+||.+.|.
T Consensus       109 ~~~~~gt~l~v~  120 (121)
T 7JOO_K          109 AAWGAGTAVTVS  120 (121)
T ss_dssp             EEECCCEEEEEC
T ss_pred             heeccceEEEEe
Confidence            578999998874


No 125
>5KEL_M Ebola surface glycoprotein, GP1, Ebola; Ebola virus surface glycoprotein, therapeutic; HET: BMA, NAG, MAN; 4.3A {Zaire ebolavirus (strain Mayinga-76)}
Probab=76.96  E-value=3.4  Score=14.56  Aligned_cols=10  Identities=40%  Similarity=0.816  Sum_probs=7.6  Template_Neff=14.900

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .|+.||+|.|
T Consensus       111 ~~~~~~~l~v  120 (121)
T 5KEL_M          111 YWGQGTSVTV  120 (121)
T ss_pred             eecCCceeEe
Confidence            6788888765


No 126
>5KEN_J Ebola surface glycoprotein, GP1, Ebola; Ebola virus surface glycoprotein, therapeutic; HET: BMA, NAG, MAN; 4.3A {Zaire ebolavirus}
Probab=76.96  E-value=3.4  Score=14.56  Aligned_cols=11  Identities=36%  Similarity=0.585  Sum_probs=8.6  Template_Neff=14.900

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.||+|.|
T Consensus       110 ~~~~~~~~l~v  120 (121)
T 5KEN_J          110 GYWGQGTSVTV  120 (121)
T ss_dssp             TEECSCEEECB
T ss_pred             ceecCCceeEe
Confidence            47888988876


No 127
>5W3L_G viral protein 1, viral protein; virus, antibody, VIRUS-IMMUNE SYSTEM complex; 2.71A {Human rhinovirus 14}
Probab=76.81  E-value=3.8  Score=14.47  Aligned_cols=12  Identities=42%  Similarity=0.980  Sum_probs=9.4  Template_Neff=14.500

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...|+.||+|.|
T Consensus        95 ~~~~~~~~~l~v  106 (107)
T 5W3L_G           95 PYTFGGGTKLEI  106 (107)
T ss_dssp             SCCBCCCBEEEE
T ss_pred             CEEECCCceeEe
Confidence            357899999876


No 128
>1FGV_H FV FRAGMENT OF A HUMANIZED; IMMUNOGLOBULIN, IMMUNE SYSTEM; 1.9A {Homo sapiens} SCOP: b.1.1.1
Probab=76.74  E-value=3.7  Score=14.65  Aligned_cols=11  Identities=45%  Similarity=0.755  Sum_probs=8.6  Template_Neff=14.800

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      +|+.||.+.|-
T Consensus       113 ~~~~~t~l~v~  123 (124)
T 1FGV_H          113 VWGQGTLVTVS  123 (124)
T ss_dssp             EECCCEEEEEC
T ss_pred             eecCCeEEEEe
Confidence            67889988874


No 129
>2OI9_B Major Histocompatibility Complex protein, T; TCR, MHC, IMMUNE SYSTEM; 2.35A {Mus musculus}
Probab=76.68  E-value=5.6  Score=14.26  Aligned_cols=13  Identities=46%  Similarity=0.894  Sum_probs=9.9  Template_Neff=14.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...++.|++|.|.
T Consensus        98 ~~~~~~~~~l~v~  110 (113)
T 2OI9_B           98 ALTFGSGTKVIVL  110 (113)
T ss_dssp             CEEECCCEEEEEC
T ss_pred             ceEecCceEEEEc
Confidence            3567889998875


No 130
>7L6V_C neurotoxin, enzyme inhibitor, ANTITOXIN; 2.01A {Clostridium botulinum}
Probab=76.63  E-value=4.4  Score=14.70  Aligned_cols=13  Identities=23%  Similarity=0.419  Sum_probs=9.8  Template_Neff=14.600

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|++||++.|.
T Consensus       114 ~~~~~~~~~l~v~  126 (127)
T 7L6V_C          114 PESWGQGIQVTVS  126 (127)
T ss_dssp             CCEECCCEEEEEE
T ss_pred             hhhccCCceEEec
Confidence            3568899998874


No 131
>4UNU_B IG LAMBDA CHAIN V-II REGION; IMMUNE SYSTEM, BENCE-JONES, LIGHT CHAINS; HET: 15P, SO4; 0.95A {HOMO SAPIENS}
Probab=76.53  E-value=5.1  Score=13.76  Aligned_cols=12  Identities=67%  Similarity=1.292  Sum_probs=9.1  Template_Neff=15.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.+++|.|+
T Consensus       100 ~~~~~~~~l~v~  111 (111)
T 4UNU_B          100 FVFGTGTKVTVL  111 (111)
T ss_dssp             EEEBCCEEEEEC
T ss_pred             EEecceeeEEEC
Confidence            567888888774


No 132
>5ACM_A MCG; IMMUNE SYSTEM, MCG, IMMUNOGLOBULIN VARIABLE; HET: SO4, MBT; 1.05A {HOMO SAPIENS}
Probab=76.53  E-value=5.1  Score=13.76  Aligned_cols=12  Identities=67%  Similarity=1.292  Sum_probs=9.1  Template_Neff=15.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.+++|.|+
T Consensus       100 ~~~~~~~~l~v~  111 (111)
T 5ACM_A          100 FVFGTGTKVTVL  111 (111)
T ss_dssp             EEEBCCEEEEEC
T ss_pred             EEecceeeEEEC
Confidence            567888888774


No 133
>3E3Q_F TCR, MHC, high affinity, cross; 2.95A {Mus musculus}
Probab=76.40  E-value=3.8  Score=15.76  Aligned_cols=14  Identities=64%  Similarity=1.025  Sum_probs=10.1  Template_Neff=13.200

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      ...|++++.|.|.+
T Consensus        98 ~~~~~~~~~l~v~~  111 (111)
T 3E3Q_F           98 TLYFGAGTRLSVLS  111 (111)
T ss_dssp             CCEECSCEEEEEEC
T ss_pred             eeEecCCeEEEEeC
Confidence            35678888888753


No 134
>6J14_A GY-14 heavy chain V fragment; tumor immunotherapy, complex structure, FG; 1.4A {Mus musculus}
Probab=76.33  E-value=3.7  Score=14.44  Aligned_cols=13  Identities=38%  Similarity=0.509  Sum_probs=9.8  Template_Neff=14.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+|+.||+|.|.
T Consensus       107 ~~~~~~~~~l~v~  119 (120)
T 6J14_A          107 FDVWGAGTTVTVS  119 (120)
T ss_dssp             CSEECCCEEEEEC
T ss_pred             eeeeccCceEEee
Confidence            3468999998874


No 135
>3NN8_A scFv; beta barrel, antibody fragment, immunoglobulin; 3.1A {Mus musculus}
Probab=76.28  E-value=3.1  Score=14.71  Aligned_cols=12  Identities=33%  Similarity=0.498  Sum_probs=9.6  Template_Neff=14.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||.|.|.
T Consensus       110 ~~~~~~~~l~v~  121 (122)
T 3NN8_A          110 DYWGQGTTVTVS  121 (122)
T ss_dssp             EEECSCEEEEEC
T ss_pred             eeeecceeEEEc
Confidence            468999998874


No 136
>3NN8_C scFv; beta barrel, antibody fragment, immunoglobulin; 3.1A {Mus musculus}
Probab=76.28  E-value=3.1  Score=14.71  Aligned_cols=13  Identities=31%  Similarity=0.404  Sum_probs=10.0  Template_Neff=14.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||.|.|.
T Consensus       109 ~~~~~~~~~l~v~  121 (122)
T 3NN8_C          109 MDYWGQGTTVTVS  121 (122)
T ss_dssp             CCEEBCCEEEEEC
T ss_pred             ceeeecceeEEEc
Confidence            3578999999874


No 137
>7K7H_H Typhoid Toxin, A2B5, Antibody, Fab;{Salmonella enterica subsp. enterica serovar Typhi str. CT18}
Probab=76.23  E-value=5  Score=13.97  Aligned_cols=12  Identities=33%  Similarity=0.462  Sum_probs=9.7  Template_Neff=15.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|++|.|.
T Consensus       106 ~~~~~~~~l~v~  117 (118)
T 7K7H_H          106 PYWGQGTLVTVS  117 (118)
T ss_dssp             EECCCCCEEEEC
T ss_pred             ceecCceEEEee
Confidence            568999999874


No 138
>7CWS_D Heavy Chain of FC05 Fab; VIRAL PROTEIN; HET: NAG; 3.4A {Homo sapiens}
Probab=76.07  E-value=3.9  Score=15.07  Aligned_cols=13  Identities=46%  Similarity=1.122  Sum_probs=9.4  Template_Neff=13.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.+++|.|.
T Consensus        93 ~~~~~~~~~l~v~  105 (107)
T 7CWS_D           93 PYIFGQGTKLEIL  105 (107)
T ss_pred             eeEecCCceEEEe
Confidence            3567888888775


No 139
>7MEP_H Immune complex, monoclonal antibodies, HIV-1; HET: BMA, NAG, MAN; 3.5A {Macaca mulatta}
Probab=75.88  E-value=4.1  Score=14.93  Aligned_cols=12  Identities=25%  Similarity=0.382  Sum_probs=9.1  Template_Neff=14.500

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||+++|.
T Consensus       117 ~~~~~~~~l~v~  128 (129)
T 7MEP_H          117 DSWGQGVVVTVS  128 (129)
T ss_pred             cccccceeEEec
Confidence            468889988763


No 140
>7KN5_C Spike protein S1, VHH E; SARS-CoV-2, Nanobody, Spike, Coronavirus, COVID-19; HET: NAG, EDO; 1.87A {Severe acute respiratory syndrome coronavirus 2}
Probab=75.80  E-value=4.4  Score=14.94  Aligned_cols=13  Identities=31%  Similarity=0.437  Sum_probs=10.3  Template_Neff=14.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||.++|.
T Consensus       116 ~~~~~~g~~l~v~  128 (129)
T 7KN5_C          116 MDYWGKGTQVTVS  128 (129)
T ss_dssp             CSEECCCEEEEEC
T ss_pred             ceeeccceeEEec
Confidence            4568999999875


No 141
>4C57_C CYCLIN-G-ASSOCIATED KINASE (E.C.2.7.11.1), NANOBODY; TRANSFERASE, KINASE, CONFORMATIONAL PLASTICITY, ACTIVATION; HET: SO4, FEF, EDO; 2.55A {Homo sapiens}
Probab=75.77  E-value=6.2  Score=15.32  Aligned_cols=13  Identities=31%  Similarity=0.297  Sum_probs=10.4  Template_Neff=13.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      .+.|+.||+|.|.
T Consensus       109 ~~~~~~~t~l~v~  121 (141)
T 4C57_C          109 NNPSSQGTQVTVS  121 (141)
T ss_dssp             SCCCSCCEEEEEC
T ss_pred             cCCCCCCcEEEEe
Confidence            5678999999874


No 142
>4C57_D CYCLIN-G-ASSOCIATED KINASE (E.C.2.7.11.1), NANOBODY; TRANSFERASE, KINASE, CONFORMATIONAL PLASTICITY, ACTIVATION; HET: SO4, FEF, EDO; 2.55A {Homo sapiens}
Probab=75.77  E-value=6.2  Score=15.32  Aligned_cols=13  Identities=31%  Similarity=0.297  Sum_probs=10.4  Template_Neff=13.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      .+.|+.||+|.|.
T Consensus       109 ~~~~~~~t~l~v~  121 (141)
T 4C57_D          109 NNPSSQGTQVTVS  121 (141)
T ss_dssp             SCCCSCCEEEEEC
T ss_pred             cCCCCCCcEEEEe
Confidence            5678999999874


No 143
>1XIW_D T-cell surface glycoprotein CD3 epsilon; CD3-epsilon, CD3-delta, UCHT1-scFv, immunoglobulin fold; 1.9A {Homo sapiens} SCOP: b.1.1.1
Probab=75.67  E-value=4.5  Score=14.29  Aligned_cols=12  Identities=50%  Similarity=0.797  Sum_probs=9.7  Template_Neff=14.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+||.||+|.|.
T Consensus       110 ~~~~~~~~l~v~  121 (122)
T 1XIW_D          110 DVWGQGTTLTVF  121 (122)
T ss_dssp             CEECCCEEEEEC
T ss_pred             eeecccceeEEe
Confidence            468999999875


No 144
>1KXV_C ALPHA-AMYLASE, PANCREATIC (E.C.3.2.1.1)/CAMELID VHH DOMAIN; BETA 8 ALPHA 8, BETA; 1.6A {Sus scrofa} SCOP: b.1.1.1
Probab=75.61  E-value=4.2  Score=14.42  Aligned_cols=13  Identities=31%  Similarity=0.555  Sum_probs=9.9  Template_Neff=14.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||+|.|-
T Consensus       108 ~~~~~~~t~l~v~  120 (121)
T 1KXV_C          108 IIPWGQGTQVTVS  120 (121)
T ss_dssp             CCCCCCCEEEEEC
T ss_pred             EEeccCCceeEEc
Confidence            3578899998874


No 145
>1KXV_D ALPHA-AMYLASE, PANCREATIC (E.C.3.2.1.1)/CAMELID VHH DOMAIN; BETA 8 ALPHA 8, BETA; 1.6A {Sus scrofa} SCOP: b.1.1.1
Probab=75.61  E-value=4.2  Score=14.42  Aligned_cols=12  Identities=33%  Similarity=0.659  Sum_probs=9.4  Template_Neff=14.800

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...||.||+|.|
T Consensus       108 ~~~~~~~t~l~v  119 (121)
T 1KXV_D          108 IIPWGQGTQVTV  119 (121)
T ss_dssp             CCCCCCCEEEEE
T ss_pred             EEeccCCceeEE
Confidence            357889998876


No 146
>4U3X_C Human VH domain antibody, Hen; Human VH domain antibody, Phage; 2.26A {Gallus gallus}
Probab=75.28  E-value=3.9  Score=14.41  Aligned_cols=13  Identities=31%  Similarity=0.330  Sum_probs=9.3  Template_Neff=14.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||+|.|.
T Consensus       108 ~~~~~~~~~l~v~  120 (121)
T 4U3X_C          108 FDYWGQGTLVTVS  120 (121)
T ss_dssp             CCEECCCEEECC-
T ss_pred             ceEecCCeeEEEe
Confidence            4568889988764


No 147
>6SXI_B Fab heavy chain, Fab light; anti-idiotype, antigen binding fragment, single; 1.85A {Mus musculus}
Probab=74.95  E-value=3.2  Score=16.00  Aligned_cols=11  Identities=45%  Similarity=0.975  Sum_probs=8.8  Template_Neff=13.100

Q ss_pred             CcccCCCCeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLS   17 (20)
Q Consensus         7 nfvfgpgtrls   17 (20)
                      .++||.||+|.
T Consensus        98 ~~~~~~g~~l~  108 (108)
T 6SXI_B           98 PYTFGGGTKLE  108 (108)
T ss_dssp             SCEECCCEEEE
T ss_pred             ceEECCCeecC
Confidence            57899999873


No 148
>2APT_B T-cell receptor beta chain V; the murine T cell receptor; 2.0A {Rattus norvegicus}
Probab=74.94  E-value=4.5  Score=15.23  Aligned_cols=12  Identities=75%  Similarity=1.171  Sum_probs=9.1  Template_Neff=13.600

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|++|.|+
T Consensus       101 ~~~~~~~~l~v~  112 (112)
T 2APT_B          101 LYFGAGTRLSVL  112 (112)
T ss_dssp             CEECCCEEEEEC
T ss_pred             EEEcCceEEEeC
Confidence            457888888875


No 149
>7N8H_C coronavirus, antibody, california, Structural Genomics; HET: FUC, NAG; 2.3A {Severe acute respiratory syndrome coronavirus 2}
Probab=74.67  E-value=3.7  Score=14.49  Aligned_cols=12  Identities=33%  Similarity=0.462  Sum_probs=9.1  Template_Neff=14.900

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...|+.||++.|
T Consensus       109 ~~~~~~~~~l~v  120 (121)
T 7N8H_C          109 YDYWGQGTLVTV  120 (121)
T ss_dssp             CCEECCCEEEEC
T ss_pred             EEEeccceeeEe
Confidence            446889998876


No 150
>6K65_H Protein A, 3LRH intrabody; antibody, protein design, STRUCTURAL PROTEIN; 1.65A {Staphylococcus aureus (strain NCTC 8325)}
Probab=74.46  E-value=5.4  Score=13.76  Aligned_cols=13  Identities=38%  Similarity=0.437  Sum_probs=9.1  Template_Neff=15.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|++|.|.
T Consensus       100 ~~~~~~~~~l~v~  112 (113)
T 6K65_H          100 FDYWGQGTTLTVS  112 (113)
T ss_dssp             SCSBCCCEEECCC
T ss_pred             eeEEcCCeEEEEc
Confidence            3467888888764


No 151
>4RZC_D Fv M6P-1 light chain ; Antibody variable fragment, mannose-6-phosphate, Immune; HET: M6P, SO4; 2.723A {Oryctolagus cuniculus}
Probab=74.46  E-value=4.1  Score=14.60  Aligned_cols=12  Identities=42%  Similarity=0.883  Sum_probs=9.4  Template_Neff=14.400

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||.+.|.
T Consensus        99 ~~~~~~~~l~v~  110 (112)
T 4RZC_D           99 YAFSGGTELEIL  110 (112)
T ss_dssp             EEECCCEEEEEE
T ss_pred             EEeCCCceEEEe
Confidence            568889988774


No 152
>7BUF_H SIgN-3C IgG heavy chain, SIgN-3C; Dengue virus, antibody, neutralization, VIRUS;{Dengue virus 2}
Probab=74.41  E-value=5.5  Score=15.09  Aligned_cols=12  Identities=25%  Similarity=0.396  Sum_probs=9.1  Template_Neff=14.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      -.||.||.++|.
T Consensus       120 ~~~~~~~~l~v~  131 (132)
T 7BUF_H          120 DPWGQGSLVTVS  131 (132)
T ss_pred             CccCCceEEEEe
Confidence            358899988774


No 153
>2E27_L anti-ciguatoxin antibody, light chain/ anti-ciguatoxin; Immunoglobulin fold, IMMUNE SYSTEM; HET: GOL, AB0; 1.7A {Mus musculus}
Probab=74.23  E-value=5.6  Score=14.50  Aligned_cols=13  Identities=38%  Similarity=0.848  Sum_probs=9.8  Template_Neff=14.300

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...++.+|+|.|.
T Consensus        97 ~~~~~~~t~l~v~  109 (119)
T 2E27_L           97 TWTFGGGTKLEIK  109 (119)
T ss_dssp             CCEECCCEEEEEE
T ss_pred             ceEecCceEEEEe
Confidence            3578899988774


No 154
>3IY2_B antibody fragment; cryoEM, neutralizing antibody, parvovirus, canine; 18.0A {Mus musculus}
Probab=74.19  E-value=4  Score=14.04  Aligned_cols=11  Identities=36%  Similarity=0.685  Sum_probs=9.1  Template_Neff=15.000

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.|+.+.|
T Consensus       100 ~~~~~~~~l~v  110 (111)
T 3IY2_B          100 VYWGQGTLVTV  110 (111)
T ss_dssp             BCCCCCCEEEE
T ss_pred             EEEcCceEEEe
Confidence            57899999887


No 155
>6NIU_F Zika Virus Envelope protein E; ZIKV-DENV, Antibody, human, Vaccination, ANTIVIRAL; 4.303A {Homo sapiens}
Probab=74.18  E-value=4.8  Score=14.16  Aligned_cols=13  Identities=31%  Similarity=0.335  Sum_probs=9.0  Template_Neff=14.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|+.+.|.
T Consensus       107 ~~~~~~~~~l~v~  119 (120)
T 6NIU_F          107 GDHWGQGILVSVS  119 (120)
T ss_pred             ceeeccceEEEec
Confidence            3467888887764


No 156
>7V3I_G VIRUS, complexed, antibody, VIRUS-IMMUNE SYSTEM;{Dengue virus type 2 (strain Thailand/NGS-C/1944)}
Probab=74.11  E-value=4.4  Score=14.80  Aligned_cols=10  Identities=40%  Similarity=0.750  Sum_probs=7.8  Template_Neff=14.500

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .||.||.+.|
T Consensus       117 ~~~~~~~l~v  126 (127)
T 7V3I_G          117 YWGQGTLVTV  126 (127)
T ss_pred             ccCCCeeeec
Confidence            6788888875


No 157
>7NKT_BBB Surface glycoprotein, neutralizing nanobody NM1226; RBD, SARS-CoV2, neutralizing nanobody, complex; HET: PEG, NAG; 2.3A {Severe acute respiratory syndrome coronavirus 2}
Probab=74.11  E-value=4.7  Score=16.19  Aligned_cols=13  Identities=23%  Similarity=0.358  Sum_probs=9.9  Template_Neff=13.300

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||+|.|.
T Consensus       112 ~~~~~~~t~l~v~  124 (144)
T 7NKT_BBB        112 YDYWGQGAPVTVS  124 (144)
T ss_pred             cceeecCcceEeC
Confidence            3478999998774


No 158
>5KEL_D Ebola surface glycoprotein, GP1, Ebola; Ebola virus surface glycoprotein, therapeutic; HET: BMA, NAG, MAN; 4.3A {Zaire ebolavirus (strain Mayinga-76)}
Probab=74.04  E-value=4.3  Score=15.15  Aligned_cols=11  Identities=45%  Similarity=1.020  Sum_probs=8.7  Template_Neff=13.600

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ++|+++|+|.|
T Consensus        96 ~~~~~~~~l~v  106 (107)
T 5KEL_D           96 LTFGAGTKLEL  106 (107)
T ss_dssp             CEECCCEEEEE
T ss_pred             EEECCCeEEEE
Confidence            56888888876


No 159
>2X1Q_B GELSOLIN NANOBODY; CONTRACTILE PROTEIN; 1.06A {LAMA GLAMA}
Probab=73.95  E-value=5.5  Score=14.43  Aligned_cols=12  Identities=33%  Similarity=0.545  Sum_probs=9.7  Template_Neff=14.600

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||+|.|-
T Consensus       115 ~~~~~~~~l~v~  126 (127)
T 2X1Q_B          115 DYWGQGTQVTVS  126 (127)
T ss_dssp             SEECCCEEEEEC
T ss_pred             ceeecceeeEec
Confidence            478999999874


No 160
>6IBB_B Succinate receptor 1, Nanobody6; SUCNR1 GPR91 GPCR G-Protein coupled; HET: GOL, CLR, OLC, H95; 2.12A {Rattus norvegicus}
Probab=73.90  E-value=5.3  Score=15.71  Aligned_cols=13  Identities=31%  Similarity=0.470  Sum_probs=10.6  Template_Neff=13.600

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||+|.|.
T Consensus       123 ~~~~~~~t~l~v~  135 (142)
T 6IBB_B          123 LETWGQGTQVTVS  135 (142)
T ss_dssp             CCCBCCCEEEEEC
T ss_pred             ceeeCCCceEEEe
Confidence            4679999999875


No 161
>6RNK_B Succinate receptor 1, Nanobody6; SUCNR1, GPR91, GPCR, G-Protein coupled; HET: KAZ, OLC; 1.94A {Rattus norvegicus}
Probab=73.90  E-value=5.3  Score=15.71  Aligned_cols=13  Identities=31%  Similarity=0.470  Sum_probs=10.5  Template_Neff=13.600

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||+|.|.
T Consensus       123 ~~~~~~~t~l~v~  135 (142)
T 6RNK_B          123 LETWGQGTQVTVS  135 (142)
T ss_dssp             CCEECCCEEEEEC
T ss_pred             ceeeCCCceEEEe
Confidence            4578999999875


No 162
>4OB5_H 4E10 antibody germline precursor 7; Immunoglobulin Fold, Anti-HIV antibody germline; HET: GOL; 1.7A {Homo sapiens}
Probab=73.74  E-value=6.1  Score=14.31  Aligned_cols=13  Identities=31%  Similarity=0.355  Sum_probs=9.6  Template_Neff=14.600

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||.+.|-
T Consensus       114 ~~~~~~~~~l~v~  126 (127)
T 4OB5_H          114 FQHWGQGTLVTVS  126 (127)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             ceeecCCceeEec
Confidence            3468899988874


No 163
>7BYR_H Spike glycoprotein, Ab23-Fab-Heavy Chain, Ab23-Fab-Light; SARS-CoV-2, antigen, RBD, neutralizing antibody; HET: BMA, NAG;{Severe acute respiratory syndrome coronavirus 2}
Probab=73.59  E-value=4.3  Score=14.52  Aligned_cols=10  Identities=50%  Similarity=0.966  Sum_probs=8.1  Template_Neff=14.800

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .|+.||+|.|
T Consensus       115 ~~~~~~~l~v  124 (126)
T 7BYR_H          115 VWGQGTTVTV  124 (126)
T ss_pred             eeecceEEEe
Confidence            7888888876


No 164
>5T93_A ALT-05 immunoglobulin light chain variable; immunoglobulin light chain, amyloid, light; HET: ACT; 1.9A {Homo sapiens}
Probab=73.42  E-value=5.3  Score=13.69  Aligned_cols=12  Identities=67%  Similarity=1.168  Sum_probs=8.2  Template_Neff=15.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..++.++++.|+
T Consensus        99 ~~~~~~~~l~v~  110 (110)
T 5T93_A           99 LVFGGGTKLTVL  110 (110)
T ss_dssp             EEEBCCEEEEEC
T ss_pred             EEEcCCeEEEEC
Confidence            456777877764


No 165
>7N9C_E CovS NB21 nanobody, VIRAL PROTEIN; 3.71A {Severe acute respiratory syndrome coronavirus 2}
Probab=73.13  E-value=5.1  Score=16.38  Aligned_cols=12  Identities=33%  Similarity=0.581  Sum_probs=9.8  Template_Neff=13.200

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ..+||.||++.|
T Consensus       129 ~~~~~~gt~l~v  140 (155)
T 7N9C_E          129 YEYWGQGTQVTV  140 (155)
T ss_dssp             CSEECCCEEECC
T ss_pred             ceeccCCeEEEE
Confidence            457899999876


No 166
>7SHZ_E IgE, omalizumab, xolair, inhibitor, immune; HET: NAG, BMA, GOL, PO4, MAN, EDO; 3.0A {Homo sapiens}
Probab=72.92  E-value=4.6  Score=14.38  Aligned_cols=12  Identities=42%  Similarity=0.628  Sum_probs=8.5  Template_Neff=14.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+|+.||+|.|.
T Consensus       110 ~~~~~~~~l~v~  121 (123)
T 7SHZ_E          110 AVWGQGTLVTVS  121 (123)
T ss_pred             EEEecCeEEEEe
Confidence            357888888764


No 167
>6MPH_H DF1W-a.01 heavy chain, DF1W-a.01 Light; Complex, Fusion peptide, Neutralizing antibody; HET: BMA, NAG, MAN; 3.8A {Macaca mulatta}
Probab=72.81  E-value=3.7  Score=14.32  Aligned_cols=13  Identities=38%  Similarity=0.524  Sum_probs=8.7  Template_Neff=15.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||+++|.
T Consensus       105 ~~~~~~~~~l~v~  117 (118)
T 6MPH_H          105 FDVWGPGFLVTVS  117 (118)
T ss_pred             ceEEeeeeEEEEc
Confidence            3567778877764


No 168
>6FYS_F Single domain antibody SD83; Influenza, single domain antibody, hemagglutinin; HET: EDO; 2.0A {Lama glama}
Probab=72.58  E-value=5.8  Score=14.59  Aligned_cols=11  Identities=36%  Similarity=0.733  Sum_probs=8.9  Template_Neff=14.400

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .|+.||+++|.
T Consensus       118 ~~~~~~~l~v~  128 (129)
T 6FYS_F          118 SWGQGTQVTVS  128 (129)
T ss_dssp             EECCCEEEEEC
T ss_pred             eccCcceEEEe
Confidence            67899998874


No 169
>6FYW_C Hemagglutinin, Hemagglutinin HA2, Single domain; Influenza, single domain antibody, hemagglutinin; HET: BMA, GOL, NAG, MAN; 2.2A {Influenza B virus (B/Brisbane/60/2008)}
Probab=72.58  E-value=5.8  Score=14.59  Aligned_cols=11  Identities=36%  Similarity=0.733  Sum_probs=9.0  Template_Neff=14.400

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .|+.||+++|.
T Consensus       118 ~~~~~~~l~v~  128 (129)
T 6FYW_C          118 SWGQGTQVTVS  128 (129)
T ss_dssp             EECCCEEEEEC
T ss_pred             eccCcceEEEe
Confidence            67899998874


No 170
>6J5D_H Envelope, antibody heavy chain, antibody; protective and neutralizing antibody, flavivirus; 1.8A {Louping ill virus}
Probab=72.55  E-value=4.5  Score=14.13  Aligned_cols=13  Identities=31%  Similarity=0.383  Sum_probs=9.9  Template_Neff=15.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||.|.|.
T Consensus       107 ~~~~~~~~~l~v~  119 (120)
T 6J5D_H          107 LDYWGQGTTVTVS  119 (120)
T ss_dssp             CCEECCCEEEEEC
T ss_pred             eeEeecCeeEEee
Confidence            3478999998874


No 171
>6VPX_P Envelope glycoprotein gp120, Envelope glycoprotein; HIV, Envelope glycoprotein, Env, neutralizing; HET: FUC, NAG, BMA, 44E, GAL, MAN; 5.0A {Human immunodeficiency virus 1}
Probab=72.46  E-value=5.6  Score=15.03  Aligned_cols=13  Identities=38%  Similarity=0.519  Sum_probs=10.3  Template_Neff=14.100

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||++.|.
T Consensus       121 ~~~~~~~t~~~v~  133 (134)
T 6VPX_P          121 MDVWGQGTTVTVS  133 (134)
T ss_dssp             EEEECCCCEEEEC
T ss_pred             eEEeccCeEEEec
Confidence            3478999999885


No 172
>6JB9_A Nanobody D3-L11; nanobody, hot-spot mutagenesis, thermodynamics, biomolecular; HET: SO4; 1.15A {Camelus dromedarius}
Probab=72.42  E-value=5.9  Score=14.64  Aligned_cols=13  Identities=31%  Similarity=0.468  Sum_probs=9.9  Template_Neff=14.300

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||.+.|-
T Consensus       115 ~~~~~~~t~l~v~  127 (128)
T 6JB9_A          115 YDYWGQGTQVTVS  127 (128)
T ss_dssp             CCEECCCEEEEEE
T ss_pred             eEEeccCceeEee
Confidence            4578999998873


No 173
>6FPV_A Nanobody; nanobody, JBP1, llama, IMMUNE SYSTEM; HET: GOL; 1.64A {Lama glama}
Probab=72.36  E-value=4.4  Score=16.75  Aligned_cols=12  Identities=33%  Similarity=0.686  Sum_probs=9.5  Template_Neff=13.000

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ..+||+|+++-|
T Consensus       131 ~~~~g~G~~~~~  142 (154)
T 6FPV_A          131 YHYWGQGTQVTV  142 (154)
T ss_dssp             EEEECCCEEEEE
T ss_pred             EEEEeCCeEEEE
Confidence            368999998865


No 174
>7D5Q_C Drug transporter, putative, ICab; NorC, major facilitator superfamily, transporter; 3.6A {Staphylococcus aureus subsp. aureus COL}
Probab=72.29  E-value=6.5  Score=14.59  Aligned_cols=15  Identities=40%  Similarity=0.649  Sum_probs=11.2  Template_Neff=14.300

Q ss_pred             CCCcccCCCCeeeeC
Q tr|A0A075B6V7|    5 GQNFVFGPGTRLSVL   19 (20)
Q Consensus         5 gqnfvfgpgtrlsvl   19 (20)
                      .....|+.||+|+|.
T Consensus       116 ~~~~~~~~~~~l~v~  130 (131)
T 7D5Q_C          116 GQYSYWGQGTQVTVS  130 (131)
T ss_dssp             TTCCEECSCEEEEEE
T ss_pred             cceeeeccCeEEEEe
Confidence            345678999999874


No 175
>1I3U_A Antibody VHH lama domain; antibody, VHH fragment, Lama glama; HET: RR1; 1.95A {Lama glama} SCOP: b.1.1.1
Probab=72.13  E-value=4.6  Score=14.75  Aligned_cols=12  Identities=33%  Similarity=0.543  Sum_probs=8.7  Template_Neff=14.500

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...||.||.+.|
T Consensus       116 ~~~~~~~~~l~v  127 (127)
T 1I3U_A          116 WNYWGQGTQVTV  127 (127)
T ss_dssp             CCEECCCEEEEC
T ss_pred             cccccCCceeeC
Confidence            456888888765


No 176
>5DHV_H Anti-Rev Antibody Fab single-chain variable; HIV, helical hairpin, RNA-binding, nuclear; 2.3A {Oryctolagus cuniculus}
Probab=71.80  E-value=6.7  Score=13.51  Aligned_cols=13  Identities=38%  Similarity=0.695  Sum_probs=9.6  Template_Neff=15.100

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.++++.|.
T Consensus       104 ~~~~~~~~~l~v~  116 (117)
T 5DHV_H          104 FTIWGPGTLVTVS  116 (117)
T ss_dssp             CCEECCCEEEEEC
T ss_pred             EEEeCCCeEEEEe
Confidence            3467888888875


No 177
>5DHY_H Anti-Rev Antibody Fab single-chain variable; HIV, helical hairpin, RNA-binding, nuclear; 3.1A {Oryctolagus cuniculus}
Probab=71.80  E-value=6.7  Score=13.51  Aligned_cols=13  Identities=38%  Similarity=0.695  Sum_probs=9.6  Template_Neff=15.100

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.++++.|.
T Consensus       104 ~~~~~~~~~l~v~  116 (117)
T 5DHY_H          104 FTIWGPGTLVTVS  116 (117)
T ss_dssp             CCEECCCEEEEEC
T ss_pred             EEEeCCCeEEEEe
Confidence            3467888888875


No 178
>5C1M_B Mu-type opioid receptor, Nanobody 39; Ligands, Mice, Agonists, Morphinans, Activation; HET: YCM, VF1, CLR, OLC, P6G; 2.07A {Mus musculus}
Probab=71.69  E-value=8  Score=13.77  Aligned_cols=14  Identities=29%  Similarity=0.456  Sum_probs=10.5  Template_Neff=14.800

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ....||.||++.|.
T Consensus       108 ~~~~~~~~~~~~v~  121 (125)
T 5C1M_B          108 DYDYWGQGTQVTVS  121 (125)
T ss_dssp             CCSEECCCEEEEEC
T ss_pred             CcccccCCeEEEEe
Confidence            34578899998875


No 179
>7VYT_H Antibody, Immune Checkpoint, TIGIT, IMMUNE; HET: FLC; 1.53A {Homo sapiens}
Probab=71.44  E-value=4  Score=14.40  Aligned_cols=12  Identities=33%  Similarity=0.443  Sum_probs=9.4  Template_Neff=14.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||++.|.
T Consensus       110 ~~~~~~~~l~v~  121 (122)
T 7VYT_H          110 DYWGQGTLVTVS  121 (122)
T ss_dssp             CEECCCEEEEEC
T ss_pred             eEEeecceeEec
Confidence            478899998874


No 180
>7LUC_I Fusion glycoprotein F0, 01.4B Fab; RSV, viral fusogen, fusion protein; 3.21A {Respiratory syncytial virus}
Probab=71.37  E-value=6  Score=14.95  Aligned_cols=11  Identities=36%  Similarity=0.821  Sum_probs=8.8  Template_Neff=13.500

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.||+|+|
T Consensus       101 ~~~~~~t~l~v  111 (112)
T 7LUC_I          101 RTFGQGTKVEI  111 (112)
T ss_dssp             CCBCCCEEEEE
T ss_pred             ceecCCeeeEe
Confidence            46888998876


No 181
>7D3M_H O/TIBET/99 VP1, O/TIBET/99 VP2, O/TIBET/99; FOOT AND MOUTH DISEASE VIRUS; 3.94A {Foot-and-mouth disease virus}
Probab=71.32  E-value=5.2  Score=18.49  Aligned_cols=12  Identities=25%  Similarity=0.490  Sum_probs=5.1  Template_Neff=11.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      -+||+||.+.|-
T Consensus       155 ~~~g~gt~~~v~  166 (167)
T 7D3M_H          155 HTWGQGLLVTVS  166 (167)
T ss_dssp             CBCTSC-----C
T ss_pred             heeccceEEEec
Confidence            348999998874


No 182
>7D3R_H A/WH/CHA/09 VP1, A/WH/CHA/09 VP2, A/WH/CHA/09; FOOT AND MOUTH DISEASE VIRUS; 3.49A {Foot-and-mouth disease virus}
Probab=71.32  E-value=5.2  Score=18.49  Aligned_cols=11  Identities=27%  Similarity=0.537  Sum_probs=2.4  Template_Neff=11.100

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      +||+||.+.|-
T Consensus       156 ~~g~gt~~~v~  166 (167)
T 7D3R_H          156 TWGQGLLVTVS  166 (167)
T ss_dssp             ---CC-----C
T ss_pred             eeccceEEEec
Confidence            48999998874


No 183
>5DFW_H CD81 antigen, SINGLE CHAIN FV; HELICAL BUNDLE, ANTIBODY-ANTIGEN COMPLEX, CELL; 2.33A {Homo sapiens}
Probab=71.20  E-value=6.1  Score=17.55  Aligned_cols=13  Identities=31%  Similarity=0.810  Sum_probs=10.7  Template_Neff=13.100

Q ss_pred             CCcccCCCCeeee
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSV   18 (20)
Q Consensus         6 qnfvfgpgtrlsv   18 (20)
                      ..+.||.||+|.|
T Consensus       230 ~~~~~~~~t~l~v  242 (243)
T 5DFW_H          230 TPWTFGGGTKVEI  242 (243)
T ss_dssp             SSCCBCCCEEEEC
T ss_pred             CceEECCceEEEe
Confidence            4578999999987


No 184
>4CDG_D BLOOM SYNDROME PROTEIN (E.C.3.6.4.12), NANOBODY; HYDROLASE; HET: ADP; 2.794A {HOMO SAPIENS}
Probab=71.18  E-value=4.9  Score=15.73  Aligned_cols=12  Identities=33%  Similarity=0.684  Sum_probs=9.0  Template_Neff=13.800

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ..+||+|+++.+
T Consensus       128 ~~~~g~G~~~~~  139 (147)
T 4CDG_D          128 QSFWGRGTQVTV  139 (147)
T ss_dssp             CEEECCCEEEEE
T ss_pred             EEeEecCeEEEE
Confidence            357899998765


No 185
>6J9O_L Heavy chain of AF4H1K1 scFv; a free scFv molecule, AF4H1K1; 1.397A {Homo sapiens}
Probab=71.09  E-value=6.2  Score=14.46  Aligned_cols=12  Identities=42%  Similarity=0.977  Sum_probs=9.5  Template_Neff=13.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      +.|+.||+|.|.
T Consensus        96 ~~~~~~~~l~v~  107 (108)
T 6J9O_L           96 FTFGQGTKVEIK  107 (108)
T ss_dssp             CEECCCEEEEEC
T ss_pred             eEeCCCeEEEEe
Confidence            578889988875


No 186
>1OL0_B IMMUNOGLOBULIN G; IMMUNOGLOBULIN, CAMELISED VARIABLE HEAVY DOMAIN; HET: SO4, GOL, MSE; 1.8A {HOMO SAPIENS} SCOP: b.1.1.1
Probab=70.94  E-value=5.5  Score=13.92  Aligned_cols=13  Identities=31%  Similarity=0.330  Sum_probs=9.5  Template_Neff=15.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||+|.|.
T Consensus       108 ~~~~~~~~~l~v~  120 (121)
T 1OL0_B          108 FDYWGQGTLVTVS  120 (121)
T ss_dssp             GCEECCCEEEEEC
T ss_pred             ceeecCceeeEEe
Confidence            3467888988874


No 187
>7RA8_G SARS-CoV-2, Spike glycoprotein, Fab S2X259; HET: NAG; 3.1A {Severe acute respiratory syndrome coronavirus 2}
Probab=70.94  E-value=6.9  Score=13.47  Aligned_cols=12  Identities=67%  Similarity=1.212  Sum_probs=7.9  Template_Neff=15.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..++.++++.|+
T Consensus       102 ~~~~~~~~l~v~  113 (113)
T 7RA8_G          102 WVFGGGTKLTVL  113 (113)
T ss_pred             eEecCCeeEEEC
Confidence            556777777664


No 188
>6VUG_D Reverse transcriptase/ribonuclease H, Reverse transcriptase; Aptamer, protein binding, complex; HET: SO4, OMC; 3.0A {Human immunodeficiency virus type 1}
Probab=70.89  E-value=5.1  Score=14.28  Aligned_cols=11  Identities=36%  Similarity=0.591  Sum_probs=8.9  Template_Neff=14.800

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .||.||+|.|-
T Consensus       113 ~~~~~~~l~v~  123 (124)
T 6VUG_D          113 HWGQGTLVTVS  123 (124)
T ss_dssp             SCCCCEEEEEC
T ss_pred             eeeCCeeeEec
Confidence            68889988874


No 189
>6RQM_B Cytotoxic T-lymphocyte protein 4, A; Antibody, check-point, CTLA-4, receptor, IMMUNE; 3.0A {Camelus bactrianus}
Probab=70.85  E-value=9.7  Score=15.26  Aligned_cols=13  Identities=31%  Similarity=0.312  Sum_probs=9.8  Template_Neff=13.300

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||+|+|.
T Consensus       115 ~~~~~~gt~l~v~  127 (144)
T 6RQM_B          115 FGYWGQGTLVTVS  127 (144)
T ss_pred             ceeecCCceEEEc
Confidence            4578999988764


No 190
>7M1H_E VHH, protease domain, TOXIN, ANTITOXIN; 2.78A {Clostridium botulinum}
Probab=70.67  E-value=6.9  Score=14.05  Aligned_cols=13  Identities=31%  Similarity=0.726  Sum_probs=10.1  Template_Neff=14.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|+.|.|.
T Consensus       113 ~~~~~~~~~l~v~  125 (126)
T 7M1H_E          113 PYYWGQGTQVTVS  125 (126)
T ss_dssp             CEEECCCEEEEEC
T ss_pred             CeeecccceEEEc
Confidence            4578999998874


No 191
>3MOQ_D New antigen receptor variable domain; AB-IGNAR, AB-12Y-2, RECEPTOR, AMYLOID, GLYCOPROTEIN; 2.054A {Orectolobus maculatus}
Probab=70.63  E-value=6.5  Score=15.75  Aligned_cols=13  Identities=38%  Similarity=0.312  Sum_probs=9.5  Template_Neff=12.900

Q ss_pred             cccCCCCeeeeCC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVLP   20 (20)
Q Consensus         8 fvfgpgtrlsvlp   20 (20)
                      |-++.++.++|.|
T Consensus       113 ~~~~~~~~~~v~~  125 (126)
T 3MOQ_D          113 GEKGAGTALTVKA  125 (126)
T ss_dssp             EEECCCEEEEEEC
T ss_pred             cccccceeeEEee
Confidence            5577888888764


No 192
>1A2Y_B COMPLEX (IMMUNOGLOBULIN-HYDROLASE), IMMUNOGLOBULIN V REGION; 1.5A {Mus musculus} SCOP: b.1.1.1
Probab=70.61  E-value=5.5  Score=13.62  Aligned_cols=11  Identities=45%  Similarity=0.745  Sum_probs=8.7  Template_Neff=15.200

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .|+.|++|.|.
T Consensus       105 ~~~~~~~l~v~  115 (116)
T 1A2Y_B          105 YWGQGTTLTVS  115 (116)
T ss_dssp             EECCCEEEEEC
T ss_pred             eeeCCeEEEEc
Confidence            67888988874


No 193
>6PCU_H Outer capsid protein VP4; rotavirus, VIRAL PROTEIN, antibody, scFv; HET: GOL, SO4; 2.4A {Rotavirus A}
Probab=70.55  E-value=8.8  Score=16.53  Aligned_cols=17  Identities=35%  Similarity=0.548  Sum_probs=12.8  Template_Neff=13.800

Q ss_pred             CCCCcccCCCCeeeeCC
Q tr|A0A075B6V7|    4 YGQNFVFGPGTRLSVLP   20 (20)
Q Consensus         4 ygqnfvfgpgtrlsvlp   20 (20)
                      +|+..+++.+++|.|.|
T Consensus       236 ~~~~~~~~~~~~l~V~~  252 (252)
T 6PCU_H          236 YSVPDVWGQGTPVTVSS  252 (252)
T ss_dssp             TCSCCEECCCEEEEECC
T ss_pred             ccccccccCCeeeEEeC
Confidence            34556889999998865


No 194
>6Q6Z_B Protein EDS1L, EDS1-specific nanobody; enhanced disease susceptibility 1, plant; 3.476A {Arabidopsis thaliana}
Probab=70.25  E-value=7.7  Score=15.15  Aligned_cols=14  Identities=36%  Similarity=0.498  Sum_probs=10.4  Template_Neff=13.700

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ....|+.||.|.|.
T Consensus       109 ~~~~~~~~t~l~v~  122 (142)
T 6Q6Z_B          109 QYDYWGQGTQVTVS  122 (142)
T ss_dssp             -CCCCCCCEEEEEE
T ss_pred             cceeecCCeEEEEc
Confidence            35678999998874


No 195
>6GJQ_F Cystic fibrosis transmembrane conductance regulator; Cystic Fibrosis, CFTR, nanobodies, thermal; HET: ATP; 2.49A {Homo sapiens}
Probab=70.17  E-value=5.9  Score=16.32  Aligned_cols=12  Identities=33%  Similarity=0.545  Sum_probs=9.6  Template_Neff=12.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||.++|-
T Consensus       109 ~~~~~gt~~~v~  120 (147)
T 6GJQ_F          109 DYWGQGTQVTVS  120 (147)
T ss_dssp             EEECCCEEEEEC
T ss_pred             EecCCCeEEEEe
Confidence            468999998874


No 196
>6VO1_I Envelope glycoprotein gp120, Envelope glycoprotein; HIV, Rhesus macaque, antibody, Fab; HET: BMA, NAG, MAN; 3.88A {Human immunodeficiency virus 1}
Probab=70.17  E-value=6.7  Score=13.53  Aligned_cols=12  Identities=25%  Similarity=0.373  Sum_probs=8.1  Template_Neff=15.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.++++.|.
T Consensus       106 ~~~~~~~~l~v~  117 (118)
T 6VO1_I          106 DYWGQGVLVTVS  117 (118)
T ss_pred             eeeeCceEEEEc
Confidence            457777777664


No 197
>6IEC_C NSmGnGc, R17 H chain, R17; RVFV, antibody, STRUCTURAL PROTEIN, STRUCTURAL; 3.2A {Rift valley fever virus}
Probab=70.10  E-value=4.4  Score=13.77  Aligned_cols=9  Identities=33%  Similarity=0.460  Sum_probs=5.6  Template_Neff=15.300

Q ss_pred             cccCCCCee
Q tr|A0A075B6V7|    8 FVFGPGTRL   16 (20)
Q Consensus         8 fvfgpgtrl   16 (20)
                      .+||.||.+
T Consensus       107 ~~~~~gt~l  115 (115)
T 6IEC_C          107 DPWGQGTLV  115 (115)
T ss_pred             CCCcCcccC
Confidence            366777754


No 198
>6ZKE_c NADH dehydrogenase [ubiquinone] flavoprotein 1; complex, respiration, NADH, proton pump; HET: PC1, SF4, 3PE, DCQ, MYR, NDP, AMP, FMN, ZMP, 2MR, AYA, CDL, SEP, FME, NAI; 2.6A {Ovis aries}
Probab=69.99  E-value=3.6  Score=23.81  Aligned_cols=16  Identities=44%  Similarity=0.812  Sum_probs=14.2  Template_Neff=5.400

Q ss_pred             CCCCCCcccCCCCeee
Q tr|A0A075B6V7|    2 DNYGQNFVFGPGTRLS   17 (20)
Q Consensus         2 dnygqnfvfgpgtrls   17 (20)
                      .+|+.||.+...+|+|
T Consensus       153 KsYadNF~~~~~~r~s  168 (170)
T 6ZKE_c          153 KSYGANFSWNKRTRVS  168 (170)
T ss_pred             cccHHHccCCCCCcee
Confidence            3799999999999987


No 199
>6ZKQ_c NADH dehydrogenase [ubiquinone] flavoprotein 1; complex, respiration, NADH, proton pump; HET: PC1, SF4, 3PE, MYR, NDP, AMP, FMN, ZMP, 2MR, AYA, CDL, SEP, FME; 3.3A {Ovis aries}
Probab=69.99  E-value=3.6  Score=23.81  Aligned_cols=16  Identities=44%  Similarity=0.812  Sum_probs=14.2  Template_Neff=5.400

Q ss_pred             CCCCCCcccCCCCeee
Q tr|A0A075B6V7|    2 DNYGQNFVFGPGTRLS   17 (20)
Q Consensus         2 dnygqnfvfgpgtrls   17 (20)
                      .+|+.||.+...+|+|
T Consensus       153 KsYadNF~~~~~~r~s  168 (170)
T 6ZKQ_c          153 KSYGANFSWNKRTRVS  168 (170)
T ss_pred             cccHHHccCCCCCcee
Confidence            3799999999999987


No 200
>1JV5_B Anti-blood group A Fv, PROTEIN; immunoglobulin, Immune System, Sugar Binding; 2.2A {Homo sapiens} SCOP: b.1.1.1
Probab=69.89  E-value=5.9  Score=13.75  Aligned_cols=11  Identities=36%  Similarity=0.613  Sum_probs=7.8  Template_Neff=15.000

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.|+++.|
T Consensus       106 ~~~~~~~~l~v  116 (117)
T 1JV5_B          106 AYWGQGTLVTV  116 (117)
T ss_dssp             EEECCCEEEEE
T ss_pred             EEecCCeeeEe
Confidence            35778888775


No 201
>6T2J_A Single domain antibody; Human Single Domain Antibody, immune; 1.7A {synthetic construct}
Probab=69.88  E-value=8.7  Score=13.46  Aligned_cols=12  Identities=33%  Similarity=0.443  Sum_probs=9.5  Template_Neff=14.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|+++.|.
T Consensus       108 ~~~~~~~~l~v~  119 (120)
T 6T2J_A          108 DYWGQGTLVTVS  119 (120)
T ss_dssp             EEECCCEEEEEC
T ss_pred             ccccCCeEEEec
Confidence            568888888875


No 202
>4H1L_H HLA class II histocompatibility antigen; PROTEIN-PROTEIN COMPLEX, immunoglobin fold, TCR; 3.3A {Homo sapiens}
Probab=69.84  E-value=4  Score=14.14  Aligned_cols=11  Identities=55%  Similarity=1.117  Sum_probs=7.6  Template_Neff=14.900

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.||+|.|
T Consensus       101 ~~~~~~~~l~v  111 (111)
T 4H1L_H          101 LFFGEGSRLTV  111 (111)
T ss_dssp             CEECCCEEEEC
T ss_pred             eeeccceeeeC
Confidence            45677887764


No 203
>2XTJ_D PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9; HYDROLASE-ANTIBODY COMPLEX, SERINE PROTEASE, LDL-C; 2.7A {HOMO SAPIENS}
Probab=69.84  E-value=4.8  Score=15.33  Aligned_cols=13  Identities=31%  Similarity=0.388  Sum_probs=10.3  Template_Neff=13.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||+|.|.
T Consensus       118 ~~~~~~gt~l~v~  130 (131)
T 2XTJ_D          118 FASWGQGTLVTVS  130 (131)
T ss_dssp             CCSBCCCEEEEEC
T ss_pred             eeeecceeEEEec
Confidence            4568999999874


No 204
>5LWY_H Adiponectin receptor protein 2, V; PROGESTIN AND ADIPOQ RECEPTOR FAMILY; HET: OLB, OLA; 2.4A {Homo sapiens}
Probab=69.80  E-value=7  Score=13.60  Aligned_cols=12  Identities=33%  Similarity=0.504  Sum_probs=9.2  Template_Neff=15.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..++++++|.|.
T Consensus       106 ~~~~~~~~l~v~  117 (119)
T 5LWY_H          106 AYWGQGTLVTVS  117 (119)
T ss_dssp             SEECCCEEEEEC
T ss_pred             EEecCceEEEEe
Confidence            467888988874


No 205
>6Y0E_A Nanobody 22 LBM; Nanobody, IMMUNE SYSTEM; 1.5A {Lama glama}
Probab=69.80  E-value=5.5  Score=15.92  Aligned_cols=11  Identities=36%  Similarity=0.676  Sum_probs=8.7  Template_Neff=13.100

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      .+||.|+++.+
T Consensus       114 ~~~g~G~~~~~  124 (132)
T 6Y0E_A          114 EYWGQGTQVTV  124 (132)
T ss_dssp             EEECCCEEEEE
T ss_pred             eEecCcEEEEe
Confidence            47899998876


No 206
>6Y0E_B Nanobody 22 LBM; Nanobody, IMMUNE SYSTEM; 1.5A {Lama glama}
Probab=69.80  E-value=5.5  Score=15.92  Aligned_cols=11  Identities=36%  Similarity=0.676  Sum_probs=8.7  Template_Neff=13.100

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      .+||.|+++.+
T Consensus       114 ~~~g~G~~~~~  124 (132)
T 6Y0E_B          114 EYWGQGTQVTV  124 (132)
T ss_dssp             EEECCCEEEEE
T ss_pred             eEecCcEEEEe
Confidence            47899998876


No 207
>6CRK_H Guanine nucleotide-binding protein G(i) subunit; Heterotrimeric G-protein antibody fragment, SIGNALING; HET: GDP, FLC; 2.0A {Homo sapiens}
Probab=69.77  E-value=6.1  Score=17.84  Aligned_cols=14  Identities=36%  Similarity=0.738  Sum_probs=10.3  Template_Neff=13.000

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      .+.||.|||+..++
T Consensus       236 ~~~~g~~t~~~~~~  249 (259)
T 6CRK_H          236 PLTFGAGTKLELKA  249 (259)
T ss_dssp             SCEECCCEEEEEC-
T ss_pred             cEEeCCCceEEeeh
Confidence            36899999987653


No 208
>2P1Y_A bispecific alpha/beta TCR; TCR, autoimmunity, immunoglobulin fold, diabody; 2.42A {Mus musculus}
Probab=69.61  E-value=5.9  Score=17.08  Aligned_cols=16  Identities=50%  Similarity=0.922  Sum_probs=12.3  Template_Neff=13.600

Q ss_pred             CCCcccCCCCeeeeCC
Q tr|A0A075B6V7|    5 GQNFVFGPGTRLSVLP   20 (20)
Q Consensus         5 gqnfvfgpgtrlsvlp   20 (20)
                      +....++.+++|.|+|
T Consensus       223 ~~~~~~~~~~~l~V~p  238 (238)
T 2P1Y_A          223 AYKVIFGKGTHLHVLP  238 (238)
T ss_dssp             TTEEEECCCEEEEEEC
T ss_pred             cceeeeccCCccccCC
Confidence            4456788889999887


No 209
>7B27_CCC Surface glycoprotein, neutralizing nanobody NM1230; SARS-CoV2, receptor binding domain, complex; HET: NAG; 2.902A {Severe acute respiratory syndrome coronavirus 2}
Probab=69.61  E-value=6.6  Score=15.52  Aligned_cols=13  Identities=31%  Similarity=0.590  Sum_probs=9.7  Template_Neff=13.500

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||.||+|.|.
T Consensus       109 ~~~~~~~t~l~v~  121 (141)
T 7B27_CCC        109 KDVWGQGAQVTVS  121 (141)
T ss_pred             eEeecCCcEEEEe
Confidence            4578888888764


No 210
>6LHF_G MHC class I, Beta-2-microglobulin, RY0808; chicken, complex, BF2*15:01, IMMUNE SYSTEM; 2.7A {Gallus gallus}
Probab=69.59  E-value=3.4  Score=14.35  Aligned_cols=11  Identities=18%  Similarity=0.320  Sum_probs=6.8  Template_Neff=14.900

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.||++.|
T Consensus       102 ~~~~~~~~l~~  112 (112)
T 6LHF_G          102 LYFSSGQPAFF  112 (112)
T ss_pred             EEEcCCeeccC
Confidence            45677776643


No 211
>7N9E_D CovS NB34 nanobody, VIRAL PROTEIN; 3.52A {Lama glama}
Probab=69.45  E-value=8.9  Score=16.02  Aligned_cols=13  Identities=31%  Similarity=0.560  Sum_probs=9.8  Template_Neff=12.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||+++|-
T Consensus       129 ~~~~~~~t~l~v~  141 (155)
T 7N9E_D          129 DDYWGQGTQVTVS  141 (155)
T ss_pred             cccccCCceEEEe
Confidence            4568999998773


No 212
>1N4X_I immunoglobulin kappa chain variable region/immunoglobulin; immunoglobulin, Immune system; 1.7A {Mus musculus} SCOP: b.1.1.1
Probab=69.38  E-value=6.8  Score=14.11  Aligned_cols=12  Identities=33%  Similarity=0.562  Sum_probs=9.2  Template_Neff=14.500

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||+|+|.
T Consensus       108 ~~~~~g~~l~v~  119 (120)
T 1N4X_I          108 TYWGQGTTVTVS  119 (120)
T ss_dssp             EEECCCEEEEEC
T ss_pred             EEecCCeEEEEe
Confidence            357889998875


No 213
>1NMB_H N9 NEURAMINIDASE, FAB NC10; COMPLEX (HYDROLASE-IMMUNOGLOBULIN), COMPLEX (HYDROLASE-IMMUNOGLOBULIN) complex; HET: BMA, NAG, MAN; 2.2A {Influenza A virus} SCOP: b.1.1.1
Probab=69.29  E-value=9.1  Score=13.46  Aligned_cols=13  Identities=38%  Similarity=0.437  Sum_probs=9.7  Template_Neff=14.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||.+.|-
T Consensus       109 ~~~~~~~~~l~v~  121 (122)
T 1NMB_H          109 FDYWGQGTTLTVS  121 (122)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             eeeecCCceEEec
Confidence            3568899988774


No 214
>4YJZ_L influenza viral hemagglutinin, scFv H2526; influenza, antibody, complex, hemagglutinin, Viral; HET: NAG; 2.72A {Influenza A virus}
Probab=69.28  E-value=6.9  Score=17.87  Aligned_cols=13  Identities=38%  Similarity=0.509  Sum_probs=10.1  Template_Neff=12.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..++|.||+|+|.
T Consensus       242 ~~~~~~~~~l~V~  254 (269)
T 4YJZ_L          242 MDVWGQGTTVAVS  254 (269)
T ss_dssp             EEEECCCEEEEC-
T ss_pred             eeeCCCCeEEEEE
Confidence            4678999999885


No 215
>4YQX_L JES6-1 VH domain, JES6-1 VL; chemokine, antibody, complex, CYTOKINE-IMMUNE SYSTEM; HET: FUC, NAG; 2.826A {Rattus norvegicus}
Probab=69.27  E-value=7.6  Score=14.28  Aligned_cols=13  Identities=38%  Similarity=0.639  Sum_probs=9.6  Template_Neff=14.100

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||+|.|.
T Consensus       103 ~~~~~~~t~l~v~  115 (118)
T 4YQX_L          103 PPTFGAGTKLELK  115 (118)
T ss_dssp             SCEECCCEEEEEE
T ss_pred             CCeecCCcEEEEe
Confidence            3568888888764


No 216
>3B9V_C heavy chain variable domain; antibody engineering, phage display, IMMUNE; 1.8A {Homo sapiens}
Probab=69.20  E-value=6.6  Score=13.79  Aligned_cols=13  Identities=31%  Similarity=0.353  Sum_probs=9.5  Template_Neff=14.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|+.+.|.
T Consensus       107 ~~~~~~~~~l~v~  119 (120)
T 3B9V_C          107 MDYWGQGTLVTVS  119 (120)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             eeeecCCceeEEc
Confidence            3568888888774


No 217
>5Y80_B Cyclin-G-associated kinase (E.C.2.7.11.1), NANOBODY; kinase, complex, TRANSFERASE-IMMUNE SYSTEM complex; HET: IRE; 2.5A {Homo sapiens}
Probab=69.07  E-value=10  Score=15.21  Aligned_cols=13  Identities=31%  Similarity=0.297  Sum_probs=10.4  Template_Neff=13.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||+|+|.
T Consensus       116 ~~~~~~gt~l~v~  128 (148)
T 5Y80_B          116 NNPSSQGTQVTVS  128 (148)
T ss_dssp             SCCCSCCEEEEEC
T ss_pred             cCCCCCCceeecc
Confidence            4578999999875


No 218
>2OTU_A Fv light chain variable domain; Antibody Fv polyglutamine complex, IMMUNE; 1.68A {Mus musculus}
Probab=69.04  E-value=4.6  Score=13.99  Aligned_cols=11  Identities=55%  Similarity=1.180  Sum_probs=7.7  Template_Neff=15.000

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.|++|+|
T Consensus       105 ~~~~~~~~l~v  115 (115)
T 2OTU_A          105 YVFGGGTKVTV  115 (115)
T ss_dssp             EEECCCEEEEC
T ss_pred             EEEcCCeEEeC
Confidence            45788888764


No 219
>2OTW_C Fv light chain avriable domain; Antibody, polyglutamine, complex, IMMUNE SYSTEM; 2.35A {Mus musculus}
Probab=69.04  E-value=4.6  Score=13.99  Aligned_cols=11  Identities=55%  Similarity=1.180  Sum_probs=7.7  Template_Neff=15.000

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.|++|+|
T Consensus       105 ~~~~~~~~l~v  115 (115)
T 2OTW_C          105 YVFGGGTKVTV  115 (115)
T ss_dssp             EEECCCEEEEC
T ss_pred             EEEcCCeEEeC
Confidence            45788888764


No 220
>1A14_L NEURAMINIDASE, SINGLE CHAIN ANTIBODY; COMPLEX (ANTIBODY-ANTIGEN), SINGLE-CHAIN ANTIBODY, GLYCOSYLATED; HET: BMA, NAG, MAN; 2.5A {Influenza A virus} SCOP: b.1.1.1
Probab=68.83  E-value=4  Score=14.95  Aligned_cols=9  Identities=56%  Similarity=0.973  Sum_probs=6.3  Template_Neff=13.800

Q ss_pred             cccCCCCee
Q tr|A0A075B6V7|    8 FVFGPGTRL   16 (20)
Q Consensus         8 fvfgpgtrl   16 (20)
                      ..||.||+|
T Consensus        96 ~~~~~~t~~  104 (104)
T 1A14_L           96 FTFGGGTAA  104 (104)
T ss_dssp             CEEBCCEEC
T ss_pred             eeecCcccC
Confidence            467888764


No 221
>7SOE_G kappa, spike, antibody, Structural Genomics; HET: NAG; 2.8A {Severe acute respiratory syndrome coronavirus 2}
Probab=68.76  E-value=4.9  Score=14.47  Aligned_cols=10  Identities=60%  Similarity=0.979  Sum_probs=6.6  Template_Neff=14.100

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .|+.||+++|
T Consensus        96 ~~~~~t~l~v  105 (105)
T 7SOE_G           96 GFGGGTKLTV  105 (105)
T ss_pred             EEcCceEEeC
Confidence            4677777654


No 222
>7JO8_B 47G4-CD828Z; Chimeric Antigen Receptor (CAR) antibody; HET: PG4, 1PE; 1.399A {synthetic construct}
Probab=68.65  E-value=6.2  Score=14.69  Aligned_cols=13  Identities=46%  Similarity=1.117  Sum_probs=9.7  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      .+.|+.|+.|.|.
T Consensus        96 ~~~~~~~~~l~v~  108 (110)
T 7JO8_B           96 RFTFGPGTKVDIK  108 (110)
T ss_dssp             SCCBCCCEEEEET
T ss_pred             eEEECCCeEEEEe
Confidence            3578899988773


No 223
>6OL7_J glVRC01 Heavy Chain, glVRC01 Light; glVRC01, Iv8, Anti-Idiotype, scFv, antibody; HET: PEG, EDO; 2.419A {Mus musculus}
Probab=68.61  E-value=8.8  Score=14.63  Aligned_cols=11  Identities=45%  Similarity=1.050  Sum_probs=8.0  Template_Neff=13.700

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..||.||.|.|
T Consensus       102 ~~~~~gt~l~v  112 (125)
T 6OL7_J          102 WTFGGGTKLEI  112 (125)
T ss_pred             ceeCCccEEEE
Confidence            46788888765


No 224
>6JRI_B Nanobody; Nanobody, therapeutic, ANTIVIRAL PROTEIN; 3.101A {Vicugna pacos}
Probab=68.59  E-value=6.4  Score=14.50  Aligned_cols=13  Identities=31%  Similarity=0.565  Sum_probs=10.0  Template_Neff=14.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||.|+|-
T Consensus       117 ~~~~~~~~~l~v~  129 (130)
T 6JRI_B          117 FIYWGQGTQVTVS  129 (130)
T ss_dssp             EEEECCCEEEEEE
T ss_pred             eEEEcCCceeEEc
Confidence            4578899998873


No 225
>6JRI_F Nanobody; Nanobody, therapeutic, ANTIVIRAL PROTEIN; 3.101A {Vicugna pacos}
Probab=68.59  E-value=6.4  Score=14.50  Aligned_cols=13  Identities=31%  Similarity=0.565  Sum_probs=10.0  Template_Neff=14.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||.|+|-
T Consensus       117 ~~~~~~~~~l~v~  129 (130)
T 6JRI_F          117 FIYWGQGTQVTVS  129 (130)
T ss_dssp             EEEECCCEEEEEE
T ss_pred             eEEEcCCceeEEc
Confidence            4578899998873


No 226
>6UZ1_I MHC class I antigen, A-2; single-chain T cell receptor, peptide; HET: MES; 3.14A {Homo sapiens}
Probab=68.55  E-value=8.8  Score=13.64  Aligned_cols=13  Identities=46%  Similarity=0.910  Sum_probs=8.9  Template_Neff=14.400

Q ss_pred             cccCCCCeeeeCC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVLP   20 (20)
Q Consensus         8 fvfgpgtrlsvlp   20 (20)
                      ..++.++++.|.|
T Consensus        97 ~~~~~~~~l~v~~  109 (110)
T 6UZ1_I           97 LQFGAGTQVVVTP  109 (110)
T ss_dssp             CEECCCEEEEEC-
T ss_pred             EEeCCCeEEEecc
Confidence            4677888888754


No 227
>6ZE1_B Cystic fibrosis transmembrane conductance regulator; cystic fibrosis, CFTR, nanobodies, allostery; HET: ATP, EDO; 2.705A {Homo sapiens}
Probab=68.40  E-value=6.5  Score=16.11  Aligned_cols=13  Identities=31%  Similarity=0.468  Sum_probs=10.1  Template_Neff=13.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      .+.||.||++.|.
T Consensus       108 ~~~~~~gt~l~v~  120 (147)
T 6ZE1_B          108 YDYWGQGTQVTVS  120 (147)
T ss_dssp             CCEECCCEEEEEC
T ss_pred             eEEecCCeEEEEc
Confidence            3589999998774


No 228
>1JTT_A Vh Single-Domain Antibody, Lysozyme; immunoglobulin, heavy chain antibody, VHH; HET: FMT; 2.1A {Gallus gallus} SCOP: b.1.1.1
Probab=68.28  E-value=8.4  Score=14.68  Aligned_cols=13  Identities=31%  Similarity=0.470  Sum_probs=10.3  Template_Neff=13.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||.+.|-
T Consensus       120 ~~~~~~~~~l~v~  132 (133)
T 1JTT_A          120 YDSWGQGTQVTVS  132 (133)
T ss_dssp             CCEECCCEEEEEE
T ss_pred             cceeccceeEEec
Confidence            4578999999874


No 229
>6K4Z_B scFv of C6; antigen binding, affinity maturation, Somatic; HET: NPA; 1.65A {Mus musculus}
Probab=68.04  E-value=6  Score=17.17  Aligned_cols=11  Identities=45%  Similarity=0.733  Sum_probs=9.3  Template_Neff=13.600

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      +||.||+|+|-
T Consensus       236 ~~~~~t~l~v~  246 (247)
T 6K4Z_B          236 YWGQGTALTVS  246 (247)
T ss_dssp             SBCCCEEEEEC
T ss_pred             EeeCCeeeEec
Confidence            58999999873


No 230
>1NMC_B NEURAMINIDASE, SINGLE CHAIN ANTIBODY; COMPLEX (SINGLE-CHAIN ANTIBODY-ANTIGEN), HYDROLASE, COMPLEX; HET: BMA, NAG, MAN; 2.5A {Influenza A virus} SCOP: b.1.1.1
Probab=68.02  E-value=9.3  Score=13.52  Aligned_cols=13  Identities=31%  Similarity=0.381  Sum_probs=9.5  Template_Neff=14.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||.|.|-
T Consensus       109 ~~~~~~~~~l~v~  121 (122)
T 1NMC_B          109 FDYWGQGTTVTVS  121 (122)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             ceeecCCeEEEec
Confidence            3468889988774


No 231
>6IVZ_H Envelope protein, Heavy chain of; Yellow fever virus, Neutralizing monoclonal; 2.4A {Yellow fever virus}
Probab=67.93  E-value=3.8  Score=14.65  Aligned_cols=9  Identities=56%  Similarity=1.180  Sum_probs=6.6  Template_Neff=14.700

Q ss_pred             ccCCCCeee
Q tr|A0A075B6V7|    9 VFGPGTRLS   17 (20)
Q Consensus         9 vfgpgtrls   17 (20)
                      +||.||.++
T Consensus       113 ~~~~gt~l~  121 (121)
T 6IVZ_H          113 VWGPGTMVT  121 (121)
T ss_dssp             EECCCEEEC
T ss_pred             EecCCcccC
Confidence            688888763


No 232
>7JVB_D Spike glycoprotein, Nanobody Nb20; SARS-CoV-2, COVID-19, nanobody, spike protein; HET: CAC; 3.287A {Severe acute respiratory syndrome coronavirus 2}
Probab=67.85  E-value=9  Score=13.17  Aligned_cols=11  Identities=36%  Similarity=0.824  Sum_probs=8.4  Template_Neff=15.100

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.|++|.|
T Consensus       105 ~~~~~~~~l~v  115 (117)
T 7JVB_D          105 IYWGQGTQVTV  115 (117)
T ss_dssp             CEECCCEEEEE
T ss_pred             EEecCCceEEE
Confidence            46788888876


No 233
>1SVZ_A single-chain Fv fragment 1696/nonamer from; antibody-antigen complex  HIV inhibiting; 1.89A {Mus musculus}
Probab=67.58  E-value=6.4  Score=17.08  Aligned_cols=11  Identities=36%  Similarity=0.679  Sum_probs=9.2  Template_Neff=13.600

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      +|+.||+|+|-
T Consensus       236 ~~~~~t~l~V~  246 (247)
T 1SVZ_A          236 YWGQGTTVTVS  246 (247)
T ss_dssp             EECCCEEEEEC
T ss_pred             EeecCeeEEec
Confidence            58999999884


No 234
>7LUC_N Fusion glycoprotein F0, 01.4B Fab; RSV, viral fusogen, fusion protein; 3.21A {Respiratory syncytial virus}
Probab=67.51  E-value=7.7  Score=14.35  Aligned_cols=12  Identities=33%  Similarity=0.531  Sum_probs=9.1  Template_Neff=14.300

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||+++|-
T Consensus       117 ~~~~~~~~l~v~  128 (129)
T 7LUC_N          117 DAWGQGTTVTVS  128 (129)
T ss_dssp             EEECCCEEEEEC
T ss_pred             eeeccceEEEeC
Confidence            467889988773


No 235
>7LY2_G Spike glycoprotein, S2M11 Fab Light; Antibody, VIRAL PROTEIN, Structural Genomics; HET: BMA, FUC, NAG; 2.5A {Severe acute respiratory syndrome coronavirus 2}
Probab=67.44  E-value=7.8  Score=13.25  Aligned_cols=10  Identities=40%  Similarity=0.750  Sum_probs=6.1  Template_Neff=15.200

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .|+.++++.|
T Consensus       107 ~~~~~~~l~v  116 (117)
T 7LY2_G          107 YWGQGTLVTV  116 (117)
T ss_pred             EeCCceEEEE
Confidence            3566776654


No 236
>1BWW_A REIV, STABILIZED IMMUNOGLOBULIN FRAGMENT, BENCE-JONES; 1.7A {Homo sapiens} SCOP: b.1.1.1
Probab=67.27  E-value=6.7  Score=14.58  Aligned_cols=11  Identities=45%  Similarity=1.138  Sum_probs=8.5  Template_Neff=13.700

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.|+.++++.|
T Consensus        98 ~~~~~~~~l~v  108 (109)
T 1BWW_A           98 YTFGQGTKLQI  108 (109)
T ss_dssp             CEECCCEEEEE
T ss_pred             EEEcCCeEEEE
Confidence            46788888876


No 237
>5GS1_N light chain, heavy chain, diabody; diabody, antibody fragment, IMMUNE SYSTEM; 2.0A {Homo sapiens}
Probab=67.12  E-value=10  Score=13.12  Aligned_cols=13  Identities=38%  Similarity=0.488  Sum_probs=9.4  Template_Neff=15.200

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.++++.|.
T Consensus       106 ~~~~~~~~~l~v~  118 (124)
T 5GS1_N          106 YDVWGQGTLVTVS  118 (124)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             eeEEccceEEEEe
Confidence            3467888888774


No 238
>6TEJ_C Drug ABC transporter ATP-binding protein; ABC transporter, Membrane protein, Sybody; HET: DMU; 2.7A {Mycolicibacterium thermoresistibile}
Probab=67.03  E-value=7.7  Score=13.70  Aligned_cols=11  Identities=36%  Similarity=0.730  Sum_probs=8.4  Template_Neff=14.900

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .|+.||++.|.
T Consensus       113 ~~~~~~~l~v~  123 (124)
T 6TEJ_C          113 YWGQGTQVTVS  123 (124)
T ss_dssp             EECCCEEEECC
T ss_pred             EecCCceeEec
Confidence            48888888764


No 239
>6U50_C Anti-Sudan ebolavirus Nucleoprotein Single Domain; Antibody, nanobody, Ebola, filovirus, IMMUNE; 1.6A {Lama glama}
Probab=66.77  E-value=11  Score=13.59  Aligned_cols=13  Identities=38%  Similarity=0.600  Sum_probs=9.5  Template_Neff=14.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...+|.|+.+.|.
T Consensus       107 ~~~~~~~~~l~v~  119 (120)
T 6U50_C          107 NDYWGQGTQVTVS  119 (120)
T ss_dssp             EEEECCCEEEEEE
T ss_pred             cceeccceeeEec
Confidence            3577888888764


No 240
>6U51_A Anti-Sudan ebolavirus Nucleoprotein Single Domain; Antibody, nanobody, Ebola, filovirus, IMMUNE; 2.52A {Lama glama}
Probab=66.77  E-value=11  Score=13.59  Aligned_cols=13  Identities=38%  Similarity=0.600  Sum_probs=9.5  Template_Neff=14.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...+|.|+.+.|.
T Consensus       107 ~~~~~~~~~l~v~  119 (120)
T 6U51_A          107 NDYWGQGTQVTVS  119 (120)
T ss_dssp             EEEECCCEEEEEE
T ss_pred             cceeccceeeEec
Confidence            3567888888764


No 241
>6IW2_E Envelope protein E, Heavy chain; Yellow fever virus, Neutralizing monoclonal; 2.9A {Yellow fever virus (strain 17D vaccine)}
Probab=66.67  E-value=3.8  Score=14.52  Aligned_cols=10  Identities=50%  Similarity=0.913  Sum_probs=7.0  Template_Neff=14.800

Q ss_pred             cccCCCCeee
Q tr|A0A075B6V7|    8 FVFGPGTRLS   17 (20)
Q Consensus         8 fvfgpgtrls   17 (20)
                      .+||.||.|+
T Consensus       111 ~~~~~gt~l~  120 (120)
T 6IW2_E          111 DVWGPGTMVT  120 (120)
T ss_dssp             EEECCCEEEC
T ss_pred             eEEeCCcccC
Confidence            3688888763


No 242
>6I2G_A ALFA nanobody, N7P-SER-ARG-LEU-GLU-GLU-GLU-LEU-ARG-ARG-ARG-LEU-THR-GLU-LPD; Nanobody, ALFA, tag, PEPTIDE BINDING; HET: SO4, N7P; 1.5A {Vicugna pacos}
Probab=66.63  E-value=8.1  Score=13.63  Aligned_cols=12  Identities=33%  Similarity=0.545  Sum_probs=8.7  Template_Neff=14.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||+|.|.
T Consensus       112 ~~~~~~~~l~v~  123 (124)
T 6I2G_A          112 DYWGQGTQVTVS  123 (124)
T ss_dssp             EEECCCEEEEEC
T ss_pred             EEecCceEEEEe
Confidence            356888888774


No 243
>2H3N_B VpreB protein/Ig lambda-5; beta sheets, v- and c-type; 2.3A {Homo sapiens}
Probab=66.57  E-value=9.2  Score=13.60  Aligned_cols=11  Identities=64%  Similarity=1.114  Sum_probs=7.5  Template_Neff=14.600

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..+|.||++++
T Consensus         3 ~~~g~~~~~~~   13 (117)
T 2H3N_B            3 HVFGSGTQLTV   13 (117)
T ss_dssp             TCBCCCEEEEE
T ss_pred             eecCCceEEEE
Confidence            35777777765


No 244
>4YGA_B ?; Serine/Threonine Protein Kinase, VHH Domain; HET: CA; 2.94A {Toxoplasma gondii}
Probab=66.48  E-value=8.2  Score=14.97  Aligned_cols=12  Identities=33%  Similarity=0.537  Sum_probs=9.6  Template_Neff=13.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|++++|.
T Consensus       112 ~~~~~~~~l~v~  123 (141)
T 4YGA_B          112 EHWGQGTQVTVS  123 (141)
T ss_dssp             BSCCCCEEEEEC
T ss_pred             eeecCCeEEEEe
Confidence            478999998875


No 245
>4YGA_H ?; Serine/Threonine Protein Kinase, VHH Domain; HET: CA; 2.94A {Toxoplasma gondii}
Probab=66.48  E-value=8.2  Score=14.97  Aligned_cols=12  Identities=33%  Similarity=0.537  Sum_probs=9.6  Template_Neff=13.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|++++|.
T Consensus       112 ~~~~~~~~l~v~  123 (141)
T 4YGA_H          112 EHWGQGTQVTVS  123 (141)
T ss_dssp             BSCCCCEEEEEC
T ss_pred             eeecCCeEEEEe
Confidence            478999998875


No 246
>6OSV_L Variable domain of Light Chain; Single chain Fv, ScFv, Antibody; 1.34A {Oryctolagus cuniculus}
Probab=66.46  E-value=8.3  Score=13.30  Aligned_cols=11  Identities=45%  Similarity=0.878  Sum_probs=8.3  Template_Neff=14.900

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.+++++|
T Consensus       100 ~~~~~~~~l~v  110 (111)
T 6OSV_L          100 TAFGGGTKLEI  110 (111)
T ss_dssp             CEECCCEEEEE
T ss_pred             eeecCceeeEe
Confidence            56788888876


No 247
>5CBA_C 3b4 heavy chain, 3b4 light; anti-CXCL13, CXCL13, scFv, IMMUNE SYSTEM; HET: EDO; 2.5A {Homo sapiens}
Probab=66.43  E-value=9.8  Score=14.86  Aligned_cols=13  Identities=31%  Similarity=0.488  Sum_probs=10.3  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+|+.|++|.|-
T Consensus       114 ~~~~~~~~~l~v~  126 (142)
T 5CBA_C          114 FDIWGQGTTVTVS  126 (142)
T ss_dssp             CCEECCCEEEEEC
T ss_pred             eeeecCCceEEEe
Confidence            4578999999874


No 248
>5CBE_A E10 heavy chain, E10 light; anti-CXCL13, E10, scFv, IMMUNE SYSTEM; 2.4A {Homo sapiens}
Probab=66.43  E-value=9.8  Score=14.86  Aligned_cols=13  Identities=31%  Similarity=0.488  Sum_probs=10.3  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+|+.|++|.|-
T Consensus       114 ~~~~~~~~~l~v~  126 (142)
T 5CBE_A          114 FDIWGQGTTVTVS  126 (142)
T ss_dssp             CCSBBCCEEEEEC
T ss_pred             eeeecCCceEEEe
Confidence            4588999999874


No 249
>2Z35_A T-cell receptor alpha-chain, T-cell receptor; immune receptor, IMMUNE SYSTEM; 2.2A {Mus musculus}
Probab=66.17  E-value=11  Score=13.60  Aligned_cols=14  Identities=43%  Similarity=0.990  Sum_probs=8.8  Template_Neff=14.200

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      ...|+.++.++|.|
T Consensus        99 ~~~~~~~~~l~v~~  112 (112)
T 2Z35_A           99 KITFGAGTKLTIKP  112 (112)
T ss_dssp             CEEECCCEEEEEEC
T ss_pred             EEEECCCeEEEECC
Confidence            34567777777654


No 250
>3ZHK_B MG2X1 SCAFFOLD ANTIBODY; IMMUNE SYSTEM, SINGLE DOMAIN ANTIBODY; HET: SO4; 1.962A {HOMO SAPIENS}
Probab=66.16  E-value=9.1  Score=14.37  Aligned_cols=12  Identities=33%  Similarity=0.476  Sum_probs=9.1  Template_Neff=14.000

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...||.||.+.+
T Consensus       106 ~~~~~~gt~~~~  117 (127)
T 3ZHK_B          106 PDYWGQGTLVTV  117 (127)
T ss_dssp             EEEECCCEEEEE
T ss_pred             CceecCCeEEEE
Confidence            357899998875


No 251
>5I0Z_A catalytic DNA antibody; 3D8 scFv, 3D8-VH, IMMUNE SYSTEM; 1.9A {Mus musculus}
Probab=66.13  E-value=8.3  Score=14.81  Aligned_cols=13  Identities=31%  Similarity=0.470  Sum_probs=9.8  Template_Neff=14.000

Q ss_pred             cccCCCCeeeeCC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVLP   20 (20)
Q Consensus         8 fvfgpgtrlsvlp   20 (20)
                      ..||.||.|.|.+
T Consensus       130 ~~~~~~~~l~v~~  142 (143)
T 5I0Z_A          130 DYWGQGTSVTVSS  142 (143)
T ss_dssp             EEECCCEEEEECC
T ss_pred             EEEcCCeEEEEeC
Confidence            4678999888753


No 252
>7Q9G_E SARS-CoV2, Spike, glycoprotein, antibody, fab; HET: NAG;{Severe acute respiratory syndrome coronavirus 2}
Probab=65.88  E-value=10  Score=13.36  Aligned_cols=12  Identities=33%  Similarity=0.423  Sum_probs=7.9  Template_Neff=14.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|+++.|.
T Consensus       107 ~~~~~~~~l~v~  118 (119)
T 7Q9G_E          107 DPWGQGTLVTVS  118 (119)
T ss_pred             eCcccceEEEEe
Confidence            456778877653


No 253
>6XRT_H Envelope glycoprotein gp41, BG505 gp120; SHIV, V1V2, V2-Apex, SOSIP, Vaccine; HET: TYS, BMA, NAG, MAN;{Human immunodeficiency virus 1}
Probab=65.71  E-value=10  Score=14.01  Aligned_cols=10  Identities=40%  Similarity=1.062  Sum_probs=6.2  Template_Neff=14.400

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      ++|+++.+.|
T Consensus       122 ~~~~~~~~~v  131 (133)
T 6XRT_H          122 LWGPGTPIII  131 (133)
T ss_pred             ccCCCCceee
Confidence            5666666655


No 254
>5C9K_G Amyloid lambda 6 light chain; LAMBDA VI SUBGROUP, BETA-SANDWICH, IMMUNOGLOBULIN; HET: ACT; 1.92A {Homo sapiens}
Probab=65.68  E-value=9.6  Score=13.39  Aligned_cols=13  Identities=62%  Similarity=1.060  Sum_probs=9.1  Template_Neff=14.600

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.+++|.|+
T Consensus        99 ~~~~~~~~~l~v~  111 (111)
T 5C9K_G           99 HVVFGGGTKLTVL  111 (111)
T ss_dssp             CEEECCCEEEEEC
T ss_pred             eEEEcCceeeeeC
Confidence            3567788888774


No 255
>6DBD_B VHH R326; nanobody VHH Listeria, IMMUNE SYSTEM; 1.755A {Lama glama}
Probab=65.43  E-value=8.1  Score=14.46  Aligned_cols=11  Identities=36%  Similarity=0.939  Sum_probs=8.8  Template_Neff=14.100

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..||.||++.|
T Consensus       104 ~~~~~~~~l~v  114 (129)
T 6DBD_B          104 WAWGQGTQVTV  114 (129)
T ss_dssp             EEECCCEEEEE
T ss_pred             eEEeCCeeEEE
Confidence            57889998876


No 256
>1OAQ_H HEAVY CHAIN, LIGHT CHAIN; IMMUNE SYSTEM, ALLERGY, IGE, CONFORMATIONAL; 1.5A {MUS MUSCULUS} SCOP: b.1.1.1
Probab=65.35  E-value=12  Score=13.23  Aligned_cols=12  Identities=42%  Similarity=0.559  Sum_probs=8.6  Template_Neff=14.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|+.|.|.
T Consensus       108 ~~~~~~~~l~v~  119 (121)
T 1OAQ_H          108 DYWGQGTTLTVS  119 (121)
T ss_dssp             EEECCCEEEEEC
T ss_pred             eeecCCeEEEEc
Confidence            356888888774


No 257
>1QFW_M GONADOTROPIN ALPHA SUBUNIT, GONADOTROPHIN BETA; GLYCOPROTEIN HORMONE, STIMULATION OF PRODUCTION; HET: NAG; 3.5A {Homo sapiens} SCOP: b.1.1.1
Probab=65.32  E-value=10  Score=13.93  Aligned_cols=12  Identities=42%  Similarity=0.946  Sum_probs=8.7  Template_Neff=13.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      +.|+.++++.|-
T Consensus        96 ~~~~~~~~~~v~  107 (108)
T 1QFW_M           96 YTFGGGTKLEIK  107 (108)
T ss_dssp             CEECCCEEEECC
T ss_pred             eEeCCCeEEEEe
Confidence            567888888764


No 258
>6ITP_B anti-cortisol camelid antibody; Cortisol, Complex, Nanobody, Camelid antibody; HET: HCY; 1.572A {Camelus bactrianus}
Probab=65.11  E-value=6.9  Score=14.26  Aligned_cols=12  Identities=33%  Similarity=0.614  Sum_probs=9.8  Template_Neff=14.500

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||+|.|.
T Consensus       115 ~~~~~~~~l~v~  126 (127)
T 6ITP_B          115 RAWGQGTQVTVS  126 (127)
T ss_dssp             CEECCCEEEEEC
T ss_pred             EEeecCcccEec
Confidence            578999998874


No 259
>6ITQ_A anti-cortisol camelid antibody; Cortisol, Complex, Nanobody, Camelid antibody; HET: HCY, SO4; 1.526A {Camelus bactrianus}
Probab=65.11  E-value=6.9  Score=14.26  Aligned_cols=12  Identities=33%  Similarity=0.614  Sum_probs=9.8  Template_Neff=14.500

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||+|.|.
T Consensus       115 ~~~~~~~~l~v~  126 (127)
T 6ITQ_A          115 RAWGQGTQVTVS  126 (127)
T ss_dssp             CEECCCEEEEEC
T ss_pred             EEeecCcccEec
Confidence            578999998874


No 260
>7LXZ_I Spike glycoprotein, S2M11 Fab Light; Antibody, VIRAL PROTEIN, Structural Genomics; HET: BMA, FUC, NAG;{Severe acute respiratory syndrome coronavirus 2}
Probab=65.08  E-value=5.9  Score=13.50  Aligned_cols=9  Identities=67%  Similarity=1.287  Sum_probs=6.1  Template_Neff=15.000

Q ss_pred             cccCCCCee
Q tr|A0A075B6V7|    8 FVFGPGTRL   16 (20)
Q Consensus         8 fvfgpgtrl   16 (20)
                      ..||.||.|
T Consensus        98 ~~~~~~~~l  106 (107)
T 7LXZ_I           98 WVFGGGTKL  106 (107)
T ss_pred             EEECCceee
Confidence            567777765


No 261
>6CVK_A PROTEIN; HEPATITIS B, SINGLE CHAIN VARIABLE; 2.38A {Oryctolagus cuniculus}
Probab=65.01  E-value=9.3  Score=16.92  Aligned_cols=11  Identities=27%  Similarity=0.525  Sum_probs=8.9  Template_Neff=13.400

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      |+++||.+.|-
T Consensus       238 v~~~~t~~~V~  248 (261)
T 6CVK_A          238 PWGLGTLVTIS  248 (261)
T ss_dssp             EECCCEEEEEC
T ss_pred             ccccCceeeee
Confidence            58999998874


No 262
>5U8R_H Insulin-like growth factor 1 receptor; Receptor, tyrosine kinase, Type 1; HET: MLT, NAG; 3.00001618041A {Homo sapiens}
Probab=64.96  E-value=9.4  Score=13.51  Aligned_cols=12  Identities=33%  Similarity=0.498  Sum_probs=9.1  Template_Neff=14.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.+++|.|.
T Consensus       108 ~~~~~~~~l~v~  119 (126)
T 5U8R_H          108 DYWGQGTSVTVS  119 (126)
T ss_dssp             CEECCCEEEEEC
T ss_pred             eEecCceEEEEe
Confidence            467888888875


No 263
>6VO0_H 43A2 light chain, 43A2 heavy; HIV, Env, antibody, VIRAL PROTEIN; HET: BMA, NAG; 3.52A {Oryctolagus cuniculus}
Probab=64.91  E-value=6.5  Score=14.08  Aligned_cols=9  Identities=44%  Similarity=0.881  Sum_probs=6.5  Template_Neff=14.600

Q ss_pred             cccCCCCee
Q tr|A0A075B6V7|    8 FVFGPGTRL   16 (20)
Q Consensus         8 fvfgpgtrl   16 (20)
                      .+||.||+|
T Consensus       112 ~~~~~gt~l  120 (120)
T 6VO0_H          112 DLWGPGTLV  120 (120)
T ss_pred             cccCCCccC
Confidence            578888764


No 264
>6VO0_I 43A2 light chain, 43A2 heavy; HIV, Env, antibody, VIRAL PROTEIN; HET: BMA, NAG; 3.52A {Oryctolagus cuniculus}
Probab=64.91  E-value=6.5  Score=14.08  Aligned_cols=9  Identities=44%  Similarity=0.881  Sum_probs=6.5  Template_Neff=14.600

Q ss_pred             cccCCCCee
Q tr|A0A075B6V7|    8 FVFGPGTRL   16 (20)
Q Consensus         8 fvfgpgtrl   16 (20)
                      .+||.||+|
T Consensus       112 ~~~~~gt~l  120 (120)
T 6VO0_I          112 DLWGPGTLV  120 (120)
T ss_pred             cccCCCccC
Confidence            578888764


No 265
>5IP4_B Neuronal migration protein doublecortin; DCX DOMAIN, UBIQUITIN-LIKE FOLD, MICROTUBULE; 1.81A {Lama glama}
Probab=64.91  E-value=12  Score=14.03  Aligned_cols=12  Identities=33%  Similarity=0.811  Sum_probs=8.3  Template_Neff=13.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||+|+.+.+.
T Consensus        99 ~~~~~g~~~~~~  110 (121)
T 5IP4_B           99 YYWGQGTQVTVS  110 (121)
T ss_dssp             TEECCCEEEEEE
T ss_pred             eEEcCCcEEEec
Confidence            467888877664


No 266
>4RZC_A Fv M6P-1 light chain ; Antibody variable fragment, mannose-6-phosphate, Immune; HET: M6P, SO4; 2.723A {Oryctolagus cuniculus}
Probab=64.88  E-value=8.9  Score=14.74  Aligned_cols=12  Identities=42%  Similarity=0.775  Sum_probs=8.8  Template_Neff=13.400

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||+||.++|.
T Consensus       107 ~~~~~g~~~~v~  118 (119)
T 4RZC_A          107 DIWGPGTLVTVS  118 (119)
T ss_dssp             EEECCCEEEEEC
T ss_pred             EEecCCeEEEEe
Confidence            357889988773


No 267
>4RZC_H Fv M6P-1 light chain ; Antibody variable fragment, mannose-6-phosphate, Immune; HET: M6P, SO4; 2.723A {Oryctolagus cuniculus}
Probab=64.88  E-value=8.9  Score=14.74  Aligned_cols=11  Identities=45%  Similarity=0.908  Sum_probs=8.0  Template_Neff=13.400

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..||+||.++|
T Consensus       107 ~~~~~g~~~~v  117 (119)
T 4RZC_H          107 DIWGPGTLVTV  117 (119)
T ss_pred             EEecCCeEEEE
Confidence            35788888776


No 268
>7LUC_H Fusion glycoprotein F0, 01.4B Fab; RSV, viral fusogen, fusion protein; 3.21A {Respiratory syncytial virus}
Probab=64.86  E-value=8  Score=13.58  Aligned_cols=12  Identities=33%  Similarity=0.578  Sum_probs=9.7  Template_Neff=14.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||.+.|.
T Consensus       109 ~~~~~~~~l~v~  120 (121)
T 7LUC_H          109 DFWGQGTQVTVS  120 (121)
T ss_dssp             CCBCCCEEEEEC
T ss_pred             eeeecceeeEec
Confidence            678999998874


No 269
>6OC8_A VHH8c; VHH heavy chain antibody, BLV; HET: SO4; 2.109A {Lama glama}
Probab=64.83  E-value=11  Score=13.50  Aligned_cols=13  Identities=31%  Similarity=0.532  Sum_probs=9.8  Template_Neff=14.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||++.|-
T Consensus       112 ~~~~~~~~~l~v~  124 (125)
T 6OC8_A          112 GPYWGQGTQVTVS  124 (125)
T ss_dssp             CSEECCCEEEEEC
T ss_pred             CeeecCCceeEec
Confidence            3578889988874


No 270
>6OC8_B VHH8c; VHH heavy chain antibody, BLV; HET: SO4; 2.109A {Lama glama}
Probab=64.83  E-value=11  Score=13.50  Aligned_cols=13  Identities=31%  Similarity=0.532  Sum_probs=9.6  Template_Neff=14.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||++.|-
T Consensus       112 ~~~~~~~~~l~v~  124 (125)
T 6OC8_B          112 GPYWGQGTQVTVS  124 (125)
T ss_dssp             CSEECCCEEEEEE
T ss_pred             CeeecCCceeEec
Confidence            3578888888774


No 271
>6Z2M_D Spike glycoprotein, Antibody Cr3022, Antibody; Antibody, nanobody complex, rbd, VIRAL; HET: NAG; 2.71A {Severe acute respiratory syndrome coronavirus 2}
Probab=64.81  E-value=12  Score=13.54  Aligned_cols=13  Identities=31%  Similarity=0.468  Sum_probs=9.4  Template_Neff=14.600

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||++.|-
T Consensus       114 ~~~~~~~~~l~v~  126 (127)
T 6Z2M_D          114 YDYWGQGTQVTVS  126 (127)
T ss_pred             ceeeecceEEEEc
Confidence            4468888888763


No 272
>6SGE_B Rho-related GTP-binding protein RhoB, ANTIBODY; GTPase, RHO, antibody, complex, immune; HET: GTP; 1.5A {Homo sapiens}
Probab=64.70  E-value=12  Score=13.76  Aligned_cols=13  Identities=31%  Similarity=0.447  Sum_probs=9.8  Template_Neff=14.500

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|+.+.|.
T Consensus       112 ~~~~~~~~~l~v~  124 (134)
T 6SGE_B          112 WNYWGQGTQVTVS  124 (134)
T ss_dssp             TTTCCCCEEEEEC
T ss_pred             eeeecCCceeEec
Confidence            3468899988874


No 273
>2UZI_L ANTI-RAS FV HEAVY CHAIN, ANTI-RAS; SIGNAL TRANSDUCTION, IMMUNOGLOBULIN DOMAIN, MEMBRANE; HET: GTP; 2.0A {HOMO SAPIENS}
Probab=64.63  E-value=6.1  Score=14.10  Aligned_cols=10  Identities=40%  Similarity=0.923  Sum_probs=7.6  Template_Neff=14.200

Q ss_pred             CcccCCCCee
Q tr|A0A075B6V7|    7 NFVFGPGTRL   16 (20)
Q Consensus         7 nfvfgpgtrl   16 (20)
                      .+.||.||+|
T Consensus        94 ~~~~~~~~~l  103 (104)
T 2UZI_L           94 PMTFGQGTKV  103 (104)
T ss_dssp             SCCBCCCEEE
T ss_pred             cceeccCeec
Confidence            3578888876


No 274
>3GKZ_A anti-methamphetamine single chain Fv; Therapeutic antibody, Methamphetamine, amphetamine, MDMA; HET: B40; 1.9A {Mus musculus}
Probab=64.10  E-value=8.6  Score=17.07  Aligned_cols=13  Identities=46%  Similarity=0.951  Sum_probs=10.6  Template_Neff=13.300

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.|||+.|-
T Consensus       236 g~~~~~~t~~~~~  248 (257)
T 3GKZ_A          236 PFTFGSGTKLEIK  248 (257)
T ss_dssp             SCEECCCEEEEEC
T ss_pred             eEEecCCceeEEe
Confidence            3579999999874


No 275
>1KXQ_E alpha-amylase, pancreatic (E.C.3.2.1.1)/antibody VHH fragment; ALPHA 8 BETA 8, BETA; 1.6A {Sus scrofa} SCOP: b.1.1.1
Probab=64.04  E-value=9.5  Score=14.16  Aligned_cols=12  Identities=42%  Similarity=0.863  Sum_probs=9.1  Template_Neff=14.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+|+.|+++.|.
T Consensus       108 ~~~~~g~~~~v~  119 (120)
T 1KXQ_E          108 FYWGQGTQVTVS  119 (120)
T ss_dssp             EEECCCEEEEEC
T ss_pred             EEecCCceeeec
Confidence            468889988763


No 276
>1PEW_A Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN; Beta Sheet, IMMUNE SYSTEM; 1.6A {Homo sapiens} SCOP: b.1.1.1
Probab=64.03  E-value=10  Score=13.79  Aligned_cols=12  Identities=75%  Similarity=1.171  Sum_probs=9.0  Template_Neff=14.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.+++|+|.
T Consensus        97 ~~~~~~~~l~v~  108 (109)
T 1PEW_A           97 VVFGGGTRLTVL  108 (109)
T ss_dssp             EEECCCEEEEEC
T ss_pred             eEEcCCeeeEEe
Confidence            457888888874


No 277
>3IY1_A Fab B; cryoEM, neutralizing antibody, parvovirus, canine; 18.0A {Rattus norvegicus}
Probab=63.63  E-value=13  Score=13.39  Aligned_cols=12  Identities=42%  Similarity=0.681  Sum_probs=9.0  Template_Neff=14.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+|+.++.|.|.
T Consensus        94 ~~~~~~~~l~v~  105 (107)
T 3IY1_A           94 RTFGGGTKLELK  105 (107)
T ss_dssp             CEECCCEEEEEE
T ss_pred             eEEcCCeEEEEe
Confidence            467888888764


No 278
>5TBD_A Fv fragment (mAb4D1) heavy chain; Immunoglobulin fold, Immune system, C-terminal; HET: ACE; 2.2A {Mus musculus}
Probab=63.44  E-value=11  Score=13.32  Aligned_cols=12  Identities=33%  Similarity=0.653  Sum_probs=8.5  Template_Neff=14.600

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..++.|+.++|.
T Consensus       102 ~~~~~g~~l~v~  113 (114)
T 5TBD_A          102 LRWGQGTSVTVS  113 (114)
T ss_dssp             CSBCCCEEEEEC
T ss_pred             eEecCCeEEEec
Confidence            357888888763


No 279
>1U3H_E T-cell receptor alpha-chain, Mouse TCRVbeta; complex, IMMUNE SYSTEM; 2.42A {Mus musculus} SCOP: b.1.1.1
Probab=63.38  E-value=14  Score=13.38  Aligned_cols=11  Identities=64%  Similarity=1.286  Sum_probs=8.0  Template_Neff=14.100

Q ss_pred             cCCCCeeeeCC
Q tr|A0A075B6V7|   10 FGPGTRLSVLP   20 (20)
Q Consensus        10 fgpgtrlsvlp   20 (20)
                      ++.+++|.|.|
T Consensus       100 ~~~~~~l~v~~  110 (110)
T 1U3H_E          100 FGTGTKLQVVP  110 (110)
T ss_dssp             CCSCEEEEEEC
T ss_pred             ccCceEEEECC
Confidence            67778887765


No 280
>6NM6_V Envelope glycoprotein gp41, 35O22 scFv; HIV-1 Envelope Prefusion Trimer, CD4-binding; HET: BMA, NAG, MAN; 2.739A {Human immunodeficiency virus 1}
Probab=63.32  E-value=8.7  Score=16.49  Aligned_cols=11  Identities=45%  Similarity=0.921  Sum_probs=7.7  Template_Neff=11.500

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .||.||+|.|.
T Consensus        93 ~~g~gt~l~v~  103 (122)
T 6NM6_V           93 FFGRGSRLHIK  103 (122)
T ss_dssp             EECCCCEEC--
T ss_pred             EECCceEEEEE
Confidence            58999998874


No 281
>6LGW_C scFv 523-11 VH, scFv 523-11; functional class, VIRAL PROTEIN; 2.9037A {Mus musculus}
Probab=63.06  E-value=10  Score=13.07  Aligned_cols=12  Identities=33%  Similarity=0.504  Sum_probs=8.0  Template_Neff=15.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.++++.|.
T Consensus       107 ~~~~~~~~l~v~  118 (119)
T 6LGW_C          107 AYWGQGTLVTVS  118 (119)
T ss_pred             eeeccceEEEEe
Confidence            467777777653


No 282
>7LXW_L S2X333 Fab Light Chain variable; Antibody, VIRAL PROTEIN, Structural Genomics; HET: FUC, NAG; 2.8A {Homo sapiens}
Probab=62.85  E-value=5.2  Score=14.08  Aligned_cols=10  Identities=50%  Similarity=1.082  Sum_probs=7.1  Template_Neff=14.300

Q ss_pred             cccCCCCeee
Q tr|A0A075B6V7|    8 FVFGPGTRLS   17 (20)
Q Consensus         8 fvfgpgtrls   17 (20)
                      ..||.||++.
T Consensus        91 ~~~~~gt~l~  100 (100)
T 7LXW_L           91 VIFGGGTKLT  100 (100)
T ss_dssp             EEECCCEEEC
T ss_pred             EEEcCceeeC
Confidence            5678888763


No 283
>7LXY_I Spike glycoprotein, S2M11 Fab Light; Antibody, VIRAL PROTEIN, Structural Genomics; HET: BMA, FUC, NAG;{Severe acute respiratory syndrome coronavirus 2}
Probab=62.85  E-value=5.2  Score=14.08  Aligned_cols=9  Identities=56%  Similarity=1.147  Sum_probs=6.5  Template_Neff=14.300

Q ss_pred             cccCCCCee
Q tr|A0A075B6V7|    8 FVFGPGTRL   16 (20)
Q Consensus         8 fvfgpgtrl   16 (20)
                      ..||.||++
T Consensus        91 ~~~~~gt~l   99 (100)
T 7LXY_I           91 VIFGGGTKL   99 (100)
T ss_pred             EEEcCceee
Confidence            567888765


No 284
>7N0R_C SARS-CoV-2, nanobody, nucleocapsid, VIRUS, VIRAL; HET: SO4; 1.42A {Severe acute respiratory syndrome coronavirus 2}
Probab=62.84  E-value=9  Score=14.44  Aligned_cols=13  Identities=31%  Similarity=0.526  Sum_probs=10.0  Template_Neff=14.100

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||+|.|-
T Consensus       110 ~~~~~~~~~l~v~  122 (134)
T 7N0R_C          110 EDYWGQGTQVTVS  122 (134)
T ss_dssp             CGGGCSCEEEEEC
T ss_pred             ceeEecCeeeEee
Confidence            3568999998874


No 285
>5IR3_A Ig lambda chain V-VI region; BETA-SANDWICH, IMMUNOGLOBULIN, AL AMYLOIDOSIS, IMMUNE; 1.7A {Homo sapiens}
Probab=62.82  E-value=12  Score=13.38  Aligned_cols=12  Identities=58%  Similarity=1.054  Sum_probs=9.1  Template_Neff=14.400

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.++++.|+
T Consensus       100 ~~~~~~~~l~v~  111 (112)
T 5IR3_A          100 VVFGGGTKVTVL  111 (112)
T ss_dssp             EEECCCEEEEEC
T ss_pred             EEecCCeEEEec
Confidence            467888888775


No 286
>1SQ2_N Lysozyme C (E.C.3.2.1.17), novel antigen; immunoglobulin fold, protein-protein complex, HYDROLASE-IMMUNE; HET: EDO; 1.45A {Gallus gallus} SCOP: b.1.1.1
Probab=62.81  E-value=11  Score=14.58  Aligned_cols=13  Identities=31%  Similarity=0.416  Sum_probs=10.3  Template_Neff=13.100

Q ss_pred             CCcccCCCCeeee
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSV   18 (20)
Q Consensus         6 qnfvfgpgtrlsv   18 (20)
                      ....|+++|.|+|
T Consensus       100 ~~~~~~~~~~~~v  112 (113)
T 1SQ2_N          100 RYAECGDGTAVTV  112 (113)
T ss_dssp             TTCCBCCCEEEEE
T ss_pred             ceeecCCCceEEe
Confidence            3567899999987


No 287
>1T6V_O Lysozyme C (E.C.3.2.1.17), novel antigen; IMMUNOGLOBULIN FOLD, PROTEIN-PROTEIN COMPLEX, HYDROLASE-IMMUNE; 1.7A {Gallus gallus} SCOP: b.1.1.1
Probab=62.81  E-value=11  Score=14.58  Aligned_cols=13  Identities=31%  Similarity=0.416  Sum_probs=10.3  Template_Neff=13.100

Q ss_pred             CCcccCCCCeeee
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSV   18 (20)
Q Consensus         6 qnfvfgpgtrlsv   18 (20)
                      ....|+++|.|+|
T Consensus       100 ~~~~~~~~~~~~v  112 (113)
T 1T6V_O          100 RYAECGDGTAVTV  112 (113)
T ss_dssp             TTCCBCCCEEEEE
T ss_pred             ceeecCCCceEEe
Confidence            3567899999987


No 288
>2A0L_E Voltage-gated potassium channel, 33H1 Fv; voltage sensor, voltage-dependent K+ channel; 3.9A {Mus musculus} SCOP: b.1.1.1
Probab=62.79  E-value=6.7  Score=13.47  Aligned_cols=9  Identities=56%  Similarity=1.176  Sum_probs=6.5  Template_Neff=14.800

Q ss_pred             cccCCCCee
Q tr|A0A075B6V7|    8 FVFGPGTRL   16 (20)
Q Consensus         8 fvfgpgtrl   16 (20)
                      ..||.||+|
T Consensus        96 ~~~~~~~~l  104 (105)
T 2A0L_E           96 LTFGSGTKL  104 (105)
T ss_dssp             EECCCCBEE
T ss_pred             ceecCCccc
Confidence            467788776


No 289
>2UUD_H NQ10-1.12 ANTI-PHOX ANTIBODY; SCFV, ANTIBODY, IMMUNOGLOBULIN, 2-PHENYL-5-OXAZOLONE, IMMUNOGLOBULIN; HET: PHX; 2.9A {MUS MUSCULUS} SCOP: b.1.1.1
Probab=62.72  E-value=10  Score=13.13  Aligned_cols=11  Identities=36%  Similarity=0.619  Sum_probs=7.7  Template_Neff=15.100

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .+++++++.|.
T Consensus       110 ~~~~~~~l~v~  120 (121)
T 2UUD_H          110 YWGQGTLVTVS  120 (121)
T ss_dssp             EECCCEEEEEC
T ss_pred             eeecceeeEEe
Confidence            45778887764


No 290
>1KB9_J UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE; oxidoreductase, ubiquinone, stigmatellin, cardiolipin, phosphatidylinositol; HET: PCF, HEM, PIE, UQ6, UMQ, PEF, CDL, SMA; 2.3A {Saccharomyces cerevisiae} SCOP: b.1.1.1
Probab=62.60  E-value=11  Score=13.36  Aligned_cols=11  Identities=36%  Similarity=0.679  Sum_probs=8.3  Template_Neff=14.900

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .++.+++|.|.
T Consensus       111 ~~~~~~~l~v~  121 (127)
T 1KB9_J          111 YWGQGTTVTVS  121 (127)
T ss_dssp             EECCCEEEEEC
T ss_pred             EecCCcEEEec
Confidence            47888888774


No 291
>3CX5_J Cytochrome b-c1 complex subunit 1; COMPLEX III, CYTOCHROME C, ELECTRON; HET: 9PE, 6PH, HEM, M3L, GLC, FRU, UMQ, CN5, 7PH, CN3, 8PE, SMA; 1.9A {Saccharomyces cerevisiae} SCOP: b.1.1.1
Probab=62.60  E-value=11  Score=13.36  Aligned_cols=11  Identities=36%  Similarity=0.679  Sum_probs=8.3  Template_Neff=14.900

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .++.+++|.|.
T Consensus       111 ~~~~~~~l~v~  121 (127)
T 3CX5_J          111 YWGQGTTVTVS  121 (127)
T ss_dssp             EECCCEEEEEC
T ss_pred             EecCCcEEEec
Confidence            47888888774


No 292
>7A3Q_I VIRAL PROTEIN, FLAVIVIRUS, CLASS 2; HET: 3CX, NAG; 2.7A {Dengue virus 4}
Probab=62.29  E-value=11  Score=14.71  Aligned_cols=11  Identities=36%  Similarity=0.619  Sum_probs=9.3  Template_Neff=13.700

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .|+.||+|.|.
T Consensus       119 ~~~~~~~l~v~  129 (144)
T 7A3Q_I          119 YWGQGTLVTVS  129 (144)
T ss_dssp             SBCCCEEEEEC
T ss_pred             eeCCceEEEee
Confidence            78999999874


No 293
>7CTH_H Dengue virus, antibody, broadly neutralizing; HET: NAG;{Dengue virus 2}
Probab=62.29  E-value=11  Score=14.71  Aligned_cols=11  Identities=36%  Similarity=0.619  Sum_probs=8.6  Template_Neff=13.700

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .|+.||+|.|.
T Consensus       119 ~~~~~~~l~v~  129 (144)
T 7CTH_H          119 YWGQGTLVTVS  129 (144)
T ss_pred             eeCCceEEEee
Confidence            68888888764


No 294
>7SHY_C IgE, omalizumab, xolair, inhibitor, immune; HET: FUC, NAG, BMA, GOL, MAN; 3.0A {Homo sapiens}
Probab=62.26  E-value=11  Score=13.24  Aligned_cols=12  Identities=42%  Similarity=0.628  Sum_probs=8.8  Template_Neff=14.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|+++.|.
T Consensus       110 ~~~~~~~~l~v~  121 (122)
T 7SHY_C          110 AVWGQGTLVTVS  121 (122)
T ss_dssp             EEECCCEEEEEC
T ss_pred             EEEcCceEEEEc
Confidence            457888888774


No 295
>6UZ1_J MHC class I antigen, A-2; single-chain T cell receptor, peptide; HET: MES; 3.14A {Homo sapiens}
Probab=62.07  E-value=12  Score=12.96  Aligned_cols=12  Identities=67%  Similarity=1.207  Sum_probs=8.5  Template_Neff=14.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.++++.|.
T Consensus       103 ~~~~~~~~l~v~  114 (115)
T 6UZ1_J          103 LYFGPGTRLTVT  114 (115)
T ss_dssp             CEECCCEEEEC-
T ss_pred             eeccCCceeeec
Confidence            577888888763


No 296
>7T3D_N anchor, antibodies, influenza A virus; HET: NAG; 3.2A {Influenza A virus (A/California/04/2009(H1N1))}
Probab=62.04  E-value=10  Score=13.60  Aligned_cols=11  Identities=36%  Similarity=0.779  Sum_probs=6.9  Template_Neff=14.200

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.|+++++++|
T Consensus        96 ~~~~~~~~l~v  106 (107)
T 7T3D_N           96 RTFGGGTKVEI  106 (107)
T ss_pred             eEEcCcEEEEE
Confidence            35677777654


No 297
>1FVC_D FV FRAGMENT OF HUMANIZED ANTIBODY; IMMUNOGLOBULIN; 2.2A {Homo sapiens} SCOP: b.1.1.1
Probab=61.94  E-value=11  Score=13.13  Aligned_cols=13  Identities=31%  Similarity=0.353  Sum_probs=9.6  Template_Neff=15.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|++|.|.
T Consensus       107 ~~~~~~~~~l~v~  119 (120)
T 1FVC_D          107 MDYWGQGTLVTVS  119 (120)
T ss_dssp             CCCBCCCEEEEEC
T ss_pred             eEEEcCCeEEEEe
Confidence            3468889988774


No 298
>4OGA_C Insulin A Chain, Insulin B; CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN; HET: BMA, FUC, NAG, MAN; 3.5A {Homo sapiens}
Probab=61.72  E-value=11  Score=13.02  Aligned_cols=13  Identities=31%  Similarity=0.404  Sum_probs=9.7  Template_Neff=15.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|+.+.|-
T Consensus       105 ~~~~~~~~~l~v~  117 (118)
T 4OGA_C          105 MDYWGQGTSVTVS  117 (118)
T ss_dssp             CCCBCCCEEEEEC
T ss_pred             ceeeecCceEEEc
Confidence            3568888888874


No 299
>1OHQ_A IMMUNOGLOBULIN; ANTIBODY, IMMUNE SYSTEM, FV FRAGMENT; 2.0A {HOMO SAPIENS} SCOP: b.1.1.1
Probab=61.43  E-value=14  Score=12.85  Aligned_cols=12  Identities=33%  Similarity=0.457  Sum_probs=8.7  Template_Neff=15.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..++.|++|.|-
T Consensus       108 ~~~~~~~~l~v~  119 (120)
T 1OHQ_A          108 GFWGQGTLVTVS  119 (120)
T ss_dssp             CCBCCCEEEEEC
T ss_pred             ceecCCceEEEe
Confidence            347888888763


No 300
>7L6V_D neurotoxin, enzyme inhibitor, ANTITOXIN; 2.01A {Clostridium botulinum}
Probab=61.41  E-value=12  Score=13.66  Aligned_cols=12  Identities=33%  Similarity=0.545  Sum_probs=9.1  Template_Neff=14.300

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|+.|+|.
T Consensus       110 ~~~~~~~~l~v~  121 (122)
T 7L6V_D          110 DYWGQGTQVTVS  121 (122)
T ss_dssp             EEECCCEEEEEC
T ss_pred             eeeccceEEEee
Confidence            467888888874


No 301
>3WUZ_A Paired immunoglobulin-like type 2 receptor; Immunoglobulin-like, Immunological receptor, Membrane, MEMBRANE; HET: CIT; 1.3A {Homo sapiens}
Probab=61.33  E-value=15  Score=13.10  Aligned_cols=11  Identities=36%  Similarity=0.468  Sum_probs=7.2  Template_Neff=14.600

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.++.|+.|.|
T Consensus       109 ~~~~~~~~l~v  119 (120)
T 3WUZ_A          109 WQSIEGTKLSI  119 (120)
T ss_dssp             EECSSCEEEEE
T ss_pred             eEecCCeeeEe
Confidence            34477887776


No 302
>3DUR_D antibody Fv fragment SAG173-04, Ig-like; antibody, KDO, twinning, pseudo-symmetry, IMMUNE; HET: PG4, KDO; 1.86A {Mus musculus}
Probab=61.27  E-value=13  Score=12.94  Aligned_cols=13  Identities=31%  Similarity=0.404  Sum_probs=9.5  Template_Neff=15.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|+++.|.
T Consensus       108 ~~~~~~~~~l~v~  120 (121)
T 3DUR_D          108 MDYWGQGTSVTVS  120 (121)
T ss_dssp             CCEECCCEEEEEC
T ss_pred             eeeeecCeEEEec
Confidence            4467888888774


No 303
>5L6Q_B H5AL antibody; Antibody, light chain, systemic AL; HET: PGE, CO3; 1.4A {Homo sapiens}
Probab=61.04  E-value=14  Score=13.13  Aligned_cols=13  Identities=62%  Similarity=0.991  Sum_probs=8.9  Template_Neff=14.500

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...++.+++|.|.
T Consensus        95 ~~~~~~~~~l~v~  107 (115)
T 5L6Q_B           95 HQVFGGGTKLTVL  107 (115)
T ss_dssp             EEEECCCEEEEEE
T ss_pred             eEEEccceEEEEc
Confidence            3566888888763


No 304
>5HM1_C lama antibodyVHH 2E7, gp41; HIV, gp41, gp120, antibodies, Immune; 2.962A {Lama glama}
Probab=60.99  E-value=14  Score=13.61  Aligned_cols=10  Identities=40%  Similarity=0.873  Sum_probs=7.4  Template_Neff=14.100

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      +||.|+.++|
T Consensus       109 ~~~~g~~~~v  118 (119)
T 5HM1_C          109 YWGQGTQVTV  118 (119)
T ss_dssp             EECCCEEEEE
T ss_pred             cccCCceeEE
Confidence            5778887776


No 305
>1KJ2_A Allogeneic H-2Kb MHC Class I; T CELL RECEPTOR, CLASS I; HET: NAG, SIA, MAN, GAL; 2.71A {Mus musculus} SCOP: b.1.1.1
Probab=60.88  E-value=15  Score=13.10  Aligned_cols=13  Identities=54%  Similarity=1.040  Sum_probs=8.2  Template_Neff=14.300

Q ss_pred             cccCCCCeeeeCC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVLP   20 (20)
Q Consensus         8 fvfgpgtrlsvlp   20 (20)
                      ..++.++.|.|-|
T Consensus        99 ~~~~~~~~l~v~~  111 (111)
T 1KJ2_A           99 LIFGTGTTVSVSP  111 (111)
T ss_pred             EEecCCeEEEEcC
Confidence            4566677776654


No 306
>6CUE_q PGT122 Heavy chain, PGT122 Light; HIV-1 Env, BG505 SOSIP, fusion; HET: BMA, NAG, MAN; 4.0A {Human immunodeficiency virus 1}
Probab=60.67  E-value=12  Score=15.28  Aligned_cols=11  Identities=27%  Similarity=0.275  Sum_probs=8.3  Template_Neff=12.600

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..||.||.++|
T Consensus       118 ~~~~~gt~l~v  128 (129)
T 6CUE_q          118 QYWCQGTVVVV  128 (129)
T ss_pred             hhccCCeEEEe
Confidence            36788888876


No 307
>6N1V_Q 17D4 Heavy chain, 17D4 Light; HIV-1 Env complex, neutralizing antibody; HET: BMA, NAG, MAN; 4.0A {Macaca mulatta}
Probab=60.67  E-value=12  Score=15.28  Aligned_cols=11  Identities=27%  Similarity=0.275  Sum_probs=8.3  Template_Neff=12.600

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..||.||.++|
T Consensus       118 ~~~~~gt~l~v  128 (129)
T 6N1V_Q          118 QYWCQGTVVVV  128 (129)
T ss_pred             hhccCCeEEEe
Confidence            36788888876


No 308
>1BFV_H FV4155, ESTRIOL 3-(B-D-GLUCURONIDE); IMMUNOGLOBULIN, FV FRAGMENT, STEROID HORMONE; HET: STG; 2.1A {Mus musculus} SCOP: b.1.1.1
Probab=60.61  E-value=11  Score=12.95  Aligned_cols=12  Identities=33%  Similarity=0.498  Sum_probs=8.4  Template_Neff=15.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|++|.|.
T Consensus       107 ~~~~~~~~l~v~  118 (119)
T 1BFV_H          107 DYWGQGTTVTVS  118 (119)
T ss_dssp             EEECCCEEEEEE
T ss_pred             eeeecCeEEEEe
Confidence            457888888763


No 309
>1CFV_H MONOCLONAL ANTIBODY FV4155, ESTRONE BETA-D-GLUCURONIDE; FV FRAGMENT, STEROID HORMONE, FINE; HET: E3G; 2.1A {Mus musculus} SCOP: b.1.1.1
Probab=60.61  E-value=11  Score=12.95  Aligned_cols=12  Identities=33%  Similarity=0.498  Sum_probs=8.5  Template_Neff=15.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|++|.|.
T Consensus       107 ~~~~~~~~l~v~  118 (119)
T 1CFV_H          107 DYWGQGTTVTVS  118 (119)
T ss_dssp             EEECCCEEEEEE
T ss_pred             eeeecCeEEEEe
Confidence            457888888763


No 310
>5A2J_H SCFV-SM3, THE NAKED PEPTIDE APDTRP; PEPTIDE BINDING PROTEIN, GLYCOPEPTIDES, ANTIBODIES; HET: EDO; 1.65A {MUS MUSCULUS}
Probab=60.56  E-value=13  Score=16.15  Aligned_cols=14  Identities=57%  Similarity=1.084  Sum_probs=11.0  Template_Neff=13.600

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ....|+.|++|.|.
T Consensus       230 ~~~~~~~~~~l~v~  243 (244)
T 5A2J_H          230 NHWVFGGGTKLTVL  243 (244)
T ss_dssp             SCEEECCCEEEEEC
T ss_pred             CceEecCceEEEEc
Confidence            34678999999885


No 311
>7SPO_C IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM; HET: FUC, NAG, EDO; 1.92A {Severe acute respiratory syndrome coronavirus 2}
Probab=60.31  E-value=11  Score=16.91  Aligned_cols=12  Identities=50%  Similarity=0.520  Sum_probs=9.7  Template_Neff=11.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||++.|.
T Consensus       105 ~~~g~gt~l~v~  116 (141)
T 7SPO_C          105 HVDGAGTVLTVN  116 (141)
T ss_dssp             EEECCCEEEEEE
T ss_pred             eeecCCeEEEEe
Confidence            578999998774


No 312
>7MEP_M Immune complex, monoclonal antibodies, HIV-1; HET: BMA, NAG, MAN; 3.5A {Macaca mulatta}
Probab=60.20  E-value=13  Score=12.95  Aligned_cols=12  Identities=50%  Similarity=0.905  Sum_probs=8.4  Template_Neff=15.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|++|.|.
T Consensus       109 ~~~~~~~~l~v~  120 (121)
T 7MEP_M          109 DVWGPGVRVTVS  120 (121)
T ss_pred             EEecCceEEEEe
Confidence            467788887763


No 313
>5EB9_A CD8 alpha chain; CD8, Co-receptor, Immunology, IMMUNE SYSTEM; 2.006A {Gallus gallus}
Probab=60.06  E-value=6.8  Score=13.78  Aligned_cols=10  Identities=20%  Similarity=0.348  Sum_probs=6.5  Template_Neff=14.800

Q ss_pred             cccCCCCeee
Q tr|A0A075B6V7|    8 FVFGPGTRLS   17 (20)
Q Consensus         8 fvfgpgtrls   17 (20)
                      ..|+.||++.
T Consensus       108 ~~~~~~~~~~  117 (118)
T 5EB9_A          108 LYFSSGQPAF  117 (118)
T ss_dssp             EEECBCEEEC
T ss_pred             EEEcCCeecc
Confidence            4567777664


No 314
>6U14_B VHH R303 C33A/C102A mutant; Nanobody, VHH, Internalin, Listeria, Disulfide; HET: SO4; 1.3A {Camelus dromedarius}
Probab=60.04  E-value=8.3  Score=15.06  Aligned_cols=13  Identities=38%  Similarity=0.578  Sum_probs=10.3  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|++|+++.|.
T Consensus       110 ~~~~~~~~~l~v~  122 (142)
T 6U14_B          110 LNVWGQGTQVTVS  122 (142)
T ss_dssp             TSEECCCEEEEEC
T ss_pred             EEEEcCCeEEEEe
Confidence            3678999998874


No 315
>5LBS_I Polyprotein, BROADLY NEUTRALIZING HUMAN ANTIBODY; IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, ZIKA; HET: SO4, EDO; 2.41A {Zika virus}
Probab=60.00  E-value=15  Score=13.62  Aligned_cols=12  Identities=42%  Similarity=0.623  Sum_probs=8.8  Template_Neff=14.500

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.+++|.|.
T Consensus       110 ~~~~~~~~l~v~  121 (141)
T 5LBS_I          110 DVWGQGTTVTVS  121 (141)
T ss_dssp             CEECCCEEEEEC
T ss_pred             eeeCCCcEEEEe
Confidence            356888888774


No 316
>7MDW_A SARS-CoV-2 Receptor binding domain nanobody; HET: NAG;{Lama glama}
Probab=59.78  E-value=13  Score=12.76  Aligned_cols=11  Identities=36%  Similarity=0.727  Sum_probs=7.3  Template_Neff=15.100

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.+++|.|
T Consensus       105 ~~~~~~~~l~v  115 (117)
T 7MDW_A          105 TYWGQGTQVTV  115 (117)
T ss_dssp             CCCCCCEECCC
T ss_pred             EEecCCceeEe
Confidence            35677777765


No 317
>6Z1O_F lambda 3 immunoglobulin light chain; amyloid, antibody, systemic amyloidosis, light; 3.2A {Homo sapiens}
Probab=59.50  E-value=7.6  Score=12.95  Aligned_cols=11  Identities=64%  Similarity=1.014  Sum_probs=7.2  Template_Neff=14.700

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.++.++|
T Consensus        79 ~~~~~~~~~~v   89 (89)
T 6Z1O_F           79 QVFGGGTKLTV   89 (89)
T ss_dssp             ESSCSCEEECC
T ss_pred             EEecCceeccC
Confidence            45677777654


No 318
>1BVK_A HULYS11, LYSOZYME; HUMANIZED ANTIBODY, ANTIBODY COMPLEX, FV; 2.7A {Homo sapiens} SCOP: b.1.1.1
Probab=59.17  E-value=15  Score=13.20  Aligned_cols=12  Identities=33%  Similarity=0.695  Sum_probs=9.3  Template_Neff=14.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.++.|+|.
T Consensus        96 ~~~~~~~~l~v~  107 (108)
T 1BVK_A           96 RTFGQGTKVEIK  107 (108)
T ss_dssp             CCBCCCEEEEEC
T ss_pred             cEeCCCeeEEEe
Confidence            467888888874


No 319
>4YQX_N JES6-1 VH domain, JES6-1 VL; chemokine, antibody, complex, CYTOKINE-IMMUNE SYSTEM; HET: FUC, NAG; 2.826A {Rattus norvegicus}
Probab=59.14  E-value=12  Score=13.24  Aligned_cols=13  Identities=31%  Similarity=0.386  Sum_probs=9.5  Template_Neff=14.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|+.|.|-
T Consensus       110 ~~~~~~~~~l~v~  122 (123)
T 4YQX_N          110 FAYWGQGTLVTVS  122 (123)
T ss_dssp             EESCCCCEEEEEC
T ss_pred             hheeccceeeEec
Confidence            3568888888774


No 320
>4WEM_B Donor strand complemented FaeG variant; Complex, llama single domain antibody; HET: PO4; 1.55A {Escherichia coli}
Probab=59.07  E-value=8.5  Score=14.63  Aligned_cols=14  Identities=29%  Similarity=0.394  Sum_probs=10.4  Template_Neff=13.800

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      ..+||+|+.+.+.|
T Consensus       108 ~~~~~~g~~~~~~~  121 (127)
T 4WEM_B          108 IEHWGKGTQVTVSS  121 (127)
T ss_dssp             CSEECCCEEEEEEC
T ss_pred             EEEEceeeeeeeec
Confidence            45789998887753


No 321
>6TYS_F Fusion glycoprotein F0, 5B3 antibody; Henipavirus, Nipah virus, Hendra virus; HET: BMA, NAG, MAN; 3.5A {Nipah virus}
Probab=59.05  E-value=14  Score=12.70  Aligned_cols=12  Identities=33%  Similarity=0.504  Sum_probs=7.4  Template_Neff=15.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.+++|.|.
T Consensus       106 ~~~~~~~~l~v~  117 (120)
T 6TYS_F          106 AYWGQGTLVTVS  117 (120)
T ss_pred             EEecCCceeEEe
Confidence            346667777654


No 322
>6NNJ_U Envelope glycoprotein gp41, 35O22 scFv; HIV-1 Envelope Prefusion Trimer, CD4-binding; HET: BMA, NAG, MAN; 2.6A {Human immunodeficiency virus 1}
Probab=58.91  E-value=12  Score=14.48  Aligned_cols=13  Identities=31%  Similarity=0.376  Sum_probs=10.4  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      .+.|+.||.|+|.
T Consensus       118 ~~~~~~~~~l~v~  130 (137)
T 6NNJ_U          118 YAHWGQGTPVVVS  130 (137)
T ss_dssp             CCEEBCCEEEEEC
T ss_pred             eeEecCCccEEEe
Confidence            4678999999875


No 323
>7DV4_H anti-tumor, VH domain, complex, IMMUNE; 2.38A {Homo sapiens}
Probab=58.78  E-value=13  Score=12.90  Aligned_cols=13  Identities=31%  Similarity=0.450  Sum_probs=9.5  Template_Neff=15.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|+.|.|.
T Consensus       107 ~~~~~~~~~l~v~  119 (120)
T 7DV4_H          107 FDIWGQGTMVTVS  119 (120)
T ss_dssp             TCEECCCEEEEEC
T ss_pred             eeeeeeceeeEEc
Confidence            3467888888774


No 324
>5L21_B Botulinum neurotoxin type A (E.C.3.4.24.69); Neutralizing antibody  VHH ; 1.68A {Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A)}
Probab=58.76  E-value=14  Score=12.89  Aligned_cols=10  Identities=30%  Similarity=0.830  Sum_probs=6.5  Template_Neff=14.900

Q ss_pred             cCCCCeeeeC
Q tr|A0A075B6V7|   10 FGPGTRLSVL   19 (20)
Q Consensus        10 fgpgtrlsvl   19 (20)
                      ++.||++.|.
T Consensus       108 ~~~~~~l~v~  117 (119)
T 5L21_B          108 WGQGTQVTIS  117 (119)
T ss_dssp             EBCCEEEEEC
T ss_pred             eccceEEEEe
Confidence            5677777653


No 325
>6GJS_B Cystic fibrosis transmembrane conductance regulator; Cystic Fibrosis, CFTR, nanobodies, thermal; HET: ATP; 1.95A {Homo sapiens}
Probab=58.70  E-value=18  Score=15.00  Aligned_cols=12  Identities=33%  Similarity=0.545  Sum_probs=9.4  Template_Neff=12.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||++.|-
T Consensus       111 ~~~~~gt~~~v~  122 (149)
T 6GJS_B          111 DYWGQGTQVTVS  122 (149)
T ss_dssp             EEECCCEEEEEC
T ss_pred             ccccCCeEEEEc
Confidence            468999988774


No 326
>6GKD_B Cystic fibrosis transmembrane conductance regulator; Cystic Fibrosis, CFTR, nanobodies, thermal; HET: MG, GLC, Z9N, GOL, ATP; 2.99A {Homo sapiens}
Probab=58.70  E-value=18  Score=15.00  Aligned_cols=12  Identities=33%  Similarity=0.545  Sum_probs=9.5  Template_Neff=12.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||++.|-
T Consensus       111 ~~~~~gt~~~v~  122 (149)
T 6GKD_B          111 DYWGQGTQVTVS  122 (149)
T ss_dssp             EEECCCEEEEES
T ss_pred             ccccCCeEEEEc
Confidence            468999988874


No 327
>1NMC_C NEURAMINIDASE, SINGLE CHAIN ANTIBODY; COMPLEX (SINGLE-CHAIN ANTIBODY-ANTIGEN), HYDROLASE, COMPLEX; HET: BMA, NAG, MAN; 2.5A {Influenza A virus} SCOP: b.1.1.1
Probab=58.65  E-value=15  Score=13.84  Aligned_cols=13  Identities=46%  Similarity=0.897  Sum_probs=9.9  Template_Neff=13.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      .+.|+.|++|.|.
T Consensus        95 ~~~~~~~~~l~v~  107 (109)
T 1NMC_C           95 PFTFGGGTKLEIR  107 (109)
T ss_dssp             SCEECCCEEEEEC
T ss_pred             ceEECCCcEEEEe
Confidence            3578889988874


No 328
>7MJH_D Spike glycoprotein, VH ab8; SARS-CoV-2, glycoprotein, fusion protein, viral; HET: NAG;{Severe acute respiratory syndrome coronavirus 2}
Probab=58.64  E-value=12  Score=15.13  Aligned_cols=12  Identities=42%  Similarity=0.623  Sum_probs=9.4  Template_Neff=13.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+||.||.+.|.
T Consensus       112 ~~~~~gt~l~v~  123 (145)
T 7MJH_D          112 DVWGQGTTVTVS  123 (145)
T ss_dssp             EECBCCEEEEES
T ss_pred             EEEcCCeEEEEc
Confidence            368999998874


No 329
>3IY1_B Fab B; cryoEM, neutralizing antibody, parvovirus, canine; 18.0A {Rattus norvegicus}
Probab=58.62  E-value=14  Score=12.99  Aligned_cols=10  Identities=50%  Similarity=1.066  Sum_probs=7.5  Template_Neff=14.500

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .+++|+.+.|
T Consensus        99 ~~~~~~~~~v  108 (109)
T 3IY1_B           99 FWGPGTMVTV  108 (109)
T ss_dssp             EECCCCEEEE
T ss_pred             eecCCeeeee
Confidence            5778888776


No 330
>43CA_C 43C9 ANTIBODY (FV FRAGMENT) +; IMMUNOGLOBULIN, CATALYTIC ANTIBODY; HET: NPO; 2.3A {Mus musculus} SCOP: b.1.1.1
Probab=58.39  E-value=16  Score=12.96  Aligned_cols=11  Identities=45%  Similarity=0.845  Sum_probs=8.3  Template_Neff=14.500

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.++++.|
T Consensus       102 ~~~~~~~~l~v  112 (113)
T 43CA_C          102 RTFGGGTKLEI  112 (113)
T ss_dssp             CCBCCCEEEEE
T ss_pred             ceecCceeeEE
Confidence            46788888876


No 331
>6IEC_D NSmGnGc, R17 H chain, R17; RVFV, antibody, STRUCTURAL PROTEIN, STRUCTURAL; 3.2A {Rift valley fever virus}
Probab=57.93  E-value=14  Score=12.77  Aligned_cols=12  Identities=58%  Similarity=1.240  Sum_probs=7.7  Template_Neff=14.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.++++.|.
T Consensus        98 ~~~~~~~~l~v~  109 (111)
T 6IEC_D           98 YVFGTGTKVTVL  109 (111)
T ss_pred             EEeccceeEEEc
Confidence            456777777653


No 332
>2ATP_B T-cell surface glycoprotein CD8 alpha; CD8ab, CD8aa, MHC, IMMUNE SYSTEM; HET: NAG; 2.4A {Mus musculus} SCOP: b.1.1.1
Probab=57.91  E-value=16  Score=14.61  Aligned_cols=13  Identities=54%  Similarity=1.076  Sum_probs=9.5  Template_Neff=12.600

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+|++++.|.|.
T Consensus       103 ~~~~~~~~~l~v~  115 (115)
T 2ATP_B          103 KMVFGTGTKLTVV  115 (115)
T ss_dssp             CEEECCCEEEEEC
T ss_pred             eEEECCceEEEeC
Confidence            3478888888764


No 333
>2ATP_D T-cell surface glycoprotein CD8 alpha; CD8ab, CD8aa, MHC, IMMUNE SYSTEM; HET: NAG; 2.4A {Mus musculus} SCOP: b.1.1.1
Probab=57.91  E-value=16  Score=14.61  Aligned_cols=11  Identities=64%  Similarity=1.192  Sum_probs=8.2  Template_Neff=12.600

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      .+|++++.|.|
T Consensus       104 ~~~~~~~~l~v  114 (115)
T 2ATP_D          104 MVFGTGTKLTV  114 (115)
T ss_pred             EEECCceEEEe
Confidence            47888888766


No 334
>5JDS_B Nanobody, Programmed cell death 1; Nanobody, IMMUNE SYSTEM; 1.7A {Camelidae}
Probab=57.64  E-value=12  Score=14.97  Aligned_cols=13  Identities=31%  Similarity=0.473  Sum_probs=9.6  Template_Neff=13.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.|+.+.|.
T Consensus       117 ~~~~~~~~~l~v~  129 (146)
T 5JDS_B          117 FQYWGQGTQVTVS  129 (146)
T ss_pred             eEEeccCeEEEEE
Confidence            4578888888764


No 335
>6BA5_F Variable domain of Light Chain; Single chain Fv, ScFv, Antibody; 1.62A {Homo sapiens}
Probab=57.63  E-value=16  Score=12.62  Aligned_cols=13  Identities=31%  Similarity=0.664  Sum_probs=9.6  Template_Neff=15.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...++.+|.|.|-
T Consensus       104 ~~~~~~~~~l~v~  116 (117)
T 6BA5_F          104 FNIWGPGTLVTIS  116 (117)
T ss_dssp             SCSBCCCEEEEEC
T ss_pred             eeeecCCeEEEEe
Confidence            4578888888763


No 336
>6BAN_F Variable domain of Light Chain; Single chain Fv, ScFv, Antibody; 1.95A {Homo sapiens}
Probab=57.63  E-value=16  Score=12.62  Aligned_cols=13  Identities=31%  Similarity=0.664  Sum_probs=9.6  Template_Neff=15.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...++.+|.|.|-
T Consensus       104 ~~~~~~~~~l~v~  116 (117)
T 6BAN_F          104 FNIWGPGTLVTIS  116 (117)
T ss_dssp             SCSBCCCEEEEEC
T ss_pred             eeeecCCeEEEEe
Confidence            4578888888763


No 337
>6X05_K Nucleoporin NUP133, VHH-SAN4; STRUCTURAL PROTEIN, Nucleoporin, Nanobody; 2.1A {Saccharomyces cerevisiae (strain ATCC 204508 / S288c)}
Probab=57.62  E-value=8.8  Score=14.29  Aligned_cols=11  Identities=36%  Similarity=0.658  Sum_probs=8.5  Template_Neff=14.000

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..||.|+.+.|
T Consensus       110 ~~~~~~~~l~v  120 (122)
T 6X05_K          110 DYWGQGTQVTV  120 (122)
T ss_dssp             CEECCCEEEEE
T ss_pred             EEeeeeeEEEe
Confidence            46788888876


No 338
>1I8K_B antibody-peptide complex, immunoglobulin fold, peptide; 1.8A {Mus musculus} SCOP: b.1.1.1
Probab=57.49  E-value=16  Score=12.90  Aligned_cols=12  Identities=33%  Similarity=0.498  Sum_probs=8.6  Template_Neff=14.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.++.|.|.
T Consensus       108 ~~~~~~~~l~v~  119 (124)
T 1I8K_B          108 DYWGQGTTVTVS  119 (124)
T ss_dssp             EEECCCEEEEEC
T ss_pred             eeecCCcEEEEe
Confidence            467788888764


No 339
>1VES_A New Antigen Receptor variable domain; IG VNAR, 12Y-2, IMMUNE SYSTEM; 2.18A {Orectolobus maculatus} SCOP: b.1.1.1
Probab=57.42  E-value=12  Score=14.10  Aligned_cols=10  Identities=50%  Similarity=0.637  Sum_probs=8.5  Template_Neff=13.500

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .|+.|+.|+|
T Consensus       103 ~~~~~~~l~v  112 (113)
T 1VES_A          103 EKGAGTALTV  112 (113)
T ss_dssp             EECCCEEEEE
T ss_pred             cCccceeeEe
Confidence            7899999887


No 340
>4NKD_E Engineered scFv heavy chain, Engineered; Antibody fragment, EYMPME binding, IMMUNE; 3.303A {Mus musculus}
Probab=57.32  E-value=12  Score=13.96  Aligned_cols=12  Identities=33%  Similarity=0.498  Sum_probs=9.1  Template_Neff=14.200

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|+++.|.
T Consensus       110 ~~~~~~~~l~v~  121 (133)
T 4NKD_E          110 DYWGQGTTVTVS  121 (133)
T ss_dssp             EEECCCEEEEEC
T ss_pred             EEEecceEEEEe
Confidence            467889988774


No 341
>5FCS_L Diabody; antibody, diabody, Pcad, CD3, IMMUNE; HET: SO4; 2.01A {Homo sapiens}
Probab=57.09  E-value=17  Score=16.37  Aligned_cols=11  Identities=36%  Similarity=0.619  Sum_probs=9.2  Template_Neff=13.000

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .|+.||+|.|.
T Consensus       232 ~~~~~~~l~V~  242 (256)
T 5FCS_L          232 YWGQGTLVTVS  242 (256)
T ss_dssp             EECCCEEEEEC
T ss_pred             EeecceEEEEe
Confidence            48999999885


No 342
>6Z1I_B lambda 3 light chain fragment; amyloid fibril, antibody, beta sheet; 3.4A {Homo sapiens}
Probab=56.48  E-value=14  Score=11.29  Aligned_cols=10  Identities=60%  Similarity=1.002  Sum_probs=5.9  Template_Neff=15.500

Q ss_pred             cccCCCCeee
Q tr|A0A075B6V7|    8 FVFGPGTRLS   17 (20)
Q Consensus         8 fvfgpgtrls   17 (20)
                      ..|+.++++.
T Consensus        71 ~~~~~~~~~~   80 (81)
T 6Z1I_B           71 QVFGGGTKLT   80 (81)
T ss_dssp             CSSCSCEEEC
T ss_pred             EEeCCCeEEe
Confidence            4566666654


No 343
>4FFY_H DENV1-E111 single chain variable fragment; Viral envelope proteins, structural genomics; 2.5A {Mus musculus}
Probab=56.42  E-value=12  Score=13.79  Aligned_cols=13  Identities=38%  Similarity=0.503  Sum_probs=9.4  Template_Neff=14.300

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|+.++|.
T Consensus       105 ~~~~~~~~~l~v~  117 (130)
T 4FFY_H          105 FDVWGTGTTVTVS  117 (130)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             eeeeecceEEEEe
Confidence            3467888888774


No 344
>7JOZ_N Dopamine receptor, D1, non-catechol agonist; HET: VFP, 1PE; 3.8A {Homo sapiens}
Probab=56.21  E-value=14  Score=15.71  Aligned_cols=13  Identities=31%  Similarity=0.404  Sum_probs=10.1  Template_Neff=12.600

Q ss_pred             CCcccCCCCeeee
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSV   18 (20)
Q Consensus         6 qnfvfgpgtrlsv   18 (20)
                      ...+||+|+++-|
T Consensus       136 ~~~~~g~g~~~~~  148 (160)
T 7JOZ_N          136 TYAYRGQGTQVTV  148 (160)
T ss_dssp             CCSSBCCCEEEEE
T ss_pred             eEEEecccceEEe
Confidence            3568999998865


No 345
>1XFP_A heavy chain antibody, Lysozyme C; beta sandwich, immunoglobulin fold, protein-protein; HET: FMT; 1.5A {Gallus gallus} SCOP: b.1.1.1
Probab=56.11  E-value=14  Score=14.64  Aligned_cols=13  Identities=31%  Similarity=0.470  Sum_probs=9.0  Template_Neff=13.400

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||+||.+.|.
T Consensus       120 ~~~~~~~~~~~~~  132 (142)
T 1XFP_A          120 YDSWGQGTQVTVS  132 (142)
T ss_dssp             CCEECCCEEEEEC
T ss_pred             eeEeeeccEEEec
Confidence            4567888877663


No 346
>7D3L_H O/TIBET/99 VP1, O/TIBET/99 VP2, O/TIBET/99; FOOT AND MOUTH DISEASE VIRUS; 3.68A {Foot-and-mouth disease virus}
Probab=55.75  E-value=17  Score=15.37  Aligned_cols=10  Identities=30%  Similarity=0.664  Sum_probs=1.6  Template_Neff=12.600

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .||+||.+.|
T Consensus       145 ~~~~~~~~~~  154 (156)
T 7D3L_H          145 AWGQGLLVTV  154 (156)
T ss_dssp             -------CEE
T ss_pred             hhcccceeEe
Confidence            4566666555


No 347
>3CX5_K Cytochrome b-c1 complex subunit 1; COMPLEX III, CYTOCHROME C, ELECTRON; HET: 9PE, 6PH, HEM, M3L, GLC, FRU, UMQ, CN5, 7PH, CN3, 8PE, SMA; 1.9A {Saccharomyces cerevisiae} SCOP: b.1.1.1
Probab=55.66  E-value=17  Score=13.41  Aligned_cols=11  Identities=45%  Similarity=1.108  Sum_probs=7.3  Template_Neff=13.700

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.|+.++++.|
T Consensus        96 ~~~~~~~~l~v  106 (107)
T 3CX5_K           96 WTFGAGTKLEI  106 (107)
T ss_dssp             CEECCCCBCCB
T ss_pred             EEeCCCeEEEE
Confidence            45677777754


No 348
>3J7E_C H16.V5 Fab light chain, H16.V5; HPV16.V5 Fab variable domain, HI; 13.6A {Mus musculus}
Probab=55.60  E-value=20  Score=12.86  Aligned_cols=13  Identities=38%  Similarity=0.787  Sum_probs=9.4  Template_Neff=14.300

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||+|.|-
T Consensus       101 ~~~~~~~t~l~v~  113 (115)
T 3J7E_C          101 PLTFGAGTKLELK  113 (115)
T ss_dssp             SCEECCCEEEEEE
T ss_pred             CcEeCCceEEEEe
Confidence            3568888888763


No 349
>6KZ0_K Genome polyprotein (E.C.3.4.22.29,3.6.1.15,3.4.22.28,2.7.7.48), GGVV H; protease, inhibitor, complex structure, VIRAL; 2.4A {Human rhinovirus 14}
Probab=55.33  E-value=17  Score=13.88  Aligned_cols=13  Identities=31%  Similarity=0.332  Sum_probs=9.9  Template_Neff=14.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||.|.|.
T Consensus       114 ~~~~~~~~~l~v~  126 (142)
T 6KZ0_K          114 LDYWGQGTLVTVS  126 (142)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             eeeecCCeEEEEE
Confidence            4578889988774


No 350
>6NM6_U Envelope glycoprotein gp41, 35O22 scFv; HIV-1 Envelope Prefusion Trimer, CD4-binding; HET: BMA, NAG, MAN; 2.739A {Human immunodeficiency virus 1}
Probab=55.27  E-value=17  Score=14.99  Aligned_cols=13  Identities=31%  Similarity=0.350  Sum_probs=10.4  Template_Neff=12.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||+|.|.
T Consensus       116 ~~~~~~gt~l~v~  128 (145)
T 6NM6_U          116 LDAWGQGTTVVVS  128 (145)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             eEEeCCCeEEEEe
Confidence            4678999999875


No 351
>6MTJ_D Envelope glycoprotein gp160, 35O22 scFv; HIV-1 Envelope Prefusion Trimer, Entry; HET: BMA, NAG, MAN, 83G; 2.336A {Human immunodeficiency virus 1}
Probab=55.24  E-value=16  Score=14.08  Aligned_cols=13  Identities=38%  Similarity=0.761  Sum_probs=9.2  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||.+.|.
T Consensus       118 ~~~~~~~~~l~v~  130 (134)
T 6MTJ_D          118 PYLWGQGTLLTVS  130 (134)
T ss_pred             eeeecCceEEEEe
Confidence            3567888888763


No 352
>6MU7_D Envelope glycoprotein gp160, 35O22 scFv; HIV-1 Envelope Prefusion Trimer, Entry; HET: BMA, JYY, NAG, MAN; 2.501A {Human immunodeficiency virus 1}
Probab=55.24  E-value=16  Score=14.08  Aligned_cols=13  Identities=38%  Similarity=0.761  Sum_probs=9.2  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||.+.|.
T Consensus       118 ~~~~~~~~~l~v~  130 (134)
T 6MU7_D          118 PYLWGQGTLLTVS  130 (134)
T ss_pred             eeeecCceEEEEe
Confidence            3567888888763


No 353
>6MU8_D Envelope glycoprotein gp160, 35O22 scFv; HIV-1 Envelope Prefusion Trimer, Entry; HET: JYS, BMA, NAG, MAN; 2.993A {Human immunodeficiency virus 1}
Probab=55.24  E-value=16  Score=14.08  Aligned_cols=13  Identities=38%  Similarity=0.761  Sum_probs=9.2  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||.+.|.
T Consensus       118 ~~~~~~~~~l~v~  130 (134)
T 6MU8_D          118 PYLWGQGTLLTVS  130 (134)
T ss_pred             eeeecCceEEEEe
Confidence            3567888888763


No 354
>7VNB_A SARS-CoV-2, nanobody, VIRAL PROTEIN; HET: NAG; 2.27A {Homo sapiens}
Probab=55.21  E-value=15  Score=12.74  Aligned_cols=13  Identities=31%  Similarity=0.419  Sum_probs=9.3  Template_Neff=15.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|+.+.|.
T Consensus       105 ~~~~~~~~~l~v~  117 (118)
T 7VNB_A          105 GDYWGQGTLVTVS  117 (118)
T ss_dssp             SCEECCCEEEEEC
T ss_pred             cceeeeceEEEEc
Confidence            3467888888774


No 355
>2Q20_B Vk1 O18/O8 germline light chain; Vk1, germline, AL, light chain; 1.3A {Homo sapiens}
Probab=55.04  E-value=17  Score=13.05  Aligned_cols=11  Identities=45%  Similarity=1.138  Sum_probs=7.8  Template_Neff=14.200

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.|++++++.|
T Consensus        98 ~~~~~~~~l~v  108 (109)
T 2Q20_B           98 YTFGQGTKLEI  108 (109)
T ss_dssp             CEECCCEEEEE
T ss_pred             EEeCCCeEeEe
Confidence            46788887765


No 356
>2APX_A T cell receptor beta chain; the murine T cell receptor; HET: MLA; 1.8A {Rattus norvegicus}
Probab=54.57  E-value=18  Score=12.32  Aligned_cols=12  Identities=75%  Similarity=1.171  Sum_probs=7.5  Template_Neff=15.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.+++++|+
T Consensus       101 ~~~~~~~~l~v~  112 (112)
T 2APX_A          101 LYFGAGTRLSVL  112 (112)
T ss_dssp             CEECCCEEEEEC
T ss_pred             EEecCCeeEecC
Confidence            356677777653


No 357
>7D6Y_B VH domain, Cap-Dependent Translation, RNA; HET: MES, MGO; 1.668A {Homo sapiens}
Probab=54.54  E-value=19  Score=15.78  Aligned_cols=12  Identities=33%  Similarity=0.254  Sum_probs=9.4  Template_Neff=12.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||.+.|.
T Consensus       123 ~~~~~gt~l~v~  134 (161)
T 7D6Y_B          123 DYRGQGTLVTVS  134 (161)
T ss_dssp             EEECCCEEEEEC
T ss_pred             eecCCceEEEEe
Confidence            357899998875


No 358
>6XXO_A NB_8; Nanobody, prostate-specific membrane antigen, antibody; 1.5A {Camelus dromedarius}
Probab=54.25  E-value=22  Score=13.88  Aligned_cols=12  Identities=33%  Similarity=0.545  Sum_probs=9.4  Template_Neff=13.700

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||.++|.
T Consensus       112 ~~~~~~~~l~v~  123 (143)
T 6XXO_A          112 DYWGQGTQVTVS  123 (143)
T ss_dssp             CEECCCEEEEEC
T ss_pred             ceecCCeEeEEe
Confidence            478899988874


No 359
>6EJG_C CD81 antigen, SINGLE CHAIN FV; HELICAL BUNDLE, ANTIBODY-ANTIGEN COMPLEX, CELL; 2.82A {Homo sapiens}
Probab=53.99  E-value=21  Score=15.39  Aligned_cols=13  Identities=31%  Similarity=0.526  Sum_probs=10.1  Template_Neff=13.800

Q ss_pred             cccCCCCeeeeCC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVLP   20 (20)
Q Consensus         8 fvfgpgtrlsvlp   20 (20)
                      .+|+.||+|+|-+
T Consensus       239 ~~~~~~~~l~V~~  251 (251)
T 6EJG_C          239 RSWGQGSALTVSS  251 (251)
T ss_dssp             CCBBCCEEEEECC
T ss_pred             eeccCCeeEEeeC
Confidence            4788999998853


No 360
>5F1O_B ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1; CD38, ADP-ribosyl cyclase, cyclic ADP-ribose; 2.2A {Homo sapiens}
Probab=53.93  E-value=26  Score=14.91  Aligned_cols=12  Identities=33%  Similarity=0.515  Sum_probs=9.6  Template_Neff=12.600

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.|++|+|.
T Consensus       116 ~~~~~g~~l~v~  127 (163)
T 5F1O_B          116 DNWGQGTQVTVS  127 (163)
T ss_dssp             CEECCCEEEEEE
T ss_pred             cccCCCeEEEEc
Confidence            378999998874


No 361
>5JYM_B Cadherin-3/Antibody scFv TSP11; Cadherin, Cell adhesion, Antibody, Protein-protein; 2.45A {Homo sapiens}
Probab=53.70  E-value=22  Score=15.71  Aligned_cols=13  Identities=38%  Similarity=0.823  Sum_probs=9.2  Template_Neff=13.400

Q ss_pred             CCcccCCCCeeee
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSV   18 (20)
Q Consensus         6 qnfvfgpgtrlsv   18 (20)
                      ....||.||++.|
T Consensus       236 ~~~~~~~gt~~~~  248 (257)
T 5JYM_B          236 YPWTFGGGTKLEI  248 (257)
T ss_dssp             SCCEECCCEEEC-
T ss_pred             CceeecCCceeeE
Confidence            3467899998865


No 362
>6ZWK_D NANOBODY, PHOSPHOPEPTIDE-RECOGNITION PROTEIN, GAMMA-H2AX, IMMUNE; HET: SEP; 1.55A {Vicugna pacos}
Probab=53.21  E-value=22  Score=14.24  Aligned_cols=12  Identities=33%  Similarity=0.562  Sum_probs=9.2  Template_Neff=13.400

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|+++.|.
T Consensus       114 ~~~~~~~~l~v~  125 (150)
T 6ZWK_D          114 EYWGQGTQVTVS  125 (150)
T ss_dssp             CEECCCEEEEEE
T ss_pred             eeecCCcEEEEc
Confidence            578889988763


No 363
>6ZWK_E NANOBODY, PHOSPHOPEPTIDE-RECOGNITION PROTEIN, GAMMA-H2AX, IMMUNE; HET: SEP; 1.55A {Vicugna pacos}
Probab=53.21  E-value=22  Score=14.24  Aligned_cols=12  Identities=33%  Similarity=0.562  Sum_probs=9.2  Template_Neff=13.400

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|+++.|.
T Consensus       114 ~~~~~~~~l~v~  125 (150)
T 6ZWK_E          114 EYWGQGTQVTVS  125 (150)
T ss_dssp             SEECCCEEEEEE
T ss_pred             eeecCCcEEEEc
Confidence            578889988763


No 364
>5FCS_H Diabody; antibody, diabody, Pcad, CD3, IMMUNE; HET: SO4; 2.01A {Homo sapiens}
Probab=52.99  E-value=21  Score=15.93  Aligned_cols=11  Identities=36%  Similarity=0.761  Sum_probs=9.4  Template_Neff=13.100

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      +||.||.|.|.
T Consensus       225 ~~~~~t~l~v~  235 (247)
T 5FCS_H          225 IWGQGTMVTVS  235 (247)
T ss_dssp             SBCCCEEEEEC
T ss_pred             EeCCCcEEEEe
Confidence            89999999874


No 365
>3WBD_B single chain Fv fragment of; beta-sandwich, immunoglobulin fold, single chain; HET: SIA, FLC; 1.8A {Mus musculus}
Probab=52.74  E-value=18  Score=16.08  Aligned_cols=12  Identities=33%  Similarity=0.495  Sum_probs=9.2  Template_Neff=13.100

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ..+||.||.|+|
T Consensus       233 ~~~~~~~~~l~v  244 (246)
T 3WBD_B          233 MDYWGQGTSVTV  244 (246)
T ss_dssp             EEEECCCEEEEE
T ss_pred             EEEecCCeEEEE
Confidence            346799998887


No 366
>7TE8_B Nanobody, Cannabidiol, Sensor, Molecular glue; HET: P0T; 1.998A {artificial sequences}
Probab=52.68  E-value=20  Score=12.93  Aligned_cols=11  Identities=36%  Similarity=0.730  Sum_probs=8.5  Template_Neff=14.400

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .|+.|+.+.|.
T Consensus       109 ~~~~~~~l~v~  119 (120)
T 7TE8_B          109 YWGQGTQVTVS  119 (120)
T ss_dssp             EECCCEEEEEC
T ss_pred             EecCCeEEEEc
Confidence            67888888774


No 367
>3J8Z_G L1, H16.1A light chain, H16.1A; L1 pentamer, quasi-HPV16, L1 capsomer; 14.0A {Human papillomavirus type 16}
Probab=52.59  E-value=17  Score=12.47  Aligned_cols=11  Identities=45%  Similarity=0.673  Sum_probs=8.0  Template_Neff=15.000

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.++.+.|
T Consensus       103 ~~~~~~~~l~v  113 (114)
T 3J8Z_G          103 DYWGQGTTLTV  113 (114)
T ss_dssp             EEECCCEEEEE
T ss_pred             eeceeceeEEe
Confidence            46788888776


No 368
>3ESV_G single-chain FV, monoclonal antibody, immunoglobulin; 2.0A {Mus musculus}
Probab=52.57  E-value=30  Score=14.81  Aligned_cols=13  Identities=31%  Similarity=0.404  Sum_probs=10.3  Template_Neff=13.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.+|+|.|-
T Consensus       239 ~~~~~~~~~l~V~  251 (252)
T 3ESV_G          239 MDYWGQGTSVTVS  251 (252)
T ss_dssp             CCEECCCEEEEEC
T ss_pred             ccccCCCeEEEEc
Confidence            4578999999885


No 369
>6LFW_A PCB4scFv(hN56D); Co-PCB, antibody fragment, IMMUNE SYSTEM; HET: OMF; 1.41A {Mus musculus}
Probab=52.35  E-value=18  Score=15.85  Aligned_cols=11  Identities=36%  Similarity=0.679  Sum_probs=8.5  Template_Neff=13.500

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .||.||+++|.
T Consensus       238 ~~~~g~~~~v~  248 (253)
T 6LFW_A          238 YWGQGTSVTVS  248 (253)
T ss_dssp             EECCCEEEEEC
T ss_pred             eecCCeeEEEe
Confidence            57888888874


No 370
>6LFX_A PCB4scFv(hN56D); Co-PCB, antibody fragment, IMMUNE SYSTEM; HET: OM4; 1.43A {Mus musculus}
Probab=52.35  E-value=18  Score=15.85  Aligned_cols=11  Identities=36%  Similarity=0.679  Sum_probs=8.5  Template_Neff=13.500

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .||.||+++|.
T Consensus       238 ~~~~g~~~~v~  248 (253)
T 6LFX_A          238 YWGQGTSVTVS  248 (253)
T ss_dssp             EECCCEEEEEC
T ss_pred             eecCCeeEEEe
Confidence            57888888874


No 371
>1QNZ_H 0.5B ANTIBODY (HEAVY CHAIN), 0.5B; ANTIBODY, V3 PEPTIDE, BINDING SITE; NMR {MUS MUSCULUS} SCOP: b.1.1.1
Probab=52.32  E-value=21  Score=12.82  Aligned_cols=12  Identities=33%  Similarity=0.498  Sum_probs=9.0  Template_Neff=14.400

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|+.+.|.
T Consensus       107 ~~~~~~~~~~v~  118 (119)
T 1QNZ_H          107 DYWGQGTSVTVS  118 (119)
T ss_dssp             CBCCSCEEEEEC
T ss_pred             eccccceeeEEc
Confidence            467888888764


No 372
>6XYF_A Nanobody 22; Nanobody, IMMUNE SYSTEM; 1.11097A {Lama glama}
Probab=52.15  E-value=22  Score=14.08  Aligned_cols=12  Identities=33%  Similarity=0.531  Sum_probs=9.0  Template_Neff=13.200

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ..+||.|+.+.|
T Consensus       113 ~~~~g~g~~~~~  124 (132)
T 6XYF_A          113 VDYWGKGTQVTV  124 (132)
T ss_dssp             CCEECCCEEEEE
T ss_pred             ccccCCCeeeEe
Confidence            347899988865


No 373
>6FRJ_H scFv-SM3, APD-SeThr-RP; IMMUNE SYSTEM, Glycopeptides, antibodies, molecular; HET: A2G, EDO; 1.4A {Mus musculus}
Probab=52.02  E-value=24  Score=15.22  Aligned_cols=13  Identities=62%  Similarity=1.150  Sum_probs=10.5  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|++|.|.
T Consensus       231 ~~~~~~~~~l~V~  243 (244)
T 6FRJ_H          231 HWVFGGGTKLTVL  243 (244)
T ss_dssp             CEEECCCEEEEEC
T ss_pred             cEEecCceEEEEe
Confidence            4578999999885


No 374
>6OSH_L Variable domain of Light Chain; Single chain Fv, ScFv, Antibody; 1.117A {Oryctolagus cuniculus}
Probab=52.01  E-value=21  Score=12.87  Aligned_cols=11  Identities=45%  Similarity=0.878  Sum_probs=8.0  Template_Neff=14.200

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.++.|.|
T Consensus       102 ~~~~~~~~l~v  112 (113)
T 6OSH_L          102 TAFGGGTKLEI  112 (113)
T ss_dssp             CEECCCEEEEE
T ss_pred             eEecCceEEEE
Confidence            45788888876


No 375
>4Y8D_C kinase domain of GAK, nanobody; TRANSFERASE, kinase, nanobody, inhibitor, Structural; HET: 49J, EDO; 2.1A {Lama glama}
Probab=51.84  E-value=27  Score=13.71  Aligned_cols=14  Identities=29%  Similarity=0.477  Sum_probs=9.5  Template_Neff=13.500

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ..+.|+.|++|+|.
T Consensus       107 ~~~~~~~~~~l~v~  120 (140)
T 4Y8D_C          107 TAITAGQGTQVTVS  120 (140)
T ss_pred             cceeecCCCEEEEe
Confidence            34567888888763


No 376
>4Y8D_D kinase domain of GAK, nanobody; TRANSFERASE, kinase, nanobody, inhibitor, Structural; HET: 49J, EDO; 2.1A {Lama glama}
Probab=51.84  E-value=27  Score=13.71  Aligned_cols=14  Identities=29%  Similarity=0.477  Sum_probs=10.5  Template_Neff=13.500

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ..+.|+.|++|+|.
T Consensus       107 ~~~~~~~~~~l~v~  120 (140)
T 4Y8D_D          107 TAITAGQGTQVTVS  120 (140)
T ss_dssp             CCSEECCCEEEEEC
T ss_pred             cceeecCCCEEEEe
Confidence            45678899988874


No 377
>7DX4_L SARS-CoV-2, Spike, neutralizing antibody, hACE2; HET: NAG;{Homo sapiens}
Probab=51.57  E-value=22  Score=12.88  Aligned_cols=12  Identities=67%  Similarity=1.035  Sum_probs=8.6  Template_Neff=14.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||.|.|.
T Consensus        99 ~~~~~~~~l~v~  110 (112)
T 7DX4_L           99 SVFGGGTKLTVL  110 (112)
T ss_dssp             EECBCCEEEEEC
T ss_pred             eEecCceEEEEe
Confidence            467788887764


No 378
>6ZXN_D Spike glycoprotein, Nanobody Ty1; SARS-CoV-2, spike protein, neutralising antibody; HET: NAG; 2.93A {Severe acute respiratory syndrome coronavirus 2}
Probab=51.45  E-value=28  Score=13.16  Aligned_cols=13  Identities=38%  Similarity=0.511  Sum_probs=9.6  Template_Neff=14.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.+++|.|.
T Consensus       107 ~~~~~~~~~l~v~  119 (134)
T 6ZXN_D          107 SSVRGQGTQVTVS  119 (134)
T ss_dssp             SCCBCCCCEECCC
T ss_pred             ccccCCccEEEEe
Confidence            4677888888764


No 379
>7JHG_N AMPK, ATP, fully inactive, KD-displaced; HET: TAK, ADP, AMP, GLC, ATP; 3.47A {Homo sapiens}
Probab=51.40  E-value=21  Score=14.06  Aligned_cols=12  Identities=33%  Similarity=0.564  Sum_probs=8.2  Template_Neff=13.900

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...++.|+++.|
T Consensus       146 ~~~~~~~~~l~v  157 (159)
T 7JHG_N          146 YDYWGQGTQVTV  157 (159)
T ss_dssp             CCCEEEEEEECB
T ss_pred             ceeecCceeeEe
Confidence            345777888766


No 380
>7MDU_H monoclonal antibody, immune complex, VIRAL; HET: BMA, NAG, MAN; 3.3A {Macaca mulatta}
Probab=51.33  E-value=22  Score=12.15  Aligned_cols=11  Identities=27%  Similarity=0.507  Sum_probs=7.0  Template_Neff=15.100

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..++.++++.|
T Consensus       104 ~~~~~~~~l~v  114 (116)
T 7MDU_H          104 DFWGQGVLVTV  114 (116)
T ss_dssp             EEECCCEEECC
T ss_pred             eeeccceeEEE
Confidence            35667777765


No 381
>6DBF_B InlB, VHH R303; nanobody VHH Listeria Internalin, IMMUNE; 1.55A {Listeria monocytogenes}
Probab=51.24  E-value=19  Score=14.06  Aligned_cols=13  Identities=38%  Similarity=0.578  Sum_probs=10.0  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||++.|.
T Consensus       110 ~~~~~~~~~l~v~  122 (142)
T 6DBF_B          110 LNVWGQGTQVTVS  122 (142)
T ss_dssp             TSEECCCEEEEEE
T ss_pred             EEEEcCCeEEEEe
Confidence            3678999988774


No 382
>5F1K_D ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1; CD38, ADP-ribosyl cyclase, cyclic ADP-ribose; 2.3A {Homo sapiens}
Probab=51.17  E-value=26  Score=14.62  Aligned_cols=13  Identities=31%  Similarity=0.478  Sum_probs=10.0  Template_Neff=12.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||++.|.
T Consensus       111 ~~~~~~~~~l~v~  123 (159)
T 5F1K_D          111 YADWGQGTQVTVS  123 (159)
T ss_dssp             CCEECCCEEEEEE
T ss_pred             eeecCCCcEEEEe
Confidence            5678899988774


No 383
>3T0V_A M8VL; immunoglobulin fold, fluorogen activation, dimethylindole; HET: PE3, EDO, 1PE; 1.451A {Homo sapiens}
Probab=51.15  E-value=20  Score=13.33  Aligned_cols=12  Identities=58%  Similarity=1.151  Sum_probs=8.6  Template_Neff=14.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..++.+++|.|.
T Consensus        99 ~~~~~~~~l~v~  110 (123)
T 3T0V_A           99 WVFGGGTKVTVL  110 (123)
T ss_dssp             EEEBCCEEEEEC
T ss_pred             EEEcCCeEEEEe
Confidence            466788888765


No 384
>3T0W_B immunoglobulin variable lambda domain; immunoglobulin fold, fluorogen activation, dimethylindole; HET: PCA, PE3, DIW; 1.501A {Homo sapiens}
Probab=51.15  E-value=20  Score=13.33  Aligned_cols=12  Identities=58%  Similarity=1.151  Sum_probs=8.7  Template_Neff=14.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..++.+++|.|.
T Consensus        99 ~~~~~~~~l~v~  110 (123)
T 3T0W_B           99 WVFGGGTKVTVL  110 (123)
T ss_dssp             EEEBCCEEEEEC
T ss_pred             EEEcCCeEEEEe
Confidence            466788888775


No 385
>5GS2_H Maltose-binding periplasmic protein, anti-repebody, anti-MBP; diabody, antibody fragment, complex, SUGAR; 3.592A {Escherichia coli (strain K12)}
Probab=51.05  E-value=18  Score=16.66  Aligned_cols=11  Identities=45%  Similarity=1.096  Sum_probs=8.4  Template_Neff=12.400

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.||.||+|.|
T Consensus       228 ~~~~~~~~l~v  238 (239)
T 5GS2_H          228 YTFGGGTKLEI  238 (239)
T ss_dssp             CEECCCEECCH
T ss_pred             EEECCCeEEEE
Confidence            56888888865


No 386
>1C08_B ANTI-HEN EGG WHITE LYSOZYME ANTIBODY; ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM-HYDROLASE COMPLEX; 2.3A {Gallus gallus} SCOP: b.1.1.1
Probab=50.98  E-value=21  Score=12.87  Aligned_cols=11  Identities=36%  Similarity=0.619  Sum_probs=7.8  Template_Neff=14.200

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .|+.|+.+.|.
T Consensus       102 ~~~~~~~~~v~  112 (114)
T 1C08_B          102 YWGQGTLVTVS  112 (114)
T ss_dssp             CBCCCEEEEEC
T ss_pred             eecCCcEEEEe
Confidence            56778877764


No 387
>3QYC_A VH domain of IgG molecule; immunoglobulin V domain fold, antibody; 1.6A {Homo sapiens}
Probab=50.97  E-value=32  Score=13.71  Aligned_cols=14  Identities=29%  Similarity=0.494  Sum_probs=10.6  Template_Neff=13.400

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ....|+.|+++.|.
T Consensus       113 ~~~~~~~~~~l~v~  126 (146)
T 3QYC_A          113 PDASWGQGTMVTVS  126 (146)
T ss_dssp             CCCCBCCCEEEEEC
T ss_pred             CCcccCCCceEEEe
Confidence            35678999998874


No 388
>4LCI_L anti canine CD28 antibody, 1C6; Immunoglobulin, antibody, CD28, IMMUNE SYSTEM; HET: GOL, FMT; 1.9A {Mus musculus}
Probab=50.91  E-value=20  Score=13.34  Aligned_cols=13  Identities=38%  Similarity=0.851  Sum_probs=9.8  Template_Neff=13.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      .+.|+.+++|+|.
T Consensus       101 ~~~~~~~~~l~v~  113 (117)
T 4LCI_L          101 PYTFGGGTKLEIK  113 (117)
T ss_dssp             SCEECCCEEEEEC
T ss_pred             CeEEcCCeEEEEE
Confidence            3578888888875


No 389
>5E9D_D HLA class I histocompatibility antigen; single chain TCR-pMHC Complex, PROTEIN; 2.51A {Homo sapiens}
Probab=50.41  E-value=29  Score=13.08  Aligned_cols=13  Identities=38%  Similarity=0.736  Sum_probs=9.4  Template_Neff=13.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|+.+.|.
T Consensus        98 ~~~~~~~~~l~v~  110 (129)
T 5E9D_D           98 KLQFGAGTQVVVT  110 (129)
T ss_dssp             CCEECCCEEEEEE
T ss_pred             cEEecCCeEEEEc
Confidence            4677888888763


No 390
>5XTB_L NADH dehydrogenase [ubiquinone] flavoprotein 1; Respiratory, OXIDOREDUCTASE-ELECTRON TRANSPORT complex; HET: NDP, FMN, 8Q1, SF4; 3.4A {Homo sapiens}
Probab=50.28  E-value=13  Score=19.73  Aligned_cols=16  Identities=44%  Similarity=0.812  Sum_probs=13.3  Template_Neff=6.600

Q ss_pred             CCCCCCcccCCCCeee
Q tr|A0A075B6V7|    2 DNYGQNFVFGPGTRLS   17 (20)
Q Consensus         2 dnygqnfvfgpgtrls   17 (20)
                      .+|+.||.+....|.|
T Consensus       101 ksYadNF~~~~~~~~~  116 (118)
T 5XTB_L          101 KSYGANFSWNKRTRVS  116 (118)
T ss_pred             cccHHhcccCCCCccc
Confidence            4699999998888776


No 391
>5XTD_L NADH dehydrogenase [ubiquinone] flavoprotein 1; Homo sapiens, Oxidoreductase, Respiratory, OXIDOREDUCTASE-ELECTRON; HET: SF4, PEE, NDP, FMN, CDL, 8Q1, PLX; 3.7A {Homo sapiens}
Probab=50.28  E-value=13  Score=19.73  Aligned_cols=16  Identities=44%  Similarity=0.812  Sum_probs=13.3  Template_Neff=6.600

Q ss_pred             CCCCCCcccCCCCeee
Q tr|A0A075B6V7|    2 DNYGQNFVFGPGTRLS   17 (20)
Q Consensus         2 dnygqnfvfgpgtrls   17 (20)
                      .+|+.||.+....|.|
T Consensus       101 ksYadNF~~~~~~~~~  116 (118)
T 5XTD_L          101 KSYGANFSWNKRTRVS  116 (118)
T ss_pred             cccHHhcccCCCCccc
Confidence            4699999998888776


No 392
>4NBZ_B TcdA, A26.8 VHH; Antibody-antigen complex, IMMUNE SYSTEM; 1.75A {Clostridium difficile}
Probab=50.19  E-value=30  Score=14.20  Aligned_cols=13  Identities=31%  Similarity=0.468  Sum_probs=9.6  Template_Neff=13.000

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|+.+.|.
T Consensus       111 ~~~~~~~~~l~v~  123 (152)
T 4NBZ_B          111 YDYWGQGTQVTVS  123 (152)
T ss_dssp             CCEECCCEEEEEE
T ss_pred             ceeccCCcEEEEc
Confidence            3578888888764


No 393
>7V2E_L Respiratory, Complex, ELECTRON TRANSPORT; HET: PEE, SF4, ADP, NDP, UQ, FMN, 2MR, CDL, 8Q1, NAI, PLX; 2.8A {Sus scrofa}
Probab=49.63  E-value=15  Score=19.71  Aligned_cols=16  Identities=44%  Similarity=0.812  Sum_probs=13.3  Template_Neff=6.500

Q ss_pred             CCCCCCcccCCCCeee
Q tr|A0A075B6V7|    2 DNYGQNFVFGPGTRLS   17 (20)
Q Consensus         2 dnygqnfvfgpgtrls   17 (20)
                      .+|+.||......|+|
T Consensus       108 ksYadNF~~~~~~~~~  123 (125)
T 7V2E_L          108 KSYGANFSWNKRTRVS  123 (125)
T ss_pred             cccHHhcccCCCCcee
Confidence            3699999999888876


No 394
>7V2H_L Respiratory, Complex, ELECTRON TRANSPORT; HET: PEE, SF4, DCQ, ADP, NDP, UQ, FMN, 2MR, CDL, 8Q1, NAI, PLX; 2.5A {Sus scrofa}
Probab=49.63  E-value=15  Score=19.71  Aligned_cols=16  Identities=44%  Similarity=0.812  Sum_probs=13.3  Template_Neff=6.500

Q ss_pred             CCCCCCcccCCCCeee
Q tr|A0A075B6V7|    2 DNYGQNFVFGPGTRLS   17 (20)
Q Consensus         2 dnygqnfvfgpgtrls   17 (20)
                      .+|+.||......|+|
T Consensus       108 ksYadNF~~~~~~~~~  123 (125)
T 7V2H_L          108 KSYGANFSWNKRTRVS  123 (125)
T ss_pred             cccHHhcccCCCCcee
Confidence            3699999999888876


No 395
>3DUU_B antibody Fv fragment SAG506-01, Ig-like; antibody, KDO, twinning, pseudo-symmetry, IMMUNE; HET: PG4, KDO; 1.95A {Mus Musculus}
Probab=49.59  E-value=25  Score=12.26  Aligned_cols=12  Identities=33%  Similarity=0.498  Sum_probs=8.6  Template_Neff=14.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..++.++++.|.
T Consensus       109 ~~~~~~~~l~v~  120 (121)
T 3DUU_B          109 DYWGQGTSVTVS  120 (121)
T ss_dssp             CEECCCEEEEEC
T ss_pred             eeecCCeeeEec
Confidence            457888888764


No 396
>2MFS_A Ep-AMP1; cystine-knot, ANTIMICROBIAL PROTEIN; NMR {N/A}
Probab=49.24  E-value=15  Score=17.94  Aligned_cols=8  Identities=25%  Similarity=0.160  Sum_probs=6.5  Template_Neff=2.500

Q ss_pred             CCcccCCC
Q tr|A0A075B6V7|    6 QNFVFGPG   13 (20)
Q Consensus         6 qnfvfgpg   13 (20)
                      -|++|||.
T Consensus         8 CN~~FGP~   15 (35)
T 2MFS_A            8 CDNDRGPR   15 (35)
T ss_dssp             CCTTTSCC
T ss_pred             cccccCCC
Confidence            48999995


No 397
>4B41_A ANTIBODY G7; IMMUNE SYSTEM, ALZHEIMER'S DISEASE; 1.191A {LAMA GLAMA}
Probab=49.00  E-value=27  Score=12.41  Aligned_cols=12  Identities=33%  Similarity=0.520  Sum_probs=9.3  Template_Neff=14.500

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..++.|+.++|.
T Consensus       106 ~~~~~~~~l~v~  117 (118)
T 4B41_A          106 DHWGQGTQVTVS  117 (118)
T ss_dssp             SCCCCCEEEEEC
T ss_pred             ceeeCCceeEEc
Confidence            578888888774


No 398
>5TBD_B Fv fragment (mAb4D1) heavy chain; Immunoglobulin fold, Immune system, C-terminal; HET: ACE; 2.2A {Mus musculus}
Probab=48.99  E-value=23  Score=13.53  Aligned_cols=11  Identities=45%  Similarity=1.032  Sum_probs=8.1  Template_Neff=13.200

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.|+.+|.|.|
T Consensus       101 ~~~~~~~~l~v  111 (112)
T 5TBD_B          101 ITFGSGTKLEI  111 (112)
T ss_dssp             CEECCCEEEEC
T ss_pred             EEECCCceEEE
Confidence            56788888765


No 399
>5TBD_G Fv fragment (mAb4D1) heavy chain; Immunoglobulin fold, Immune system, C-terminal; HET: ACE; 2.2A {Mus musculus}
Probab=48.99  E-value=23  Score=13.53  Aligned_cols=11  Identities=45%  Similarity=1.032  Sum_probs=7.1  Template_Neff=13.200

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.|+.+|.|.|
T Consensus       101 ~~~~~~~~l~v  111 (112)
T 5TBD_G          101 ITFGSGTKLEI  111 (112)
T ss_pred             EEECCCceEEE
Confidence            45677777665


No 400
>4QY8_A Fv fragment(mAb6D8) heavy chain, Fv; Immunoglobulin fold, IMMUNE SYSTEM, N-TERMINAL; 1.353A {Mus musculus}
Probab=48.96  E-value=26  Score=12.14  Aligned_cols=11  Identities=36%  Similarity=0.619  Sum_probs=7.5  Template_Neff=14.800

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .++.|+.+.|-
T Consensus       103 ~~~~~~~l~v~  113 (114)
T 4QY8_A          103 YWGQGTLVTVS  113 (114)
T ss_dssp             EECCCEEEEEC
T ss_pred             EEcCCeEEEeC
Confidence            56777777764


No 401
>4QYO_A Fv fragment(mAb6D8) heavy chain, Fv; Immunoglobulin fold, IMMUNE SYSTEM, N-TERMINAL; 1.208A {Mus musculus}
Probab=48.96  E-value=26  Score=12.14  Aligned_cols=11  Identities=36%  Similarity=0.619  Sum_probs=7.5  Template_Neff=14.800

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .++.|+.+.|-
T Consensus       103 ~~~~~~~l~v~  113 (114)
T 4QYO_A          103 YWGQGTLVTVS  113 (114)
T ss_dssp             EECCCEEEEEC
T ss_pred             EEcCCeEEEeC
Confidence            56777777764


No 402
>1MQK_L antibody 7E2 FV fragment, light; antibody, membrane protein, cytochrome C; 1.28A {Mus musculus} SCOP: b.1.1.1
Probab=48.96  E-value=30  Score=12.84  Aligned_cols=12  Identities=42%  Similarity=0.861  Sum_probs=9.5  Template_Neff=13.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||+|.|.
T Consensus        97 ~~~~~~~~l~v~  108 (120)
T 1MQK_L           97 LTFGGGTKLEIK  108 (120)
T ss_dssp             CCBCCCEEEEEC
T ss_pred             EEECCCceEEEC
Confidence            578889988874


No 403
>3K3Q_A llama Aa1 VHH domain, Botulinum; llama, VHH, antibody, botulinum, neurotoxin; 2.6A {Lama glama}
Probab=48.94  E-value=34  Score=15.08  Aligned_cols=13  Identities=31%  Similarity=0.378  Sum_probs=10.1  Template_Neff=11.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||++.|.
T Consensus       127 ~~~~~~gt~l~v~  139 (151)
T 3K3Q_A          127 ADHWGQGTLVTVS  139 (151)
T ss_dssp             CSEECCCEEEEEE
T ss_pred             cccccCCcEEEec
Confidence            4578999998874


No 404
>6TCS_A Omalizumab scFv; Fab, Antibody, immunoglobulin, IMMUNE SYSTEM; HET: PEG; 2.3A {Homo sapiens}
Probab=48.79  E-value=22  Score=16.18  Aligned_cols=14  Identities=36%  Similarity=0.475  Sum_probs=10.8  Template_Neff=13.100

Q ss_pred             CcccCCCCeeeeCC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVLP   20 (20)
Q Consensus         7 nfvfgpgtrlsvlp   20 (20)
                      ..+|++|+.|.|.+
T Consensus       241 ~~~~~~~~~l~V~~  254 (277)
T 6TCS_A          241 FAVWGQGTLVTVSS  254 (277)
T ss_dssp             CSEECCCEEEEECC
T ss_pred             EEEECCCeEEEEee
Confidence            45689999998853


No 405
>6NNJ_V Envelope glycoprotein gp41, 35O22 scFv; HIV-1 Envelope Prefusion Trimer, CD4-binding; HET: BMA, NAG, MAN; 2.6A {Human immunodeficiency virus 1}
Probab=48.53  E-value=31  Score=12.83  Aligned_cols=10  Identities=40%  Similarity=1.019  Sum_probs=5.7  Template_Neff=13.800

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .|+.|+++.|
T Consensus        93 ~~~~~~~l~v  102 (117)
T 6NNJ_V           93 TFGQGTKVDI  102 (117)
T ss_dssp             EECCCEEEC-
T ss_pred             eeCCceEEEE
Confidence            4666776654


No 406
>5GS0_F Toll-like receptor 3, light chain; diabody, antibody fragment, complex, IMMUNE; HET: BMA, NAG, MAN; 3.275A {Homo sapiens}
Probab=48.53  E-value=25  Score=12.32  Aligned_cols=11  Identities=36%  Similarity=0.619  Sum_probs=7.7  Template_Neff=15.000

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .++.|+.|.|.
T Consensus       111 ~~~~~~~l~v~  121 (127)
T 5GS0_F          111 YWGQGTLVTVS  121 (127)
T ss_dssp             EECCCEEEEEC
T ss_pred             EEecCeEEEEe
Confidence            56778877764


No 407
>5WB1_A Envelope protein US28,nanobody 7; chemokine receptor, MEMBRANE PROTEIN; 3.508A {Human cytomegalovirus}
Probab=48.42  E-value=28  Score=17.51  Aligned_cols=13  Identities=31%  Similarity=0.496  Sum_probs=10.5  Template_Neff=12.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||.||+|.|.
T Consensus       441 ~~~~~~~~~l~v~  453 (458)
T 5WB1_A          441 ADYWGQGTQVTVS  453 (458)
T ss_dssp             CCEEBCCEEEECS
T ss_pred             CcccccceEEEEe
Confidence            4579999999874


No 408
>7LY2_K Spike glycoprotein, S2M11 Fab Light; Antibody, VIRAL PROTEIN, Structural Genomics; HET: BMA, FUC, NAG; 2.5A {Severe acute respiratory syndrome coronavirus 2}
Probab=48.13  E-value=12  Score=12.67  Aligned_cols=9  Identities=44%  Similarity=1.132  Sum_probs=4.6  Template_Neff=14.900

Q ss_pred             cccCCCCee
Q tr|A0A075B6V7|    8 FVFGPGTRL   16 (20)
Q Consensus         8 fvfgpgtrl   16 (20)
                      +.|+.||+|
T Consensus        96 ~~~~~~t~l  104 (104)
T 7LY2_K           96 WTFGQGTKV  104 (104)
T ss_pred             EEEccCeeC
Confidence            345666543


No 409
>6OSH_H Variable domain of Light Chain; Single chain Fv, ScFv, Antibody; 1.117A {Oryctolagus cuniculus}
Probab=47.56  E-value=27  Score=11.86  Aligned_cols=12  Identities=42%  Similarity=0.789  Sum_probs=8.0  Template_Neff=15.100

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...|+.++.+.|
T Consensus       102 ~~~~~~~~~l~v  113 (114)
T 6OSH_H          102 LNIWGPGTLVTV  113 (114)
T ss_dssp             CCCBCCCEEEEE
T ss_pred             EEEEcCCeEEEe
Confidence            345777777765


No 410
>4NBX_B TcdA, A20.1 VHH; Antibody-antigen complex, IMMUNE SYSTEM; 1.75A {Clostridium difficile}
Probab=47.38  E-value=24  Score=14.35  Aligned_cols=12  Identities=33%  Similarity=0.606  Sum_probs=9.3  Template_Neff=13.200

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||++.|.
T Consensus       118 ~~~~~~~~l~v~  129 (154)
T 4NBX_B          118 AYWGQGTQVTVS  129 (154)
T ss_dssp             EEECCCEEEEEE
T ss_pred             EEEeCCcEEEEe
Confidence            678889888763


No 411
>6H3U_H scFv 4B6 VH, scFv 4B6; Envelope Glycoprotein, scFv Antibody, VIRAL; HET: BMA, FUC, NAG, MAN; 3.168A {Mus musculus}
Probab=47.29  E-value=26  Score=13.30  Aligned_cols=12  Identities=42%  Similarity=0.636  Sum_probs=8.7  Template_Neff=14.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||++.|.
T Consensus       110 ~~~~~~~~l~v~  121 (142)
T 6H3U_H          110 DVWGAGTTVTVS  121 (142)
T ss_dssp             EEECCCEEEBCC
T ss_pred             EEeccCeEEEEe
Confidence            467888888764


No 412
>6H3U_I scFv 4B6 VH, scFv 4B6; Envelope Glycoprotein, scFv Antibody, VIRAL; HET: BMA, FUC, NAG, MAN; 3.168A {Mus musculus}
Probab=47.29  E-value=26  Score=13.30  Aligned_cols=12  Identities=42%  Similarity=0.636  Sum_probs=8.7  Template_Neff=14.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||++.|.
T Consensus       110 ~~~~~~~~l~v~  121 (142)
T 6H3U_I          110 DVWGAGTTVTVS  121 (142)
T ss_dssp             EEECCCEEEBCC
T ss_pred             EEeccCeEEEEe
Confidence            467888888764


No 413
>5H8D_A VHH nanobody; VHH nanobody, ASC-binding, antibody fragment; 1.89A {Lama glama}
Probab=47.19  E-value=27  Score=12.33  Aligned_cols=10  Identities=40%  Similarity=0.840  Sum_probs=6.5  Template_Neff=14.500

Q ss_pred             cCCCCeeeeC
Q tr|A0A075B6V7|   10 FGPGTRLSVL   19 (20)
Q Consensus        10 fgpgtrlsvl   19 (20)
                      +|.||.+.|.
T Consensus       102 ~~~~~~~~v~  111 (114)
T 5H8D_A          102 WGQGTQVTVS  111 (114)
T ss_dssp             ECCCEEEEEC
T ss_pred             EecCeEEEEe
Confidence            5677777653


No 414
>5M7Q_A Nanobody NbD2; Nanobody, VHH, variable domain, Camelids; HET: SO4; 1.8A {Camelus dromedarius}
Probab=47.15  E-value=31  Score=13.22  Aligned_cols=14  Identities=29%  Similarity=0.413  Sum_probs=10.1  Template_Neff=13.800

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ....|+.||+|.|.
T Consensus       104 ~~~~~~~~~~l~v~  117 (137)
T 5M7Q_A          104 TWRYWGQGTQVTVS  117 (137)
T ss_dssp             CCSEECCCEEEEEE
T ss_pred             ceeEeccceEEEEc
Confidence            34678888888763


No 415
>5F3J_C Duffy receptor, Antibody 2D10 single; Plasmodium, vivax, duffy binding protein; 4.001A {Plasmodium vivax (strain Salvador I)}
Probab=46.79  E-value=27  Score=16.73  Aligned_cols=12  Identities=42%  Similarity=0.559  Sum_probs=8.9  Template_Neff=12.400

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||+++|.
T Consensus       277 ~~~~~~t~~~v~  288 (305)
T 5F3J_C          277 DYWGQGTTLTVS  288 (305)
T ss_dssp             EEECSCEEEEC-
T ss_pred             EEeCCCcEEEEc
Confidence            468999998873


No 416
>6J11_H Spike glycoprotein, VH of 7D10; MERS-CoV, Antibody, VIRAL PROTEIN; HET: BMA, NAG, MAN; 3.0A {Middle East respiratory syndrome-related coronavirus}
Probab=46.78  E-value=24  Score=12.89  Aligned_cols=12  Identities=33%  Similarity=0.498  Sum_probs=8.4  Template_Neff=14.500

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.+|+|.|.
T Consensus       120 ~~~~~~~~l~v~  131 (132)
T 6J11_H          120 DYWGQGTSVTVS  131 (132)
T ss_dssp             EEECCCEEEBCC
T ss_pred             eeeecCeeeEec
Confidence            457788888763


No 417
>6UFT_B Botulinum neurotoxin type B (E.C.3.4.24.69); Botulinum neurotoxin (BoNT), VHH, receptor-binding; HET: SO4; 2.90008139771A {Clostridium botulinum}
Probab=46.71  E-value=28  Score=14.34  Aligned_cols=12  Identities=33%  Similarity=0.581  Sum_probs=9.3  Template_Neff=13.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||++.|.
T Consensus       135 ~~~~~~~~l~v~  146 (155)
T 6UFT_B          135 RYWGQGTQVTVS  146 (155)
T ss_dssp             ECCCCCEEEEEE
T ss_pred             eeeccCcEEEEe
Confidence            468899988763


No 418
>1YJD_C Fab fragment of 5.11A1 antibody; IgSF, CD28 homodimer, IMMUNE SYSTEM-SIGNALING; HET: NAG; 2.7A {Mus musculus} SCOP: b.1.1.1
Probab=46.53  E-value=32  Score=14.29  Aligned_cols=10  Identities=30%  Similarity=0.228  Sum_probs=8.0  Template_Neff=12.500

Q ss_pred             cCCCCeeeeC
Q tr|A0A075B6V7|   10 FGPGTRLSVL   19 (20)
Q Consensus        10 fgpgtrlsvl   19 (20)
                      |++||.|.|.
T Consensus       111 ~~~~t~l~v~  120 (140)
T 1YJD_C          111 KSNGTIIHVK  120 (140)
T ss_dssp             CCCCEEEECC
T ss_pred             ccCCcEEEEE
Confidence            7888888774


No 419
>3U6R_A Antibody 1:7 (Heavy chain), Antibody; Ig-like domain, neutralizing single chain; 2.67A {Homo sapiens}
Probab=46.46  E-value=31  Score=13.55  Aligned_cols=13  Identities=31%  Similarity=0.330  Sum_probs=9.7  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|++|.|.
T Consensus       116 ~~~~~~~~~l~v~  128 (149)
T 3U6R_A          116 FDYWGQGTLVTVS  128 (149)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             hhhccCCeEEEEe
Confidence            4568888888774


No 420
>6KYZ_B Genome polyprotein (E.C.3.4.22.29,3.6.1.15,3.4.22.28,2.7.7.48), YDF H; protease, inhibitor, complex structure, VIRAL; 1.845A {Human rhinovirus 14}
Probab=46.10  E-value=31  Score=13.16  Aligned_cols=12  Identities=42%  Similarity=0.611  Sum_probs=8.9  Template_Neff=14.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.++.+.|.
T Consensus       118 ~~~~~~~~l~v~  129 (145)
T 6KYZ_B          118 DVWGKGTTVTVS  129 (145)
T ss_dssp             EEECCCEEEEEC
T ss_pred             EEecCCceEEEE
Confidence            467888888775


No 421
>5LHN_B Urokinase-type plasminogen activator (E.C.3.4.21.73), Camelid-Derived; Trypsin-like serine proteases, Nanobody, Inhibitor; HET: SO4, EDO; 2.55A {Mus musculus}
Probab=45.86  E-value=31  Score=14.27  Aligned_cols=14  Identities=29%  Similarity=0.396  Sum_probs=11.1  Template_Neff=12.900

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ....||.||.+.|.
T Consensus       119 ~~~~~~~gt~l~v~  132 (152)
T 5LHN_B          119 GMEYWGKGTQVTVS  132 (152)
T ss_dssp             TCSEECCCEEEEEC
T ss_pred             ceeeeccceeeEee
Confidence            45688999999874


No 422
>5LHQ_B Urokinase-type plasminogen activator (E.C.3.4.21.73), Camelid-Derived; Trypsin-like serine proteases, Nanobody, Inhibitor; HET: SO4, 0GJ; 2.6A {Mus musculus}
Probab=45.86  E-value=31  Score=14.27  Aligned_cols=14  Identities=29%  Similarity=0.396  Sum_probs=11.1  Template_Neff=12.900

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      ....||.||.+.|.
T Consensus       119 ~~~~~~~gt~l~v~  132 (152)
T 5LHQ_B          119 GMEYWGKGTQVTVS  132 (152)
T ss_dssp             TCSEECCCEEEEEC
T ss_pred             ceeeeccceeeEee
Confidence            45688999999874


No 423
>5E03_A CTLA-4 nanobody; IG FOLD, nanobody, SIGNALING PROTEIN; 1.685A {Camelidae}
Probab=45.76  E-value=31  Score=12.85  Aligned_cols=11  Identities=36%  Similarity=0.676  Sum_probs=7.8  Template_Neff=14.100

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .++.|+++.|.
T Consensus       104 ~~~~~~~l~v~  114 (129)
T 5E03_A          104 NWGRGTQVTVS  114 (129)
T ss_dssp             CCCSCEEEEEC
T ss_pred             eecCCEEEEEe
Confidence            46778877764


No 424
>7P78_B SARS-CoV-2 spike protein sybody, VIRAL; HET: BMA, NAG;{Severe acute respiratory syndrome coronavirus 2}
Probab=45.75  E-value=25  Score=13.27  Aligned_cols=10  Identities=40%  Similarity=0.787  Sum_probs=6.4  Template_Neff=13.500

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .++.|+.|+|
T Consensus       104 ~~~~g~~l~v  113 (114)
T 7P78_B          104 YIGQGTQVTV  113 (114)
T ss_pred             eeecCeeeEe
Confidence            4567776665


No 425
>6Z3X_A DesAb-anti-HSA-P1; protein design, artificial antibody, specific; HET: CAC; 1.74A {synthetic construct}
Probab=45.49  E-value=28  Score=13.96  Aligned_cols=11  Identities=36%  Similarity=0.619  Sum_probs=8.7  Template_Neff=13.100

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .||.||.+.|.
T Consensus       118 ~~~~gt~~~~~  128 (137)
T 6Z3X_A          118 YWGQGTLVTVS  128 (137)
T ss_dssp             EECCCEEEEEC
T ss_pred             HhcCceEEEec
Confidence            58999988763


No 426
>6Z3X_B DesAb-anti-HSA-P1; protein design, artificial antibody, specific; HET: CAC; 1.74A {synthetic construct}
Probab=45.49  E-value=28  Score=13.96  Aligned_cols=11  Identities=36%  Similarity=0.619  Sum_probs=8.8  Template_Neff=13.100

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .||.||.+.|.
T Consensus       118 ~~~~gt~~~~~  128 (137)
T 6Z3X_B          118 YWGQGTLVTVS  128 (137)
T ss_dssp             EECCCEEEEEC
T ss_pred             HhcCceEEEec
Confidence            68999988763


No 427
>7CEA_A HUTS-4 VH(S112C)-SARAH, HUTS-4 VL(C87Y)-SARAH(S37C); Antibody fragment, Fv-clasp, Integrin, IMMUNE; 2.55A {Mus musculus}
Probab=45.38  E-value=24  Score=14.53  Aligned_cols=12  Identities=42%  Similarity=0.653  Sum_probs=9.2  Template_Neff=13.400

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|+.+.|.
T Consensus       111 ~~~~~~~~l~v~  122 (174)
T 7CEA_A          111 DVWGAGTTVTVC  122 (174)
T ss_dssp             EEECCCEECEEC
T ss_pred             eeecccEEEEEE
Confidence            458899988774


No 428
>7K93_E Non-structural protein 1, 2B7 Fab; Flavivirus NS1, Antibody, Fab fragment; HET: NAG; 2.89A {Dengue virus 2}
Probab=45.00  E-value=48  Score=14.10  Aligned_cols=12  Identities=42%  Similarity=0.910  Sum_probs=9.3  Template_Neff=14.000

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...|+.+++|.|
T Consensus       239 ~~~~~~~~~l~v  250 (251)
T 7K93_E          239 PLTFGAGTKLEL  250 (251)
T ss_dssp             SCEECCCEEEEE
T ss_pred             CeeeCCCceEEe
Confidence            357888888876


No 429
>7K93_I Non-structural protein 1, 2B7 Fab; Flavivirus NS1, Antibody, Fab fragment; HET: NAG; 2.89A {Dengue virus 2}
Probab=45.00  E-value=48  Score=14.10  Aligned_cols=12  Identities=42%  Similarity=0.910  Sum_probs=9.3  Template_Neff=14.000

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...|+.+++|.|
T Consensus       239 ~~~~~~~~~l~v  250 (251)
T 7K93_I          239 PLTFGAGTKLEL  250 (251)
T ss_dssp             SCEECCCEEEEE
T ss_pred             CeeeCCCceEEe
Confidence            357888888876


No 430
>6OL6_H ib2 Heavy Chain, ib2 Light; glb12, Antibody, ib2, Fab, complex; 2.6A {Mus musculus}
Probab=44.70  E-value=22  Score=13.30  Aligned_cols=13  Identities=38%  Similarity=0.508  Sum_probs=9.9  Template_Neff=14.300

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.|+.|.|.
T Consensus       116 ~~~~~~~~~l~v~  128 (139)
T 6OL6_H          116 MDVWGKGTTVTVS  128 (139)
T ss_dssp             CCEECCCEEEEEC
T ss_pred             eeeeeceEEEEec
Confidence            4578999988774


No 431
>6VEP_I Insulin A chain, Insulin B; HORMONE, HORMONE RECEPTOR-HORMONE-IMMUNE SYSTEM complex; HET: BMA, FUC, NAG, MAN; 2.9A {Homo sapiens}
Probab=44.03  E-value=40  Score=12.86  Aligned_cols=13  Identities=31%  Similarity=0.404  Sum_probs=10.0  Template_Neff=13.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.++.+.|.
T Consensus       105 ~~~~~~~~~l~v~  117 (138)
T 6VEP_I          105 MDYWGQGTSVTVS  117 (138)
T ss_dssp             SCSBCCCCEEEEC
T ss_pred             cceecCCeEEEEe
Confidence            4578999988774


No 432
>6VEP_O Insulin A chain, Insulin B; HORMONE, HORMONE RECEPTOR-HORMONE-IMMUNE SYSTEM complex; HET: BMA, FUC, NAG, MAN; 2.9A {Homo sapiens}
Probab=44.03  E-value=40  Score=12.86  Aligned_cols=13  Identities=31%  Similarity=0.404  Sum_probs=9.9  Template_Neff=13.900

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.++.+.|.
T Consensus       105 ~~~~~~~~~l~v~  117 (138)
T 6VEP_O          105 MDYWGQGTSVTVS  117 (138)
T ss_dssp             SCCBCCCCEEEES
T ss_pred             cceecCCeEEEEe
Confidence            4578999988774


No 433
>5OVW_K Vitamin B12-binding protein, Nanobody; Nanobody, Inhibitor, vitamin B12, substrate-binding; HET: GOL; 2.653A {Escherichia coli}
Probab=43.85  E-value=34  Score=14.24  Aligned_cols=11  Identities=36%  Similarity=0.727  Sum_probs=6.9  Template_Neff=12.900

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      -+||+|+.+.|
T Consensus       137 ~~~~~g~~~~~  147 (159)
T 5OVW_K          137 VSWGQGTPVTV  147 (159)
T ss_dssp             CEECBCEEECB
T ss_pred             eecCCCceeEe
Confidence            35777776544


No 434
>6C5W_C calcium uniporter, nanobody; MEMBRANE PROTEIN; 3.10010233314A {Metarhizium acridum (strain CQMa 102)}
Probab=43.30  E-value=35  Score=11.95  Aligned_cols=11  Identities=36%  Similarity=0.727  Sum_probs=7.8  Template_Neff=14.700

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.|+.+.|
T Consensus       105 ~~~~~~~~l~v  115 (117)
T 6C5W_C          105 TYWGQGTQVTV  115 (117)
T ss_dssp             EEECCCEEEEE
T ss_pred             EEEecCceEEe
Confidence            35778887776


No 435
>4LCI_H anti canine CD28 antibody, 1C6; Immunoglobulin, antibody, CD28, IMMUNE SYSTEM; HET: GOL, FMT; 1.9A {Mus musculus}
Probab=43.27  E-value=35  Score=12.83  Aligned_cols=10  Identities=50%  Similarity=0.929  Sum_probs=6.7  Template_Neff=13.700

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      +||.|+.+.+
T Consensus       103 ~~g~g~~~~~  112 (120)
T 4LCI_H          103 FWGQGTTLTV  112 (120)
T ss_dssp             EECCCEEEEE
T ss_pred             eecCCcEEEe
Confidence            5777876654


No 436
>7E6U_B G-protein-coupled receptor (GPCR)  Calcium-sensing;{Homo sapiens}
Probab=42.82  E-value=33  Score=13.27  Aligned_cols=13  Identities=31%  Similarity=0.503  Sum_probs=9.7  Template_Neff=13.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...||.||++.|.
T Consensus       111 ~~~~~~~t~l~v~  123 (143)
T 7E6U_B          111 YNYWGQGTQVTVS  123 (143)
T ss_dssp             CSEECCCCEECCC
T ss_pred             ceEeeCCeEEEEe
Confidence            3578889988764


No 437
>7CWS_G Heavy Chain of FC05 Fab; VIRAL PROTEIN; HET: NAG; 3.4A {Homo sapiens}
Probab=42.80  E-value=35  Score=11.82  Aligned_cols=10  Identities=40%  Similarity=0.816  Sum_probs=6.6  Template_Neff=15.000

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .++.++++.|
T Consensus       108 ~~~~~~~l~v  117 (122)
T 7CWS_G          108 YWGQGTTVTV  117 (122)
T ss_pred             ccccceEEEE
Confidence            5667777665


No 438
>3ESU_F single-chain FV, monoclonal antibody, immunoglobulin; 1.3A {Mus musculus}
Probab=42.77  E-value=29  Score=14.92  Aligned_cols=13  Identities=31%  Similarity=0.404  Sum_probs=10.1  Template_Neff=13.800

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      +..|+.+++|.|-
T Consensus       237 ~~~~~~~~~l~V~  249 (250)
T 3ESU_F          237 MDYWGQGTSVTVS  249 (250)
T ss_dssp             CCEECCCEEEEEC
T ss_pred             EeeecCceEEEEe
Confidence            3478999999874


No 439
>7LK4_G swap dimer, antibody fragments, APOPTOSIS; HET: MPD; 3.1A {Homo sapiens}
Probab=42.29  E-value=36  Score=11.81  Aligned_cols=11  Identities=45%  Similarity=1.063  Sum_probs=6.9  Template_Neff=14.600

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.|+.++++.|
T Consensus        98 ~~~~~~~~l~v  108 (109)
T 7LK4_G           98 LTFGSGTKLEI  108 (109)
T ss_dssp             CEECCCEEEEE
T ss_pred             ceecCCceeEE
Confidence            45667776654


No 440
>7JTR_B Maltose/maltodextrin-binding periplasmic protein, single-chain Fv; Maltose, antibody, scFv, complex, SUGAR; HET: GLC; 2.5A {Escherichia coli}
Probab=42.21  E-value=35  Score=15.18  Aligned_cols=13  Identities=38%  Similarity=0.851  Sum_probs=10.1  Template_Neff=13.200

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||.||++.++
T Consensus       231 ~~~~~~gt~~~~~  243 (251)
T 7JTR_B          231 PYTFGGGTKLEIK  243 (251)
T ss_dssp             TCCBCCCEEEEEC
T ss_pred             CEEeCCCeeEEEe
Confidence            4688999988764


No 441
>7JTR_F Maltose/maltodextrin-binding periplasmic protein, single-chain Fv; Maltose, antibody, scFv, complex, SUGAR; HET: GLC; 2.5A {Escherichia coli}
Probab=42.21  E-value=35  Score=15.18  Aligned_cols=13  Identities=38%  Similarity=0.851  Sum_probs=9.9  Template_Neff=13.200

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ..+||.||++.++
T Consensus       231 ~~~~~~gt~~~~~  243 (251)
T 7JTR_F          231 PYTFGGGTKLEIK  243 (251)
T ss_dssp             TCCBCCCEEEEEE
T ss_pred             CEEeCCCeeEEEe
Confidence            4688999988663


No 442
>6E0P_N Histone H3-like centromeric protein A; CENP-A, Centromere, Native alpha satellite; 2.6A {Homo sapiens}
Probab=42.15  E-value=32  Score=15.61  Aligned_cols=12  Identities=42%  Similarity=1.002  Sum_probs=10.0  Template_Neff=13.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.+|+|.|-
T Consensus       252 ~~~~~~t~l~v~  263 (265)
T 6E0P_N          252 YTFGSGTKLEIK  263 (265)
T ss_dssp             CEECCCCEEEEC
T ss_pred             EEeCCCcEEEEe
Confidence            578999999885


No 443
>2VYR_H MDM4 PROTEIN, HUMAN SINGLE DOMAIN; NUCLEUS, HUMAN MDM4, IMMUNE SYSTEM; HET: SO4; 2.0A {HOMO SAPIENS}
Probab=42.13  E-value=34  Score=13.84  Aligned_cols=12  Identities=33%  Similarity=0.443  Sum_probs=9.4  Template_Neff=13.300

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||.+.|.
T Consensus       112 ~~~~~~t~l~v~  123 (153)
T 2VYR_H          112 DYWGQGTLVTVS  123 (153)
T ss_dssp             CEECSCEEEEEC
T ss_pred             eEecCCeEEEEe
Confidence            478999988774


No 444
>2VYR_L MDM4 PROTEIN, HUMAN SINGLE DOMAIN; NUCLEUS, HUMAN MDM4, IMMUNE SYSTEM; HET: SO4; 2.0A {HOMO SAPIENS}
Probab=42.13  E-value=34  Score=13.84  Aligned_cols=12  Identities=33%  Similarity=0.443  Sum_probs=9.2  Template_Neff=13.300

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..||.||.+.|.
T Consensus       112 ~~~~~~t~l~v~  123 (153)
T 2VYR_L          112 DYWGQGTLVTVS  123 (153)
T ss_dssp             EEECCCEEEEEC
T ss_pred             eEecCCeEEEEe
Confidence            378889988764


No 445
>6A3W_G utomilumab VH, utomilumab VL, Tumor; complex structure, 4-1BB, angonist monoclonal; HET: NAG; 2.0A {Homo sapiens}
Probab=42.06  E-value=34  Score=11.71  Aligned_cols=12  Identities=33%  Similarity=0.443  Sum_probs=8.1  Template_Neff=15.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.+++|.|.
T Consensus       104 ~~~~~~~~l~v~  115 (116)
T 6A3W_G          104 DYWGQGTLVTVS  115 (116)
T ss_dssp             CEECCCEEEEEC
T ss_pred             eeeecceEEEEe
Confidence            356778877764


No 446
>6H3T_H scFv 1C11 VH, scFv 1C11; Envelope Glycoprotein, scFv Antibody, VIRAL; HET: BMA, FUC, NAG, MAN; 2.836A {Mus musculus}
Probab=42.00  E-value=37  Score=12.82  Aligned_cols=12  Identities=33%  Similarity=0.498  Sum_probs=8.2  Template_Neff=14.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.++++.|.
T Consensus       108 ~~~~~~~~l~v~  119 (140)
T 6H3T_H          108 DYWGQGTSVTVS  119 (140)
T ss_dssp             EEECCCEEEECT
T ss_pred             eEeCCCeEEEEe
Confidence            467777777664


No 447
>7A48_A coiled-coil, nanobody, antibody, protein design; 1.547A {Lama glama}
Probab=41.86  E-value=39  Score=12.08  Aligned_cols=12  Identities=33%  Similarity=0.584  Sum_probs=8.5  Template_Neff=14.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..++.++.+.|.
T Consensus       106 ~~~~~~~~l~v~  117 (133)
T 7A48_A          106 NYWGQGTQVTVS  117 (133)
T ss_dssp             CEECCCEEEEEC
T ss_pred             EEecCCceeEEe
Confidence            456788887764


No 448
>1UAC_H ANTIGEN-ANTIBODY COMPLEX, HYHEL-10, MUTANT, ANTI-LYSOZYME; 1.7A {Meleagris gallopavo} SCOP: b.1.1.1
Probab=41.76  E-value=36  Score=12.17  Aligned_cols=11  Identities=36%  Similarity=0.619  Sum_probs=7.7  Template_Neff=14.300

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .|+.|+.+.|.
T Consensus       102 ~~~~~~~~~v~  112 (114)
T 1UAC_H          102 YWGQGTLVTVS  112 (114)
T ss_dssp             CBCCCEEEEES
T ss_pred             eecCCeEEEEe
Confidence            56777777764


No 449
>6AD0_H VL of Fab 2G8, VH; CVA10, immune complex, neutralizing antibody; HET: SPH; 3.9A {Mus musculus}
Probab=41.75  E-value=21  Score=12.40  Aligned_cols=6  Identities=50%  Similarity=1.143  Sum_probs=4.2  Template_Neff=14.800

Q ss_pred             ccCCCC
Q tr|A0A075B6V7|    9 VFGPGT   14 (20)
Q Consensus         9 vfgpgt   14 (20)
                      +||.||
T Consensus       110 ~~g~gt  115 (115)
T 6AD0_H          110 VWGAGP  115 (115)
T ss_dssp             SBCCCC
T ss_pred             eeecCC
Confidence            677775


No 450
>6A78_I Roundabout homolog 1, Light chain; hepatocellular carcinoma antigen, angiogenesis, immune; HET: SO4; 2.1A {Homo sapiens}
Probab=41.75  E-value=41  Score=12.35  Aligned_cols=13  Identities=31%  Similarity=0.383  Sum_probs=9.2  Template_Neff=14.500

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...++.++.+.|.
T Consensus       109 ~~~~~~~~~l~v~  121 (138)
T 6A78_I          109 LDYWGQGTSVTVS  121 (138)
T ss_dssp             EEEECCCEEEEEC
T ss_pred             eeeecCCceEEEE
Confidence            4467888888764


No 451
>1EEQ_B Human Kappa-4 Immunoglobulin Light chain; 1.5A {Homo sapiens} SCOP: b.1.1.1
Probab=41.43  E-value=36  Score=12.25  Aligned_cols=11  Identities=45%  Similarity=1.108  Sum_probs=7.4  Template_Neff=14.200

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.|+.++++.|
T Consensus       102 ~~~~~~~~l~v  112 (114)
T 1EEQ_B          102 YSFGQGTKLEI  112 (114)
T ss_dssp             CEECCCEEEEE
T ss_pred             eEECCceEeEE
Confidence            45677777765


No 452
>6NNF_U Envelope glycoprotein gp41, 35O22 scFv; HIV-1 Envelope Prefusion Trimer, CD4-binding; HET: BMA, NAG, MAN; 2.762A {Human immunodeficiency virus 1}
Probab=40.95  E-value=37  Score=14.48  Aligned_cols=11  Identities=36%  Similarity=0.456  Sum_probs=8.5  Template_Neff=12.100

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..||.||++.|
T Consensus       116 ~~~~~gt~l~v  126 (142)
T 6NNF_U          116 EHWGRGTPVIV  126 (142)
T ss_dssp             EEECCCEEEEC
T ss_pred             eEEcCCceEEE
Confidence            46888988876


No 453
>6J7W_B UniAb, Tumor necrosis factor receptor; Heavy chain antibodies, VH domains; 2.6A {Homo sapiens}
Probab=40.68  E-value=37  Score=11.57  Aligned_cols=10  Identities=40%  Similarity=0.494  Sum_probs=5.9  Template_Neff=15.100

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .|+.++++.|
T Consensus       108 ~~~~~~~l~v  117 (118)
T 6J7W_B          108 HRGQGTLVTV  117 (118)
T ss_pred             cccCCeEEEe
Confidence            3466666654


No 454
>6NM6_D Envelope glycoprotein gp41, 35O22 scFv; HIV-1 Envelope Prefusion Trimer, CD4-binding; HET: BMA, NAG, MAN; 2.739A {Human immunodeficiency virus 1}
Probab=40.67  E-value=38  Score=14.16  Aligned_cols=12  Identities=42%  Similarity=0.883  Sum_probs=8.9  Template_Neff=12.700

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...|+.||+|.|
T Consensus       118 ~~~~~~~t~l~v  129 (153)
T 6NM6_D          118 PYLWGQGTLLTV  129 (153)
T ss_pred             ceeecCceEEEE
Confidence            357888888866


No 455
>6NNJ_D Envelope glycoprotein gp41, 35O22 scFv; HIV-1 Envelope Prefusion Trimer, CD4-binding; HET: BMA, NAG, MAN; 2.6A {Human immunodeficiency virus 1}
Probab=40.67  E-value=38  Score=14.16  Aligned_cols=12  Identities=42%  Similarity=0.883  Sum_probs=8.9  Template_Neff=12.700

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...|+.||+|.|
T Consensus       118 ~~~~~~~t~l~v  129 (153)
T 6NNJ_D          118 PYLWGQGTLLTV  129 (153)
T ss_pred             ceeecCceEEEE
Confidence            357888888866


No 456
>7O85_B Anthrax, PA, neutralizing, Fab, TOXIN; HET: CA; 3.3A {Bacillus anthracis}
Probab=40.44  E-value=26  Score=12.05  Aligned_cols=8  Identities=50%  Similarity=1.140  Sum_probs=4.2  Template_Neff=14.600

Q ss_pred             cccCCCCe
Q tr|A0A075B6V7|    8 FVFGPGTR   15 (20)
Q Consensus         8 fvfgpgtr   15 (20)
                      .+||.||+
T Consensus        96 ~~~~~gt~  103 (104)
T 7O85_B           96 WTFGGGTK  103 (104)
T ss_dssp             CBCCCEEC
T ss_pred             ceeCCcee
Confidence            45555554


No 457
>5FOJ_A VIRUS, NANOBODY, COMPLEX; 2.8A {Grapevine fanleaf virus}
Probab=39.86  E-value=41  Score=13.45  Aligned_cols=9  Identities=33%  Similarity=0.844  Sum_probs=5.2  Template_Neff=13.100

Q ss_pred             ccCCCCeee
Q tr|A0A075B6V7|    9 VFGPGTRLS   17 (20)
Q Consensus         9 vfgpgtrls   17 (20)
                      +||+|+.+-
T Consensus       120 ~~~~g~~~~  128 (137)
T 5FOJ_A          120 YWGQGTQVT  128 (137)
T ss_dssp             EECCCCBCC
T ss_pred             eccCCeeEE
Confidence            566666543


No 458
>2GWR_A DNA-binding response regulator mtrA; Two-component regulatory system, Transcription regulation; HET: GOL, MSE; 2.1A {Mycobacterium tuberculosis}
Probab=39.50  E-value=24  Score=15.63  Aligned_cols=14  Identities=36%  Similarity=0.418  Sum_probs=7.5  Template_Neff=13.100

Q ss_pred             CCCCcccCCCCeee
Q tr|A0A075B6V7|    4 YGQNFVFGPGTRLS   17 (20)
Q Consensus         4 ygqnfvfgpgtrls   17 (20)
                      +|..+.|.|+||.|
T Consensus       219 ~~~gy~~~~~~~~~  232 (238)
T 2GWR_A          219 RGVGYKAGPPTSGS  232 (238)
T ss_dssp             TTTEEEECCC----
T ss_pred             CCceeEecCCCCCC
Confidence            45667888888876


No 459
>2HP4_B CD8, Co-receptor, Soluble protein, KD; HET: SO4, GOL; 2.1A {Homo sapiens}
Probab=39.34  E-value=40  Score=11.56  Aligned_cols=11  Identities=9%  Similarity=0.048  Sum_probs=5.9  Template_Neff=14.900

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.|+.++.+.+
T Consensus       102 ~~~~~~~~~~~  112 (114)
T 2HP4_B          102 MYFSHFVPVFL  112 (114)
T ss_dssp             EEECCCEEECC
T ss_pred             eEecCCeeEEe
Confidence            34566665543


No 460
>3QZW_G HLA class I histocompatibility antigen; Immunoglobulin family, IMMUNE SYSTEM, coreceptor; 2.798A {Homo sapiens}
Probab=39.12  E-value=40  Score=11.63  Aligned_cols=11  Identities=9%  Similarity=0.048  Sum_probs=6.0  Template_Neff=14.800

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|+.++++.+
T Consensus       102 ~~~~~~~~~~~  112 (114)
T 3QZW_G          102 MYFSHFVPVFL  112 (114)
T ss_dssp             EEECCCEEECC
T ss_pred             EEEcCCeeEEe
Confidence            34566665543


No 461
>3KG5_A B-cell antigen receptor complex-associated protein; CD79b, Ig-beta, BCR, Immunoglobulin domain; 3.2A {Homo sapiens}
Probab=39.05  E-value=52  Score=12.77  Aligned_cols=11  Identities=45%  Similarity=0.504  Sum_probs=8.2  Template_Neff=13.500

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.|+.+++|.|
T Consensus       107 ~~~~~~~~l~v  117 (134)
T 3KG5_A          107 VYQGCGTELRV  117 (134)
T ss_dssp             EEECCCEEEEE
T ss_pred             eeeccCcEEEE
Confidence            46788888865


No 462
>6KR0_A Diabody, IMMUNE SYSTEM; 2.3A {Homo sapiens}
Probab=38.94  E-value=64  Score=15.35  Aligned_cols=14  Identities=29%  Similarity=0.812  Sum_probs=10.1  Template_Neff=12.400

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      +.+.|+.+|+|.|.
T Consensus       248 ~~~~~~~~~~l~v~  261 (290)
T 6KR0_A          248 EPYTFGQGTKVEIK  261 (290)
T ss_dssp             TTCCBCCCEEEEC-
T ss_pred             CCEEeCCCeEEEEc
Confidence            34678999988774


No 463
>6KR0_C Diabody, IMMUNE SYSTEM; 2.3A {Homo sapiens}
Probab=38.94  E-value=64  Score=15.35  Aligned_cols=14  Identities=29%  Similarity=0.812  Sum_probs=10.8  Template_Neff=12.400

Q ss_pred             CCcccCCCCeeeeC
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSVL   19 (20)
Q Consensus         6 qnfvfgpgtrlsvl   19 (20)
                      +.+.|+.+|+|.|.
T Consensus       248 ~~~~~~~~~~l~v~  261 (290)
T 6KR0_C          248 EPYTFGQGTKVEIK  261 (290)
T ss_dssp             TTCCBCCCEEEEEC
T ss_pred             CCEEeCCCeEEEEc
Confidence            34678999998875


No 464
>4XVJ_H HCV E2 antigen, antibody heavy; Antibody-antigen complex, IMMUNE SYSTEM; 2.0A {Homo sapiens}
Probab=38.82  E-value=49  Score=12.42  Aligned_cols=12  Identities=33%  Similarity=0.443  Sum_probs=8.5  Template_Neff=14.200

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.++++.|.
T Consensus       116 ~~~~~~~~l~v~  127 (141)
T 4XVJ_H          116 DYWGQGTLVTVS  127 (141)
T ss_dssp             EEECCCEEEEEC
T ss_pred             ccccCCcEEEEE
Confidence            457788888764


No 465
>7RG7_A IMMUNE SYSTEM; HET: MTX; 1.83A {Nanoa}
Probab=38.77  E-value=49  Score=15.94  Aligned_cols=13  Identities=31%  Similarity=0.480  Sum_probs=9.8  Template_Neff=12.300

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...+|.||.++|.
T Consensus       293 ~~~~~~gt~~~v~  305 (306)
T 7RG7_A          293 PDYWGQGTQVTVS  305 (306)
T ss_dssp             CSEECCCEEEEEE
T ss_pred             CCcccCCeEEEec
Confidence            3468899988874


No 466
>4QO1_A Nb139  Nanobody against the; Immunoglobulin fold, DNA binding, Apoptosis; 1.924A {Lama glama}
Probab=38.70  E-value=44  Score=13.66  Aligned_cols=13  Identities=31%  Similarity=0.470  Sum_probs=9.3  Template_Neff=13.100

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      ...|+.||++.|.
T Consensus       111 ~~~~~~~t~l~v~  123 (154)
T 4QO1_A          111 WTYWGQGTQVTVS  123 (154)
T ss_dssp             EEEECCCEEEEEE
T ss_pred             eEEecCCcEEEEe
Confidence            3578888888763


No 467
>5WTS_A Green fluorescent protein linked PMI; FLUORESCENT PROTEIN-INHIBITOR complex; HET: PG4, CRO, GOL, PO4; 3.004A {Aequorea victoria}
Probab=38.68  E-value=35  Score=18.88  Aligned_cols=11  Identities=36%  Similarity=0.730  Sum_probs=9.4  Template_Neff=9.800

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .||+||++.|-
T Consensus       342 ~~g~g~~~~~~  352 (358)
T 5WTS_A          342 YWGQGTQVTVS  352 (358)
T ss_dssp             EECCCCEEEEC
T ss_pred             EEcCCeEEEec
Confidence            89999999873


No 468
>5DXW_A PD-L1 nanobody; IG FOLD, SIGNALING PROTEIN; HET: SO4; 1.441A {Camelidae}
Probab=38.62  E-value=48  Score=12.24  Aligned_cols=11  Identities=36%  Similarity=0.733  Sum_probs=7.1  Template_Neff=14.200

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .|+.|+++.|.
T Consensus       105 ~~~~~~~l~v~  115 (130)
T 5DXW_A          105 SWGQGTQVTVS  115 (130)
T ss_dssp             EECCCEEEEEC
T ss_pred             eecCceEEEEe
Confidence            36777777663


No 469
>3UPC_H heavy chain variable domain; immunoglobulin fold, IMMUNE SYSTEM; HET: PGE, PG4, 1PE; 2.8A {Homo sapiens}
Probab=38.61  E-value=45  Score=11.96  Aligned_cols=10  Identities=40%  Similarity=0.750  Sum_probs=6.9  Template_Neff=14.200

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .|+.|+.+.|
T Consensus       103 ~~~~~~~l~v  112 (113)
T 3UPC_H          103 YWGQGTLVTV  112 (113)
T ss_dssp             TTTCCEEEEE
T ss_pred             eecCCeEEEe
Confidence            4677777765


No 470
>6S3Y_J PlyP35; HYDROLASE; HET: MSE; 2.043A {Listeria phage P35}
Probab=38.36  E-value=45  Score=17.80  Aligned_cols=18  Identities=22%  Similarity=0.180  Sum_probs=14.6  Template_Neff=7.200

Q ss_pred             CCCCCcccCCCCeeeeCC
Q tr|A0A075B6V7|    3 NYGQNFVFGPGTRLSVLP   20 (20)
Q Consensus         3 nygqnfvfgpgtrlsvlp   20 (20)
                      +-|+.|.+-||+.+++++
T Consensus        95 ~~g~~~~~k~g~k~~~~~  112 (140)
T 6S3Y_J           95 NGGDFINLKRGFKGITHP  112 (140)
T ss_dssp             SSSSEEEEETTCEEEECC
T ss_pred             CCCceEEEcCCeeEEEec
Confidence            557788889999998875


No 471
>6S4S_J PlyP35; ----, HYDROLASE; HET: MLI; 2.15A {Listeria phage P35}
Probab=38.36  E-value=45  Score=17.80  Aligned_cols=18  Identities=22%  Similarity=0.180  Sum_probs=14.6  Template_Neff=7.200

Q ss_pred             CCCCCcccCCCCeeeeCC
Q tr|A0A075B6V7|    3 NYGQNFVFGPGTRLSVLP   20 (20)
Q Consensus         3 nygqnfvfgpgtrlsvlp   20 (20)
                      +-|+.|.+-||+.+++++
T Consensus        95 ~~g~~~~~k~g~k~~~~~  112 (140)
T 6S4S_J           95 NGGDFINLKRGFKGITHP  112 (140)
T ss_dssp             SSSSEEEEETTCEEEECC
T ss_pred             CCCceEEEcCCeeEEEec
Confidence            557788889999998875


No 472
>6J5D_L Envelope, antibody heavy chain, antibody; protective and neutralizing antibody, flavivirus; 1.8A {Louping ill virus}
Probab=38.25  E-value=43  Score=11.53  Aligned_cols=12  Identities=42%  Similarity=0.905  Sum_probs=8.5  Template_Neff=14.700

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.++++.|-
T Consensus        97 ~~~~~~~~l~v~  108 (109)
T 6J5D_L           97 WTFGGGTKLEIK  108 (109)
T ss_dssp             CCBCCCEEEEEC
T ss_pred             ccccCceEEEEe
Confidence            467788888764


No 473
>4F9L_C Butyrophilin subfamily 3 member A1; B7 superfamily, Butyrophilin, CD277, IMMUNE; HET: NAG; 3.1404A {Homo sapiens}
Probab=38.06  E-value=39  Score=14.55  Aligned_cols=12  Identities=33%  Similarity=0.487  Sum_probs=9.4  Template_Neff=13.900

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+|+.+++|.|.
T Consensus       241 ~~~~~~~~l~V~  252 (259)
T 4F9L_C          241 DYWGQGTAVTVS  252 (259)
T ss_dssp             ESCCCCEEEEES
T ss_pred             eEeccCeeeEEe
Confidence            458889998876


No 474
>4NFD_A Paired immunoglobulin-like type 2 receptor; IgV-like, immune-related activation receptor, CD99; HET: SIA; 1.708A {Homo sapiens}
Probab=37.96  E-value=39  Score=11.95  Aligned_cols=10  Identities=30%  Similarity=0.368  Sum_probs=6.4  Template_Neff=14.600

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .+++++.+.|
T Consensus       110 ~~~~~~~l~v  119 (120)
T 4NFD_A          110 QSIKGTKLTI  119 (120)
T ss_dssp             ECSSCEEEEE
T ss_pred             eeecceEEEE
Confidence            4667776665


No 475
>4I13_B Dihydrofolate reductase (E.C.1.5.1.3), Protein ca1697; alpha/beta fold, immunoglobulin fold, reductase; HET: FOL; 1.6A {Escherichia coli}
Probab=37.95  E-value=39  Score=12.96  Aligned_cols=11  Identities=18%  Similarity=0.268  Sum_probs=5.3  Template_Neff=13.700

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..|++++.|.|
T Consensus       106 ~~~~~~~~l~v  116 (133)
T 4I13_B          106 WNTIPYNKLTL  116 (133)
T ss_dssp             TTTSCGGGCCE
T ss_pred             cccCCCceeEE
Confidence            34555555443


No 476
>3UZQ_A anti-dengue Mab 4E11, envelope protein; dengue antibody neutralization, IMMUNE SYSTEM; HET: MES, EDO; 1.6A {Mus musculus}
Probab=37.52  E-value=56  Score=14.32  Aligned_cols=12  Identities=42%  Similarity=0.905  Sum_probs=9.9  Template_Neff=13.500

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.+|+|.|.
T Consensus       232 ~~~~~~t~l~v~  243 (253)
T 3UZQ_A          232 WTFGGGTKLEIK  243 (253)
T ss_dssp             CCBCCCEEEEEC
T ss_pred             EEecCceeEEEC
Confidence            578999999885


No 477
>6HUD_B Monoclonal immunoglobulin light chains (LC); immunoglobulin light chains  amyloid; 4.0A {Homo sapiens}
Probab=37.43  E-value=43  Score=12.90  Aligned_cols=11  Identities=64%  Similarity=1.201  Sum_probs=3.3  Template_Neff=13.700

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..||.|+.+.|
T Consensus       100 ~~~~~~~~l~v  110 (136)
T 6HUD_B          100 WVFGGGTKLTV  110 (136)
T ss_dssp             SCEEEC-----
T ss_pred             EEEcCceEEEE
Confidence            34566666654


No 478
>5GRV_L homo-specific diabody heavy chain, homo-specific; diabody, antibody fragment, IMMUNE SYSTEM; 2.3A {Homo sapiens}
Probab=36.90  E-value=46  Score=11.53  Aligned_cols=12  Identities=42%  Similarity=0.567  Sum_probs=8.6  Template_Neff=15.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.++.+.|.
T Consensus       107 ~~~~~~~~l~v~  118 (124)
T 5GRV_L          107 DVWGQGTLVTVS  118 (124)
T ss_dssp             EEECCCEEEEEC
T ss_pred             eEEccceEEEEe
Confidence            457788888764


No 479
>4LLQ_B Putative uncharacterized protein DKFZp686G11190, IGL@; IgG domain redesign, IMMUNE SYSTEM; HET: PG6; 1.42A {Homo sapiens}
Probab=36.86  E-value=33  Score=14.54  Aligned_cols=12  Identities=0%  Similarity=0.119  Sum_probs=0.0  Template_Neff=12.400

Q ss_pred             CCcccCCCCeeee
Q tr|A0A075B6V7|    6 QNFVFGPGTRLSV   18 (20)
Q Consensus         6 qnfvfgpgtrlsv   18 (20)
                      ...+||.||+ .|
T Consensus        10 ~~~~~g~gt~-~v   21 (151)
T 4LLQ_B           10 AGLLLLAAQP-AM   21 (151)
T ss_dssp             -------------
T ss_pred             heeeecCccc-ee
Confidence            3456788887 55


No 480
>2COQ_A new antigen receptor variable domain; IG VNAR, NATURAL TYPE2, 12A-9; 2.1A {Orectolobus maculatus}
Probab=36.81  E-value=47  Score=11.62  Aligned_cols=11  Identities=45%  Similarity=0.679  Sum_probs=7.7  Template_Neff=14.400

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..+++++.|.|
T Consensus        97 ~~~~~~~~l~v  107 (108)
T 2COQ_A           97 YKEGAGTVLTV  107 (108)
T ss_dssp             CEECCCEEEEE
T ss_pred             eecccceEEEe
Confidence            35778887765


No 481
>6LCS_A AGE, antibody fragment, fv-clasp, IMMUNE; HET: E9R, PO4; 2.6A {Mus musculus}
Probab=36.65  E-value=45  Score=13.58  Aligned_cols=12  Identities=33%  Similarity=0.515  Sum_probs=8.7  Template_Neff=13.500

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|+.+.|.
T Consensus       108 ~~~~~~~~l~v~  119 (171)
T 6LCS_A          108 DYWGQGTTVTVC  119 (171)
T ss_dssp             EEECCCEEEEEC
T ss_pred             eeeccCcEEEEE
Confidence            457888888774


No 482
>4L1H_A Ig kappa chain V-I region; immunoglobulin kappa-chains, recombinant, IMMUNE SYSTEM; 1.68A {Homo sapiens}
Probab=36.53  E-value=46  Score=11.55  Aligned_cols=11  Identities=45%  Similarity=1.138  Sum_probs=6.6  Template_Neff=14.500

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      ..++.++.+.|
T Consensus        96 ~~~~~~~~~~v  106 (107)
T 4L1H_A           96 YTFGQGTKLEI  106 (107)
T ss_dssp             CEECCCEEEEE
T ss_pred             eEecCCeEeEe
Confidence            34666766654


No 483
>3E5P_C alr, alanine racemase, plp, scp; HET: PPI, 2PE, EPE, PLP; 2.5A {Enterococcus faecalis}
Probab=36.53  E-value=49  Score=18.36  Aligned_cols=17  Identities=24%  Similarity=0.638  Sum_probs=10.6  Template_Neff=9.900

Q ss_pred             CCCCcccCCCCeeeeCC
Q tr|A0A075B6V7|    4 YGQNFVFGPGTRLSVLP   20 (20)
Q Consensus         4 ygqnfvfgpgtrlsvlp   20 (20)
                      ||+.+...+++++.++|
T Consensus       267 yg~~~~~~~~~~~a~~~  283 (371)
T 3E5P_C          267 YGETYVTEAEEWIGTVP  283 (371)
T ss_dssp             GGGCEECSSSEEEEEES
T ss_pred             cCCceeCCCCeEEEEEe
Confidence            56666666666666543


No 484
>3E6E_A alr, scp, Isomerase, Pyridoxal phosphate; HET: DCS; 2.5A {Enterococcus faecalis}
Probab=36.53  E-value=49  Score=18.36  Aligned_cols=17  Identities=24%  Similarity=0.638  Sum_probs=10.4  Template_Neff=9.900

Q ss_pred             CCCCcccCCCCeeeeCC
Q tr|A0A075B6V7|    4 YGQNFVFGPGTRLSVLP   20 (20)
Q Consensus         4 ygqnfvfgpgtrlsvlp   20 (20)
                      ||+.+...+++++.++|
T Consensus       267 yg~~~~~~~~~~~a~~~  283 (371)
T 3E6E_A          267 YGETYVTEAEEWIGTVP  283 (371)
T ss_dssp             GGGCEECSSSEEEEEES
T ss_pred             cCCceeCCCCeEEEEEe
Confidence            56666666666666543


No 485
>4UT7_H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2; IMMUNE SYSTEM, BROADLY NEUTRALIZING ANTIBODY; 1.7A {HOMO SAPIENS}
Probab=36.52  E-value=54  Score=13.03  Aligned_cols=12  Identities=42%  Similarity=0.623  Sum_probs=8.9  Template_Neff=13.500

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+|+.||.+.|.
T Consensus       121 ~~~~~~~~l~v~  132 (150)
T 4UT7_H          121 DVWGQGTTVTVS  132 (150)
T ss_dssp             EEECCCEEEEEC
T ss_pred             eeecCCeEEEEe
Confidence            467888888774


No 486
>6OQ6_D Toxin B, 5D; Toxin VHH, TOXIN; 2.97A {Clostridioides difficile}
Probab=36.49  E-value=49  Score=12.80  Aligned_cols=12  Identities=42%  Similarity=0.639  Sum_probs=9.1  Template_Neff=14.000

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|+.+.|.
T Consensus       118 ~~~~~~~~l~v~  129 (153)
T 6OQ6_D          118 DVWGRGTQVAVS  129 (153)
T ss_dssp             EEECCCEEEEEC
T ss_pred             eEEcCCeEEEEe
Confidence            368889888774


No 487
>6IW0_H Envelope protein E, Heavy chain; Yellow fever virus, Envelope protein; 3.6A {Yellow fever virus (strain 17D vaccine)}
Probab=36.45  E-value=54  Score=12.31  Aligned_cols=12  Identities=50%  Similarity=0.797  Sum_probs=8.0  Template_Neff=14.300

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.|+.+.|.
T Consensus       112 ~~~~~~~~~~v~  123 (145)
T 6IW0_H          112 DVWGPGTMVTVS  123 (145)
T ss_dssp             CCBCCCEEECSC
T ss_pred             eEeCCCceEEEe
Confidence            457778877653


No 488
>7JLK_L iv1 Heavy Chain, glVRC01 Heavy; iv1, glVRC01, Fab, scFv, HIV-1; HET: NA, CL, PEG, EDO; 1.99A {Mus musculus}
Probab=36.45  E-value=54  Score=12.33  Aligned_cols=13  Identities=38%  Similarity=0.772  Sum_probs=8.8  Template_Neff=13.700

Q ss_pred             CcccCCCCeeeeC
Q tr|A0A075B6V7|    7 NFVFGPGTRLSVL   19 (20)
Q Consensus         7 nfvfgpgtrlsvl   19 (20)
                      .+.|+.++.+.|.
T Consensus        95 ~~~~~~~~~l~v~  107 (122)
T 7JLK_L           95 PLTFGGGTKLEIK  107 (122)
T ss_dssp             SCEECCCEEEEES
T ss_pred             CeEECCCcEEEEe
Confidence            3467778877764


No 489
>3JBE_7 Capsid protein VP1, Capsid protein; poliovirus, nanobodies, VHH, neutralizing antibodies; HET: MYR, PLM; 4.2A {Human poliovirus 1 Mahoney}
Probab=36.38  E-value=60  Score=12.72  Aligned_cols=12  Identities=33%  Similarity=0.603  Sum_probs=8.4  Template_Neff=13.300

Q ss_pred             CcccCCCCeeee
Q tr|A0A075B6V7|    7 NFVFGPGTRLSV   18 (20)
Q Consensus         7 nfvfgpgtrlsv   18 (20)
                      ...||+|+.+.|
T Consensus       113 ~~~~g~g~~~~~  124 (132)
T 3JBE_7          113 YNYWGQGTQVTV  124 (132)
T ss_dssp             CCBCBCCCEEEE
T ss_pred             cccccCCeEEEE
Confidence            346888887654


No 490
>1DLF_H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S); FV FRAGMENT, IMMUNOGLOBULIN; HET: SO4; 1.45A {Mus musculus} SCOP: b.1.1.1
Probab=36.28  E-value=37  Score=11.88  Aligned_cols=11  Identities=36%  Similarity=0.619  Sum_probs=8.2  Template_Neff=14.900

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .++.++++.|.
T Consensus       110 ~~~~~~~l~v~  120 (124)
T 1DLF_H          110 YWGQGTLVTVS  120 (124)
T ss_dssp             CCCCCEEEEEC
T ss_pred             eeeeceEEEee
Confidence            57788888764


No 491
>5GS0_X Toll-like receptor 3, light chain; diabody, antibody fragment, complex, IMMUNE; HET: BMA, NAG, MAN; 3.275A {Homo sapiens}
Probab=36.20  E-value=47  Score=11.44  Aligned_cols=10  Identities=40%  Similarity=0.750  Sum_probs=5.4  Template_Neff=15.000

Q ss_pred             ccCCCCeeee
Q tr|A0A075B6V7|    9 VFGPGTRLSV   18 (20)
Q Consensus         9 vfgpgtrlsv   18 (20)
                      .++.++.+.|
T Consensus       105 ~~~~~~~l~v  114 (121)
T 5GS0_X          105 YWGQGTLVTV  114 (121)
T ss_pred             EEcCCeEEEE
Confidence            4555565554


No 492
>6OSV_H Variable domain of Light Chain; Single chain Fv, ScFv, Antibody; 1.34A {Oryctolagus cuniculus}
Probab=36.10  E-value=48  Score=11.52  Aligned_cols=11  Identities=36%  Similarity=0.745  Sum_probs=6.9  Template_Neff=15.000

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .|+.++++.|.
T Consensus       105 ~~~~~~~l~v~  115 (126)
T 6OSV_H          105 IWGQGTLVTVS  115 (126)
T ss_dssp             EECCCEEEEEC
T ss_pred             EecCCeEEEEe
Confidence            35677777653


No 493
>5WB2_A Envelope protein US28,nanobody 7, CX3CL1; chemokine receptor, engineered proteins, MEMBRANE; HET: MES, YCM, CLR, OLC; 3.5A {Human cytomegalovirus}
Probab=35.98  E-value=47  Score=16.92  Aligned_cols=12  Identities=33%  Similarity=0.545  Sum_probs=10.0  Template_Neff=12.500

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      .+||.||+|.|.
T Consensus       441 ~~~~~~~~l~v~  452 (460)
T 5WB2_A          441 DYWGQGTQVTVS  452 (460)
T ss_dssp             CEEBCCEEEEES
T ss_pred             cccccceEEEEe
Confidence            569999999875


No 494
>6R7T_A anti MAGEB1 nanobody, Melanoma-associated antigen; Melanoma, immune system; 2.682A {Lama glama}
Probab=35.94  E-value=46  Score=11.53  Aligned_cols=11  Identities=36%  Similarity=0.525  Sum_probs=7.5  Template_Neff=15.000

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .|+.++++.|.
T Consensus       109 ~~~~~~~l~v~  119 (123)
T 6R7T_A          109 YRGQGTQVTVS  119 (123)
T ss_dssp             EECCCEEEEEC
T ss_pred             eeecceEEEEE
Confidence            45778877764


No 495
>5YY5_C MERS-CoV RBD, Heavy chain, Light; MERS-CoV, spike glycorptotein, neutralizing antibody; HET: NAG; 2.8A {Middle East respiratory syndrome coronavirus}
Probab=35.88  E-value=30  Score=11.61  Aligned_cols=8  Identities=38%  Similarity=0.733  Sum_probs=4.5  Template_Neff=15.100

Q ss_pred             ccCCCCee
Q tr|A0A075B6V7|    9 VFGPGTRL   16 (20)
Q Consensus         9 vfgpgtrl   16 (20)
                      .||.||++
T Consensus       101 ~~~~gt~~  108 (109)
T 5YY5_C          101 YWGQGTLV  108 (109)
T ss_dssp             CCCBCCEE
T ss_pred             EEcCCeec
Confidence            35666655


No 496
>6PIL_A scFv-M204 antibody; anti-tau-oligomer scFv antibody, IMMUNE SYSTEM; 2.2A {Oryctolagus cuniculus}
Probab=35.82  E-value=49  Score=14.85  Aligned_cols=12  Identities=42%  Similarity=0.670  Sum_probs=9.5  Template_Neff=13.100

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      ..|+.||+|.|-
T Consensus       233 ~~~~~~~~l~V~  244 (257)
T 6PIL_A          233 VSFGGGTEVGVK  244 (257)
T ss_dssp             CEECCCEEEEEE
T ss_pred             EeeCCCeEEEEe
Confidence            578999998763


No 497
>6S4S_K PlyP35; ----, HYDROLASE; HET: MLI; 2.15A {Listeria phage P35}
Probab=35.76  E-value=52  Score=17.52  Aligned_cols=18  Identities=22%  Similarity=0.180  Sum_probs=14.5  Template_Neff=7.200

Q ss_pred             CCCCCcccCCCCeeeeCC
Q tr|A0A075B6V7|    3 NYGQNFVFGPGTRLSVLP   20 (20)
Q Consensus         3 nygqnfvfgpgtrlsvlp   20 (20)
                      +-|+.|.+-||+.+++++
T Consensus        94 ~~g~~~~~k~g~k~~~~~  111 (139)
T 6S4S_K           94 NGGDFINLKRGFKGITHP  111 (139)
T ss_dssp             SSSSEEEEETTCEEEECC
T ss_pred             CCCceEEEcCCeeEEEec
Confidence            557788888999998875


No 498
>5VXK_B single-domain antibody JMK-H2, Invasin IpaD; tip protein, VHH, T3SS, IMMUNE; 2.55A {Vicugna pacos}
Probab=35.67  E-value=55  Score=12.84  Aligned_cols=12  Identities=42%  Similarity=0.706  Sum_probs=8.1  Template_Neff=13.800

Q ss_pred             cccCCCCeeeeC
Q tr|A0A075B6V7|    8 FVFGPGTRLSVL   19 (20)
Q Consensus         8 fvfgpgtrlsvl   19 (20)
                      +.|+.++++.|.
T Consensus       119 ~~~~~~~~l~v~  130 (155)
T 5VXK_B          119 RVWGQGTQVTVS  130 (155)
T ss_pred             eceeeeeEEEec
Confidence            367788877653


No 499
>6UC6_D Botulinum neurotoxin type B (E.C.3.4.24.69); Botulinum neurotoxin (BoNT), VHH, receptor-binding; 2.32005878384A {Clostridium botulinum}
Probab=35.65  E-value=54  Score=13.41  Aligned_cols=11  Identities=36%  Similarity=0.721  Sum_probs=8.5  Template_Neff=13.100

Q ss_pred             ccCCCCeeeeC
Q tr|A0A075B6V7|    9 VFGPGTRLSVL   19 (20)
Q Consensus         9 vfgpgtrlsvl   19 (20)
                      .|+.|+.+.|.
T Consensus       135 ~~~~~~~l~v~  145 (154)
T 6UC6_D          135 SWGQGTQVAVS  145 (154)
T ss_dssp             HHCCCEEEEEC
T ss_pred             eecCCeEEEee
Confidence            56899988774


No 500
>4QY8_B Fv fragment(mAb6D8) heavy chain, Fv; Immunoglobulin fold, IMMUNE SYSTEM, N-TERMINAL; 1.353A {Mus musculus}
Probab=35.45  E-value=49  Score=11.41  Aligned_cols=11  Identities=45%  Similarity=1.096  Sum_probs=7.0  Template_Neff=14.700

Q ss_pred             cccCCCCeeee
Q tr|A0A075B6V7|    8 FVFGPGTRLSV   18 (20)
Q Consensus         8 fvfgpgtrlsv   18 (20)
                      +.++.++++.|
T Consensus       100 ~~~~~~~~~~v  110 (111)
T 4QY8_B          100 YTFGGGTKLEI  110 (111)
T ss_dssp             CEECCCEEEEE
T ss_pred             eeecCCeEEEE
Confidence            45666776665


